{
 "cells": [
  {
   "cell_type": "markdown",
   "metadata": {
    "collapsed": true
   },
   "source": [
    "## Data Exploration"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 1,
   "metadata": {},
   "outputs": [],
   "source": [
    "\n",
    "s3_data =\"s3://aegovan-data/human_output/human_keyinteractions.json\"\n",
    "s3_annotations =\"s3://aegovan-data/input_data_pubtator_annotated.txt\"\n",
    "human_idmapping_dat = \"/Users/aeg/Downloads/HUMAN_9606_idmapping.dat\""
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 2,
   "metadata": {},
   "outputs": [],
   "source": [
    "import boto3\n",
    "\n",
    "def download_single_file(bucket_name_path, local_path):\n",
    "    index = bucket_name_path.find(\"://\")\n",
    "\n",
    "    # remove the s3:// if present\n",
    "    if index > -1:\n",
    "        bucket_name_path = bucket_name_path[index + 3:]\n",
    "\n",
    "    key_start_index = bucket_name_path.find(\"/\")\n",
    "    bucket_name = bucket_name_path\n",
    "    key = \"/\"\n",
    "    if key_start_index > -1:\n",
    "        bucket_name = bucket_name_path[0:key_start_index]\n",
    "        key = bucket_name_path[key_start_index + 1:]\n",
    "        \n",
    "    client = boto3.resource('s3')\n",
    "    client.Bucket(bucket_name).download_file(key, local_path)\n"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 3,
   "metadata": {},
   "outputs": [],
   "source": [
    "data_file=\"input_data.json\"\n",
    "annotations_file=\"input_data_annotations.txt\""
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 4,
   "metadata": {},
   "outputs": [],
   "source": [
    "download_single_file(s3_data, data_file)"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 5,
   "metadata": {},
   "outputs": [],
   "source": [
    "download_single_file(s3_annotations, annotations_file)"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 6,
   "metadata": {},
   "outputs": [
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "Total number of records: 3381\n"
     ]
    }
   ],
   "source": [
    "\n",
    "import pandas as pd\n",
    "\n",
    "data = pd.read_json(data_file)\n",
    "\n",
    "print(\"Total number of records: {}\".format(data.shape[0]))"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 7,
   "metadata": {},
   "outputs": [],
   "source": [
    "\n",
    "pd.set_option('display.max_columns', None)\n",
    "pd.set_option('display.max_colwidth', 10000)\n",
    "pd.set_option('display.max_rows', 100)"
   ]
  },
  {
   "cell_type": "markdown",
   "metadata": {},
   "source": [
    "### Sneak preview of the data"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 8,
   "metadata": {},
   "outputs": [],
   "source": [
    "#TODO: Fix data format\n",
    "data[\"pubmedId\"] = data[\"pubmedId\"].astype(str)\n",
    "data[\"interactionId\"] = data[\"interactionId\"].astype(str)\n",
    "data[\"isNegative\"] = data.isNegative.isin(['true', '1', 'True'])"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 9,
   "metadata": {},
   "outputs": [
    {
     "data": {
      "text/html": [
       "<div>\n",
       "<style scoped>\n",
       "    .dataframe tbody tr th:only-of-type {\n",
       "        vertical-align: middle;\n",
       "    }\n",
       "\n",
       "    .dataframe tbody tr th {\n",
       "        vertical-align: top;\n",
       "    }\n",
       "\n",
       "    .dataframe thead th {\n",
       "        text-align: right;\n",
       "    }\n",
       "</style>\n",
       "<table border=\"1\" class=\"dataframe\">\n",
       "  <thead>\n",
       "    <tr style=\"text-align: right;\">\n",
       "      <th></th>\n",
       "      <th>interactionId</th>\n",
       "      <th>interactionType</th>\n",
       "      <th>isNegative</th>\n",
       "      <th>participants</th>\n",
       "      <th>pubmedId</th>\n",
       "      <th>pubmedTitle</th>\n",
       "      <th>pubmedabstract</th>\n",
       "    </tr>\n",
       "  </thead>\n",
       "  <tbody>\n",
       "    <tr>\n",
       "      <th>0</th>\n",
       "      <td>2503510</td>\n",
       "      <td>phosphorylation</td>\n",
       "      <td>False</td>\n",
       "      <td>[{'uniprotid': 'P43405', 'alias': [['ksyk_human'], ['Tyrosine-protein kinase SYK'], ['SYK'], ['Spleen tyrosine kinase'], ['p72-Syk']]}]</td>\n",
       "      <td>25605870</td>\n",
       "      <td>None</td>\n",
       "      <td>NLRP3 is the most crucial member of the NLR family, as it detects the existence of pathogen invasion and self-derived molecules associated with cellular damage. Several studies have reported that excessive NLRP3 inflammasome-mediated caspase-1 activation is a key factor in the development of diseases. Recent studies have reported that Syk is involved in pathogen-induced NLRP3 inflammasome activation; however, the detailed mechanism linking Syk to NLRP3 inflammasome remains unclear. In this study, we showed that Syk mediates NLRP3 stimuli-induced processing of procaspase-1 and the consequent activation of caspase-1. Moreover, the kinase activity of Syk is required to potentiate caspase-1 activation in a reconstituted NLRP3 inflammasome system in HEK293T cells. The adaptor protein ASC bridges NLRP3 with the effector protein caspase-1. Herein, we find that Syk can associate directly with ASC and NLRP3 by its kinase domain but interact indirectly with procaspase-1. Syk can phosphorylate ASC at Y146 and Y187 residues, and the phosphorylation of both residues is critical to enhance ASC oligomerization and the recruitment of procaspase-1. Together, our results reveal a new molecular pathway through which Syk promotes NLRP3 inflammasome formation, resulting from the phosphorylation of ASC. Thus, the control of Syk activity might be effective to modulate NLRP3 inflammasome activation and treat NLRP3-related immune diseases.</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>1</th>\n",
       "      <td>2503513</td>\n",
       "      <td>phosphorylation</td>\n",
       "      <td>False</td>\n",
       "      <td>[{'uniprotid': 'P43405', 'alias': [['ksyk_human'], ['Tyrosine-protein kinase SYK'], ['SYK'], ['Spleen tyrosine kinase'], ['p72-Syk']]}, {'uniprotid': 'Q9BSZ5', 'alias': [['asc_human'], ['Apoptosis-associated speck-like protein containing a CARD'], ['PYD and CARD domain-containing protein'], ['Target of methylation-induced silencing 1'], ['Caspase recruitment domain-containing protein 5'], ['ASC'], ['CARD5'], ['TMS1'], ['PYCARD']]}]</td>\n",
       "      <td>25605870</td>\n",
       "      <td>None</td>\n",
       "      <td>NLRP3 is the most crucial member of the NLR family, as it detects the existence of pathogen invasion and self-derived molecules associated with cellular damage. Several studies have reported that excessive NLRP3 inflammasome-mediated caspase-1 activation is a key factor in the development of diseases. Recent studies have reported that Syk is involved in pathogen-induced NLRP3 inflammasome activation; however, the detailed mechanism linking Syk to NLRP3 inflammasome remains unclear. In this study, we showed that Syk mediates NLRP3 stimuli-induced processing of procaspase-1 and the consequent activation of caspase-1. Moreover, the kinase activity of Syk is required to potentiate caspase-1 activation in a reconstituted NLRP3 inflammasome system in HEK293T cells. The adaptor protein ASC bridges NLRP3 with the effector protein caspase-1. Herein, we find that Syk can associate directly with ASC and NLRP3 by its kinase domain but interact indirectly with procaspase-1. Syk can phosphorylate ASC at Y146 and Y187 residues, and the phosphorylation of both residues is critical to enhance ASC oligomerization and the recruitment of procaspase-1. Together, our results reveal a new molecular pathway through which Syk promotes NLRP3 inflammasome formation, resulting from the phosphorylation of ASC. Thus, the control of Syk activity might be effective to modulate NLRP3 inflammasome activation and treat NLRP3-related immune diseases.</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>10</th>\n",
       "      <td>1796163</td>\n",
       "      <td>phosphorylation</td>\n",
       "      <td>False</td>\n",
       "      <td>[{'uniprotid': 'Q8WUB1', 'alias': [['kc1g2_human'], ['Casein kinase I isoform gamma-2'], ['CK1G2'], ['CSNK1G2']]}, {'uniprotid': 'Q6ZS50', 'alias': [['lrrk2_human'], ['Leucine-rich repeat serine/threonine-protein kinase 2'], ['LRRK2'], ['PARK8'], ['Dardarin']]}]</td>\n",
       "      <td>25500533</td>\n",
       "      <td>None</td>\n",
       "      <td>LRRK2, a gene relevant to Parkinson's disease, encodes a scaffolding protein with both GTPase and kinase activities. LRRK2 protein is itself phosphorylated and therefore is subject to regulation by cell signalling; however, the kinase(s) responsible for this event have not been definitively identified. Here using an unbiased siRNA kinome screen, we identify and validate casein kinase 1α (CK1α) as being responsible for LRRK2 phosphorylation, including in the adult mouse striatum. We further show that LRRK2 recruitment to TGN46-positive Golgi-derived vesicles is modulated by constitutive LRRK2 phosphorylation by CK1α. These effects are mediated by differential protein interactions of LRRK2 with a guanine nucleotide exchange factor, ARHGEF7. These pathways are therefore likely involved in the physiological maintenance of the Golgi in cells, which may play a role in the pathogenesis of Parkinson's disease.</td>\n",
       "    </tr>\n",
       "  </tbody>\n",
       "</table>\n",
       "</div>"
      ],
      "text/plain": [
       "   interactionId  interactionType  isNegative  \\\n",
       "0        2503510  phosphorylation       False   \n",
       "1        2503513  phosphorylation       False   \n",
       "10       1796163  phosphorylation       False   \n",
       "\n",
       "                                                                                                                                                                                                                                                                                                                                                                                                                                           participants  \\\n",
       "0                                                                                                                                                                                                                                                                                                               [{'uniprotid': 'P43405', 'alias': [['ksyk_human'], ['Tyrosine-protein kinase SYK'], ['SYK'], ['Spleen tyrosine kinase'], ['p72-Syk']]}]   \n",
       "1   [{'uniprotid': 'P43405', 'alias': [['ksyk_human'], ['Tyrosine-protein kinase SYK'], ['SYK'], ['Spleen tyrosine kinase'], ['p72-Syk']]}, {'uniprotid': 'Q9BSZ5', 'alias': [['asc_human'], ['Apoptosis-associated speck-like protein containing a CARD'], ['PYD and CARD domain-containing protein'], ['Target of methylation-induced silencing 1'], ['Caspase recruitment domain-containing protein 5'], ['ASC'], ['CARD5'], ['TMS1'], ['PYCARD']]}]   \n",
       "10                                                                                                                                                                               [{'uniprotid': 'Q8WUB1', 'alias': [['kc1g2_human'], ['Casein kinase I isoform gamma-2'], ['CK1G2'], ['CSNK1G2']]}, {'uniprotid': 'Q6ZS50', 'alias': [['lrrk2_human'], ['Leucine-rich repeat serine/threonine-protein kinase 2'], ['LRRK2'], ['PARK8'], ['Dardarin']]}]   \n",
       "\n",
       "    pubmedId pubmedTitle  \\\n",
       "0   25605870        None   \n",
       "1   25605870        None   \n",
       "10  25500533        None   \n",
       "\n",
       "                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                    pubmedabstract  \n",
       "0   NLRP3 is the most crucial member of the NLR family, as it detects the existence of pathogen invasion and self-derived molecules associated with cellular damage. Several studies have reported that excessive NLRP3 inflammasome-mediated caspase-1 activation is a key factor in the development of diseases. Recent studies have reported that Syk is involved in pathogen-induced NLRP3 inflammasome activation; however, the detailed mechanism linking Syk to NLRP3 inflammasome remains unclear. In this study, we showed that Syk mediates NLRP3 stimuli-induced processing of procaspase-1 and the consequent activation of caspase-1. Moreover, the kinase activity of Syk is required to potentiate caspase-1 activation in a reconstituted NLRP3 inflammasome system in HEK293T cells. The adaptor protein ASC bridges NLRP3 with the effector protein caspase-1. Herein, we find that Syk can associate directly with ASC and NLRP3 by its kinase domain but interact indirectly with procaspase-1. Syk can phosphorylate ASC at Y146 and Y187 residues, and the phosphorylation of both residues is critical to enhance ASC oligomerization and the recruitment of procaspase-1. Together, our results reveal a new molecular pathway through which Syk promotes NLRP3 inflammasome formation, resulting from the phosphorylation of ASC. Thus, the control of Syk activity might be effective to modulate NLRP3 inflammasome activation and treat NLRP3-related immune diseases.  \n",
       "1   NLRP3 is the most crucial member of the NLR family, as it detects the existence of pathogen invasion and self-derived molecules associated with cellular damage. Several studies have reported that excessive NLRP3 inflammasome-mediated caspase-1 activation is a key factor in the development of diseases. Recent studies have reported that Syk is involved in pathogen-induced NLRP3 inflammasome activation; however, the detailed mechanism linking Syk to NLRP3 inflammasome remains unclear. In this study, we showed that Syk mediates NLRP3 stimuli-induced processing of procaspase-1 and the consequent activation of caspase-1. Moreover, the kinase activity of Syk is required to potentiate caspase-1 activation in a reconstituted NLRP3 inflammasome system in HEK293T cells. The adaptor protein ASC bridges NLRP3 with the effector protein caspase-1. Herein, we find that Syk can associate directly with ASC and NLRP3 by its kinase domain but interact indirectly with procaspase-1. Syk can phosphorylate ASC at Y146 and Y187 residues, and the phosphorylation of both residues is critical to enhance ASC oligomerization and the recruitment of procaspase-1. Together, our results reveal a new molecular pathway through which Syk promotes NLRP3 inflammasome formation, resulting from the phosphorylation of ASC. Thus, the control of Syk activity might be effective to modulate NLRP3 inflammasome activation and treat NLRP3-related immune diseases.  \n",
       "10                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                            LRRK2, a gene relevant to Parkinson's disease, encodes a scaffolding protein with both GTPase and kinase activities. LRRK2 protein is itself phosphorylated and therefore is subject to regulation by cell signalling; however, the kinase(s) responsible for this event have not been definitively identified. Here using an unbiased siRNA kinome screen, we identify and validate casein kinase 1α (CK1α) as being responsible for LRRK2 phosphorylation, including in the adult mouse striatum. We further show that LRRK2 recruitment to TGN46-positive Golgi-derived vesicles is modulated by constitutive LRRK2 phosphorylation by CK1α. These effects are mediated by differential protein interactions of LRRK2 with a guanine nucleotide exchange factor, ARHGEF7. These pathways are therefore likely involved in the physiological maintenance of the Golgi in cells, which may play a role in the pathogenesis of Parkinson's disease.   "
      ]
     },
     "execution_count": 9,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "data.head(n=3)"
   ]
  },
  {
   "cell_type": "markdown",
   "metadata": {},
   "source": [
    "### Number of interactions per paper\n",
    "**Note: The number of interactions per paper only takes the filtered interactions extracted from the Intact database**"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 10,
   "metadata": {},
   "outputs": [
    {
     "data": {
      "text/plain": [
       "<Figure size 1500x500 with 1 Axes>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    }
   ],
   "source": [
    "import matplotlib.pyplot as plt\n",
    "\n",
    "data.pubmedId.value_counts().hist (bins=50, figsize=(15,5), color = 'red')\n",
    "plt.title('Papers vs number of interactions distribution')\n",
    "plt.xlabel('Number of interactions per paper')\n",
    "plt.ylabel('Total number of papers')\n",
    "\n",
    "plt.show()"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 11,
   "metadata": {},
   "outputs": [
    {
     "data": {
      "image/png": "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\n",
      "text/plain": [
       "<Figure size 1080x360 with 1 Axes>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    }
   ],
   "source": [
    "df = data.pubmedId.value_counts().hist (bins=range(1, 30), figsize=(15,5), color = 'red')\n",
    "\n",
    "plt.title('Papers vs number of interactions distribution ( Filtered distribution of interactions between 1 to 30)')\n",
    "plt.xlabel('Number of interactions per paper')\n",
    "plt.ylabel('Total number of interactions')\n",
    "\n",
    "plt.show()"
   ]
  },
  {
   "cell_type": "markdown",
   "metadata": {},
   "source": [
    "### Filter out interactions from paper with more than 15 interactions"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 12,
   "metadata": {},
   "outputs": [],
   "source": [
    "pubmed_interaction_count = data.pubmedId.value_counts().to_frame().rename(columns={\"pubmedId\":\"interactionCountPerPubmed\"})\n"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 13,
   "metadata": {},
   "outputs": [
    {
     "data": {
      "image/png": "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\n",
      "text/plain": [
       "<Figure size 360x360 with 1 Axes>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    }
   ],
   "source": [
    "interactions_count= pd.DataFrame()\n",
    "data[\"lessThanThreshold\"] = data.apply(lambda r: r[\"pubmedId\"] in  pubmed_interaction_count.query('interactionCountPerPubmed <= 15').index , 1)\n",
    "\n",
    "\n",
    "data.lessThanThreshold.value_counts().plot.pie(autopct='%.2f',figsize=(5, 5))\n",
    "plt.title('Has more than 15 interactions')\n",
    "plt.show()"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 14,
   "metadata": {},
   "outputs": [],
   "source": [
    "data = data.query(\"lessThanThreshold == 1\")"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 15,
   "metadata": {},
   "outputs": [
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "Total number of records after filter: 2036\n"
     ]
    }
   ],
   "source": [
    "print(\"Total number of records after filter: {}\".format(data.shape[0]))"
   ]
  },
  {
   "cell_type": "markdown",
   "metadata": {},
   "source": [
    "### Interaction Types distribution"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 16,
   "metadata": {},
   "outputs": [
    {
     "data": {
      "image/png": "iVBORw0KGgoAAAANSUhEUgAAAgcAAAHUCAYAAACu44snAAAABHNCSVQICAgIfAhkiAAAAAlwSFlzAAALEgAACxIB0t1+/AAAADl0RVh0U29mdHdhcmUAbWF0cGxvdGxpYiB2ZXJzaW9uIDMuMC4wLCBodHRwOi8vbWF0cGxvdGxpYi5vcmcvqOYd8AAAIABJREFUeJzs3Xl4XHXd/vH3Z2ayt0n3fZnuZS9QWiiFVjaXgKCCIIqoICKbKKDjDv5UgvoojyLyiCKggAiKYkdUREpLy9YCpWwF2qa0ULrvaZLJzPf3xzlpJ23STNqZnJnkfl1XrmS2c+6ZtJnPfFdzziEiIiLSLBR0ABEREckvKg5ERESkBRUHIiIi0oKKAxEREWlBxYGIiIi0oOJAREREWlBxILIPZvaKmc0MOkdQzGy0mW3P4vF+Y2bf8H8+xcxqs3jsmWb2SraOJ9KdqTiQnDOzWjM7JcP7zjazi3OdqY1z32lm30+/zjl3iHNudpbP84qZbfe/kmZWn3b5G9k8Vzs5LvbP33zu5WZ2h5mNa76Pc26Zc65Hhsea3d79nHMXO+d+eIDRMbOImTkzi6Yde7Zz7pADPbaIqDiQLsbMwkFnaI9fcPTw33TnAlc0X87GG2cHzfVzVAGnAAlggZkdlO0TFcLvRkQ8Kg6kU5nZZ8zsSTP7iZlt8j+tftC/7QfACcAt/ifZW/zrJ5rZo2a20cyWmNnH0453p5n9ysz+YWY7gPeZWbWZvWBmW81spZldv0eG6WY238w2+7d/xswuAT4JfNU/99/9++5q9TCzEjO72cze9b9uNrMS/7aZZrbKzK4xs7VmttrMPrsfr0+pn+ugtOsGm1mdmfVtboo3s++Y2Qb/9Ttvj8f/1H9ea8zsVjMrbe+8zrmkc26pc+4LwFPAd/3jjTWzXcuomtlF/vm3mdkyMzvPzA4DbgFO8F+79f59/2BmvzSzf/q/mxP86/b8fbT1XJ40s8+kXU5vnZjjf29uhfnYnt0UZnaImT3hv56Lzaw67bY/mNnPzewR/7k8ZWaj2nudRLoLFQcShKnAEqAf8CPgt2Zmzrlv0vKT9BVmVgE8CtwLDADOA241s4PTjnc+8AOgJ/AksAP4NNALqAa+aGZnAZjZSOAR4BdAf2AS8KJz7tfAPcCP/HOf0UrubwLH+o85ApgCfCvt9kF4n8CHAhcBvzSz3h15YZxz9cCfgE/t8fz+5Zzb4F8e5j/XIf557jCzsf5tPwZGAYcD44Con7sj/oJXpLVgZpXAT4FTnXM9geOBl5xzi4Er8FshnHP99sh+g5/3qVbOta/nsi8n+t+bW2H+vEfWYmAWEMf7PX8ZuH+PY58PfBvoA7wN/L8MzivSLag4kCCscM7d7pxLAncBg4GBbdz3dKDWOfc751yTc+4F4M/AOWn3+Ztzbp5zLuWcq/f7nhf7l18C7gNm+Pc9H/iPc+4+51zCObfBOfdihrk/CXzPObfWObcO703vgrTbE/7tCefcP4DtwIQMj53uLuB8MzP/8gXA79NuTwHfdc41OOf+C/wTOMfMQsDngaudc5ucc1uBG/EKqo54F+8NszUOONTMSp1zq51zr7ZzrIecc0/5v4uGVm5v9bl0MG9rjgeKgR/7v4//4BWF6a/Fg865Bc65BF5hOCkL5xXpElQcSBDea/7BOVfn/9jWoLeRwFS/aXizmW3Ge5MelHaflekPMLOpZva4ma0zsy3ApXitFADDgaX7mXsIsCLt8gr/umYbnHNNaZfraPt5tck5Nw9oAqab2aHACLxPwOnnqUu73JxjEFACLEp7rWbhtbh0xFBgYyu5tgKfAC4H3jOzWWY2vp1jrWzn9raey4EaArztWu4stwLvuTV7L+3n/fpdiXRVKg4k3+y5TehK4AnnXK+0rx7OuS/u4zH3Ag8Dw51zVcBtgKUdb0yG597Tu3jFSrMR/nW5cDde18IFwJ/2+NTd18zKWsmxBmgEJqS9VlX+a9ARZ+F17+zFOfeIc+4UvNaet4D/a76pjWO195q29VzA6x4qT7stvSDM5Hc1PK31pfnY77TzOBFBxYHknzXA6LTLs4DxZnaBmRX5X8fYvkfT9wQ2OufqzWwKXldCs3uAU8zs4+ZNh+trZs3NyXuee0/3Ad8ys/5m1g/4DvCHjj7BDP0eOBsv+9173BYCrjezYvPWYPggXhN5EvgNcLOf0cxsmJmd1t7JzCxs3poGtwLTaaX/3R8YeYaZleMVITvwugXAe+2GmVlRB59nq8/Fv+1F4GNmVua3UHyu+UH+c91A27+v+XitL9f4/2ZOAj4E3N/BfCLdkooDyTf/C5xt3kyGnzvntgGn4fUVv4vXFHwTXvN5Wy4Dvmdm2/DewP/UfINz7m28N4lr8JrOX8QbXAjwW+Bgv0n+r60c9/vAAuAlYDHwvH9d1jnnav1zNDjn5u9x8yq8N+bVeOMTLnbOvenfdg1e8/mzwBbg33gDE9tygnmLHG0F/ov3SX2yc661xYTCwHX+eTcA0/C6GMAbNPomsMbM3mvlsW3Z13P5CV4LwVrgDvYuxL4L3Ov/vj6afoPf0nIGcCawHvg5cH7asUVkH6xll5yI5AszuxtY5py7Pu26U4DfOOeiQeUSka4vEnQAEdmbmY3G+9R7WNBZRKT7UbeCSJ4xsxuBRcAP/W4QEZFOpW4FERERaUEtByIiItKCigMRERFpQcWBiIiItKDiQERERFpQcSAiIiItqDgQERGRFlQciIiISAsqDkRERKQFFQciIiLSgooDERERaUHFgYiIiLSg4kBERERaUHEgIiIiLag4EBERkRZUHIiIiEgLKg5ERESkBRUHIiIi0oKKAxEREWlBxYGIiIi0oOJAREREWlBxICIiIi2oOBAREZEWVByIiIhICyoOREREpAUVByIiItKCigMRERFpQcWBiIiItKDiQERERFpQcSAiIiItqDgQERGRFlQciIiISAsqDkRERKQFFQciIiLSgooDERERaUHFgYiIiLSg4kBERERaUHEgIiIiLag4EBERkRZUHIiIiEgLKg5ERESkBRUHIiIi0oKKAxEREWlBxYGIiIi0oOJAREREWogEHUBE9i0ai4eBnnj/X5NAU/r32prqZIDxRKQLMudc0BlEuoVoLF4KDAdGAMOAPkAlUNXO9x4ZHH6vogGoA9YBa9O+r23tcm1N9Y5sPEcR6RpUHIhkSTQWN7w3/7FpX2OAkXgFQf/g0rWrDlgNvAm8nv5VW1O9JshgItL5VByI7IdoLN4DOAqY7H8dAYwGSoPMlSObgCXsUTQAS2trqpuCDCYiuaHiQKQd0Vi8AjgSrwg42v8+Hg3obQAWAvP8r/m1NdXrgo0kItmg4kBkD9FY/FBgJnAMXiEwERUCmXqTtGIBeK22plp/ZEQKjIoD6faisXgf4FTg/cBpwNBgE3UpG4Gn8IqFucBTml0hkv9UHEi3E43FI8CxeIXA+/FaB9Qy0Dk2Av8AHgb+WVtTvS3gPCLSChUH0i1EY/GRwAfwioGT8KYJSrAagdnA34CHa2uqVwUbR0SaqTiQLisaiw8AzgPOB6YGHEfa9wJei8LDtTXVzwcdRqQ7U3EgXUo0Fu8JfASvIDgFCAebSPbTSuAvwB21NdUvBR1GpLtRcSAFLxqLF+F1GXwS+DBQFmwiybKFwB3AvbU11ZuDDiPSHag4kILkr0Y4Ha8gOAdvKWLp2nYCDwG/BR7XFEmR3FFxIAXFX5nwc8CVeMsTS/e0HPgdcGdtTfXKoMOIdDUqDqQgRGPxUXgFwefQTAPZLQU8itea8JCWcxbJDhUHkteisfhM4Et4Ywm0FoHsy0rgf4Ffa/0EkQOj4kDyTjQWLwE+gVcUTAo4jhSeLcDtwP9q7QSR/aPiQPJGNBYfCFwGXAoMCDiOFL4EcB9wY21N9etBhxEpJCoOJHDRWLwvEAMuR9MQJftSeGsmfL+2pnpR0GFECoGKAwmMv2DRV/yvyoDjSPcwC69IeCboICL5TMWBdLpoLF4KXAF8DegXcBzpnv4OXFdbU70k6CAi+UjFgXQafyXDi4BvoW2RJXhNwP8B19fWVK8POoxIPlFxIDkXjcVDeHsdXA+MCTaNyF62Aj8Ebq6tqW4IOoxIPlBxIDkVjcWrgRrg0KCziLSjFvh6bU31H4MOIhK0gikOzKwWmOycy0nzn5ltd871yMFxrwe2O+d+so/7nAW84Zx71b/8PWCOc+4/2c7TWaKx+HDgF8CZQWcR6aBngGtqa6rnBR1EJCgqDnYff7+LAzOLOOdaXbY1w+LgTmCWc+7B/Tl/PonG4hHgarwuhIpg04gckD8DX6utqV4adBCRzpZ3y9GaWdTMXjeze8zsNTN70MzK/ZuvNLPnzWyxmU3079/HzP5qZi+Z2dNmdrh//Qwze9H/esHMeprZTDObY2ZxM1tiZreZWSjt3D8ws0X+cQam5fmvf/zHzGyEf/2d/uOfAX5kZm+aWX//tpCZvdV8Oe34nzez5/xz/NnMys1sGt7SwD/2s47xj322/5iT/fyLzewOMyvxr681sxv2fD2CFI3FpwHPAz9GhYEUvo8Br0Zj8W/7Ra9It5F3xYFvAnCrc+4gvMFCl/nXr3fOHQX8CrjWv+4G4AXn3OHAN4C7/euvBS53zk0CTsDb7hVgCt4GPgfjDY77qH99BfC0c+4IYA7wef/6XwB3+ce/B/h5Ws5hwDTn3FeAP+BtHwxwCrDIObduj+f1F+fcMf45XgMucs7NBx4GrnPOTXLO7fqUYmalwJ3Auc65w4AI8MW047X2enS6aCzeJxqL3w48CRwWVA6RHCgGvgc8F43Fjww6jEhnydfiYKVzrrm/7w/AdP/nv/jfFwJR/+fpwO8BnHP/BfqaWSUwD/ipmV0F9Epr9n/WObfMOZfEW1q1+diNeAuk7Hn844B7/Z9/n3Z/gAf84wDcAXza//lzeNvJ7ulQM5trZovxColD9vUi4BVJy51zb/iX7wJOTLu9tdejU0Vj8QuB14GLAQsig0gnmAQ8G43Ff+Dv/SHSpeVrcbDnQIjmy83TjJJ4n6LbPoBzNXhvWGXAvLRm97aOnXC7B2C0e3zfjrTzrQTWmNlJeK0Tj7Ry/zuBK/xWgBuA0gzOsS8Zvx7ZFo3FD4rG4rPxnlP/fd9bpEuI4LVOvhCNxY8NOoxILuVrcTDCzI7zfz4fr7m6LXPxm/PNbCZeU/tWMxvjnFvsnLsJeA5oLg6mmNkof6zBue0cG2A+cJ7/8yf987XlN3gtHektCul6AqvNrIjdXRAA2/zb9rQEiJrZWP/yBcAT7eTNqWgsbtFY/DrgRWBGkFlEAnIQMC8ai/80GotrLxDpkvK1OFgCXG5mrwG98frU23I9cLSZvYQ3n/5C//qrzexl//oEuz/JPwfcgtfnvxx4qJ0sVwKf9Y9zAd42wm15GOhB610KAN/GmyY1D68pvtkfgev8gYe7FglyztUDnwUe8LsiUsBt7eTNmWgsPhj4N/AjvL5Yke4qBHwZWByNxWcGnEUk6/JuKqOZRfGm9WV90Ry/ZeFa59zp2T62f/zJwM+ccyfk4vhBisbiZ+CNq9BeCCItObxlmK+rraneHnQYkWzI15aDgmNmMbx50V8POks2RWPx0mgs/ku8VhEVBiJ7M+BSvBkN7Q0yFikIeddyIPkjGosfhjdTQ0sfi2SmDvhibU313e3eUySPqTiQVkVj8SvxxhYc6IwKke7oN8CVtTXV9UEHEdkfKg6khWgs3h9vQGV10FlECtyLwDm1NdVvBR1EpKM05kB2icbixwOLUGEgkg2TgIXRWPyj7d5TJM+o5UAAiMbiFwO/RFMURXLhZ3ibOCWCDiKSCRUH3Vw0Fi8Cbmb3/hUikhtPAR+vraleFXQQkfaoOOjG/PEFD6CVDkU6y3rgrNqa6nnt3lMkQBpz0E3587GfRYWBSGfqB/wnGot/LOggIvui4qAbisbip+Et4RwNOIpId1QK/Ckai18ddBCRtqhboZuJxuKXAr+gk3dxFJFW3Qx8pbamWn+IJa+oOOgmorF4CPgJ3mYxIpI/HgQu0IJJkk9UHHQD/oyEe4Gzg84iIq2aB3y4tqZ6Y9BBREDFQZcXjcVL8DaE0sJGIvltCfDB2prq5UEHEdGAxC4sGouXA7NQYSBSCCYAT0Vj8clBBxFRcdBFRWPxnsC/gFOCziIiGRsIzI7G4icHHUS6N3UrdEHRWLw38E9gStBZRGS/1AGn19ZUPx50EOmeVBx0Mf6qh48CRwSdRUQOSB3eGIQ5QQeR7kfFQRcSjcUHA48BBwWdRUSyYgfwgdqa6ieDDiLdi8YcdBHRWHwEMAcVBiJdSQXwSDQWnxZ0EOle1HLQBURj8dHA48CIoLOISE5sA06rral+Ougg0j2oOChw0Vh8IDAfGB10FhHJqS3AqbU11c8FHUS6PnUrFDB/uuIjqDAQ6Q6qgH9HY/Gjgw4iXZ+KgwIVjcWLgYeAI4POIiKdphfwaDQW1/97ySkVBwUoGosbcDeghVJEup/eeC0IY4IOIl2XioPC9L/AuUGHEJHA9APi/oJnIlmn4qDARGPxrwNXBp1DRAI3AXjI72IUySoVBwUkGot/Fvhh0DlEJG/MAG4POoR0PSoOCkQ0Fq8Gfh10DhHJO5+OxuLfCjqEdC1a56AARGPxY/GWRS4POouI5CUHnF9bU/3HoINI16DiIM9FY/EhwPN4W7mKiLSlATi5tqZ6XtBBpPCpWyGPRWPxIuABVBiISPtKgL9qiqNkg4qD/PZTQBuuiEimNMVRskLFQZ6KxuKfAq4IOoeIFJwJwIPRWDwcdBApXCoO8lA0Fj8c+L+gc4hIwToJ+HbQIaRwaUBinonG4r2ABYD6DUXkQKSAU2prqh8POogUHrUc5JG0PRNUGIjIgQoB90Rj8f5BB5HCo+Igv3wTOCPoECLSZQwG7vY/eIhkTMVBnojG4u8Hbgg6h4h0OR8Args6hBQWjTnIA9FYfDjwAtA36Cwi0iU1ASfW1lQ/FXQQKQxqOcgPv0WFgYjkTgS4T+sfSKZUHAQsGot/ATg16Bwi0uWNxPsgItIudSsEKBqLR4HFQI+Ao4hI93FVbU31L4IOIflNxUFA/NHD/wVmBhxFRLqXBmBybU31y0EHkfylboXgXIEKAxHpfCXAHVpeWfZFxUEAorH4WKAm6Bwi0m0dA3w56BCSv9St0MmisXgImAMcH3QWEenWdgJH1NZUvxl0EMk/ajnofF9GhYGIBK8M+I1WT5TWqDjoRNFYfCLw/aBziIj4TgS+EHQIyT/qVugkfnfCfGBq0FlERNJsASbW1lS/F3QQyR9qOeg8F6HCQETyTxXws6BDSH5Ry0EniMbiVcAbwICgs4iItOG02prqR4MOIflBLQed49uoMBCR/ParaCxeGnQIyQ8qDnIsGouPB64KOoeISDvGAN8IOoTkBxUHufc/QFHQIUREMnBdNBYfFnQICZ6KgxyKxuLvB04POoeISIZKgRuCDiHB04DEHInG4hHgJeCgoLOIiHRAEm/lxFeCDiLBiQQdoAu7DBUGbUpsWMW6h2/adblp83v0mv4pkts3UPfWs1g4QqTXIPp96GpCpXvvaL3+Hzezc+lzhMurGHLRrbuuT+7cxvq/3UTT1jVEKgfS76wY4VYeLyJtCgM3Ah8OOogERy0HORCNxfsCbwK9g85SCFwqyapbL2TwBT8lsXEVpSOPwEJhNs3+HQC9Z352r8fUr3wZKyplQ/ynLYqDTY/fQaisJ1XHnsOWpx8gVb+91ceLSLtOqK2pfjLoEBIMjTnIje+hwiBj9SsWUdRrMJGqAZSNOgoLeTvJlgyZQNO29a0+pnT4oYTLeu51fd1bz1Bx6MkAVBx6MnVvPp274CJd24+CDiDBUXGQZdFYfAJaq7xDdrw2h/KDTtzr+u0vPUrZ6MkdOlZyx2YiPfoAEK7oTXLH5qxkFOmGjovG4h8JOoQEQ8VB9n0Tr89OMuCSCXa+9SwVE6e3uH7L/PshFKbi4Jn7fWwzQ9vNiRyQH0Zjcf0964ZUHGRRNBYfDZwfdI5CsnPZQooHjiFcsbsXZvvi/1C39Fn6nXEtZh17ew9X9KJp+0YAmrZvJFTRK6t5RbqZicDngg4hnU/FQXZ9HbUadMiOV5+gIq1LYeeyhWx95s8M+Nh3CBV1fCXX8rFT2fHyY96xX36M8rHa60rkAF0fjcXLgw4hnUvFQZZEY/HhwKeDzlFIUo311Ne+SPmEabuu2/jobaQad7Lm/m/x7u+uZMO/bgGgadsG1jzw3V33W/fwj3jv99eS2PgOq355IdsW/RuAymPPpr72Bd759eepr32RymPP6dwnJdL1DEFLwHc7msqYJdFY/Bbg8qBziIjkwFpgRG1NdUPQQaRzqOUgC6Kx+CDgoqBziIjkyADUMtqtqDjIjmvx1iQXEemqvhKNxTUBqJtQcXCAorF4P+DSoHOIiOTYRKA66BDSOVQcHLgvAxVBhxAR6QTXBh1AOocGJB6AaCzeC1gBVAadRUSkk0yuraleGHQIyS21HByYy1BhICLdi1oPugG1HOynaCweApYBI4POIiLSiZqAMbU11W8HHURyRy0H++/9qDAQke4nAlwddAjJLRUH+087L4pId3VxNBavCjqE5I6Kg/0QjcWHAKcHnUNEJCA9gUuCDiG5o+Jg/1yENlgSke5NxUEXpgGJHeQPRFwOjAg6i4hIwI6vrameH3QIyT61HHTcB1BhICICcGHQASQ3VBx0nAYiioh4Ph6NxbWvTBek4qADorH4ULS2uIhIs17Ah4MOIdmn4qBjNBBRRKQlbeXcBWlAYob8gYi1wPCAo4iI5JMmYFhtTfWaoINI9qjlIHMzUGEgIrKnCHB+0CEku1QcZO6coAOIiOQpzVroYtStkIFoLB4G3gEGBp1FRCRPTaqtqV4UdAjJDrUcZOZEVBiIiOyLBiZ2ISoOMvPxoAOIiOS5T0RjcQs6hGSHioN2+LMUPhp0DhGRPDcYODroEJIdKg7adzwwIOgQIiIF4ENBB5DsUHHQPq3+JSKSGa0g20WoOGjfmUEHEBEpEJOjsXj/oEPIgVNxsA/RWPwgYFzQOURECkQI+GDQIeTAqTjYN7UaiIh0jMYddAEqDvbtjKADiIgUmNP8heOkgKk4aEM0Fu8BTAk6h4hIgekNTAs6hBwYFQdtm4a3oYiIiHSMuhYKnIqDts0IOoCISIHSlMYCp+KgbScGHUBEpEAdFo3FhwUdQvafioNWRGPxUuCYoHOIiBSwU4IOIPtPxUHrjgVKgg4hIlLApgYdQPafioPWqUtBROTAHBt0ANl/Kg5ap8GIIiIH5rBoLF4edAjZPyoO9hCNxYtQxSsicqDCaAvngqXiYG+TAVW7IiIHTh+0CpSKg72pS0FEJDs0KLFAZVQcmFl/M/s/M5vlXz7YzD6T02TBmR50ABGRLkLFQYHKtOXgTuAJYLh/+U3gmlwEygNHBh1ARKSLGBaNxYcGHUI6LtPiYIBz7l4gBeCcSzT/3JVEY/FewJCgc4iIdCFqPShAmRYHO8ysD+AAzOwYYGvOUgXn0KADiIh0MSoOClCmuw5eC/wdGG1mTwBDgbNzlio4hwQdQESki9GMhQKUUXHgnFtgZu8DDgIMeNU515jTZMFQy4GISHZNCjqAdFymsxVKgEuBbwJfBy7xr+tq1HIgIpJdldFYfEDQIaRjMu1WuAtoAG73L5+PN+XvvFyECpBaDkREsm8csDboEJK5TIuDw51zB6ddftTMXs1FoKBEY/H+QP+gc4iIdEHjgHlBh5DMZTpbYZE/QwEAMzsaeCE3kQKjLgURkdwYG3QA6ZhMWw4OA54xs2X+5VHAa2b2AuCcc0flJF3nUpeCiEhujAs6gHRMpsXBmTlNkR/UciAikhtqOSgwmRYHlwC/dc69kcswAVNxICKSGyoOCkymYw6WA783s3lmdrGZ9cxlqICMDDqAiEgXpemMBSaj4sA5d5tzbirweWAisNjM7jazE3KarpNEY3EDBgWdQ0SkC9O4gwKSacsBZhbCG4gYBTYBS4BvmNkfchOtU/UFioMOISLShalroYBkNObAzH4MnAXMAX7qnJufdltXGIcwOOgAIiJdnFoOCsg+iwMzG+Gcext4AzjKObetlbt1hU01VByIiOTWqKADSOba61b4K4Bz7vY2CgOccxuznqrzqTgQEcmtvkEHkMy1VxxYp6QInooDEZHc6hN0AMlce2MOhprZz9u60Tl3VZbzBEXFgYhIbqnloIC0VxzsBBZ2RpCAqTgQEckttRwUkPaKgw3Oubs6JUmwVByIiORWVTQWD9fWVCeDDiLta2/MQWOnpAjekKADiIh0cQb0DjqEZGafLQfOuV3TFM1sKN4Sw5G02+fkLlqnUsuBiEju9QHWBx1C2pfpIkg3AecCrwLNTUIOb1GkghaNxYuBsqBziIh0Axp3UCAy3ZXxLGCCc64hl2ECUhJ0ABGRbkLFQYHIdG+FZUBRLoMESMWBiEjn0HTGApFpy0Ed8KKZPQbsaj3oIuscqDgQEekcajkoEJkWBw/7X12RigMRkc6h2QoFIqPiwDl3l5kVA+P9q5Y45xK5i9WpVByIiHQO/b0tEJnOVpgJ3AXU4s1VHW5mF3aRqYzFQQcQEekmwkEHkMxk2q3wP8BpzrklAGY2HrgPODpXwTqRKlkRkc6h4qBAZDpboai5MABwzr1B15m9oOJARKRzqDgoEJm2HCwws98Af/AvfxJYkJtInU7FgYhI51BxUCAyLQ6+CFwONE9dnAvcmpNEnU/FgRScUDKxrZ9zG0ojpWbeOCCRvJeC+qAzSGYyna3QAPzU/+pqVBxIwbmm9K6nt66xHYM2HxZJ9uhVWmY7EqXWVFwWihRXRKpS5ZFKysI9IsXhspKiUElF2CJVhvU1M/17P0DX/KOGx5bOp295bx67aO9Na//15lx+Mve3hCxEOBTm+pOvZMqwwwH4weO/4r9LnyLlUpww6hhuOPkqzLpVbVcRdADJzD6LAzP7k3Pu42a2GG8vhRacc4fnLFnnyXTchUje+KC92uOewxqKn161pMfn/jOg+K1x5256r2rcUY7GVKp+5bJU4rUtqaZVIZcE9+x1AAAgAElEQVTaOgBSI5ofVxQq2VoW7rGpPFK5tSJStaMiUpWoiFSlyiI9rDRcUVQcKi2PWHGPkIX7AL2sm71zZeKcwz7AZ476CFfHf9jq7dNHHs1pY6djZry2dilf/Nt3mf35P7Bg1WIWvLOYf3/udwB89J4reHrlixw34sjOjB+0VNABJDPttRx8yf9+eq6DBKgu6AAiHTXM1g/62oamoVMP6rF6ydB1xT++439dSaIsuXTMWS+uHnTcWFc8dlLzfV1q5+ZU09vLkonl25qa3inZmtg4fGtiw2HtncOwptJwxcaySM/NFZHK7RWRXjsrIlVNfqtEuGR3q0SlEepnZqW5fdb54djhk1i5ZXWbt1cUl+/6uS6xc1efj5nR0NRIY7IJcCRSTfQr73ZrAu31IVPyU3tbNjf/D7jMOfe19Nv8nRq/tvejCs6OoAOIdEQZDXVFNI00CF23YdO7N/brc9zFXwr3/9oD9fMmvXHfiRPe+GNq1dAZTy0bdXrPZKTsUAuV9QoXTzgqXDxh1zFcasf6VOLt2mRi2Y5U8t0yUttHgBuUfh6Hi+xMbh+wM7l9wMaGtt8Mm0WseHtZpMfG8nDl1opI5Y6Kol6NFZHKVFm4p9cqES4rK7KiHiGL9AZ6m1mXbbV75I053PTEr1lft4m7zr4JgKOHHspxI45k8i8/gnOOC4/+KOP6RYMN2vmS7d9F8kGmAxJPZe9C4IOtXFeIVBxIQTky9OZyMw4BOH/b9uNu6d3rpW3h0OE3nhueMfOl1LNfjKfGDX9n9nHD35nNxl4TXl4y/rxtO8v6T8Fs10hxC1X0C5cc1C9cctCu47rUtjXJxIq3U4nldamm1eW47VGgf6a5mlxjj22JjT22JTa2e1/DkiXh8vVl4Z6bvFaJqp0VRb2ayiM9XVm4Z7gkXFZcFCqtiHitEn3NrLzdg+aRD44/kQ+OP5GnV77IT+b+lvvO+xnLN63irQ0rePayBwE4//5reGblIqYOPyLgtJ0qJwMSzex6YLtz7icdfNxM4Frn3F6t42b2D+B859zm/cgzGfi0c+4q/xyNzrn5/m2XAnXOubv347hRYJpz7t49z9PRY7WnvTEHXwQuA8aY2UtpN/UE5mc7TEC2Bx1ApCOOD73c4t33Z2vXhS8eNMBhZrMPD015bbituumO5LvljRzSZ/OSQ4979gZ2lvZb9fr485Zu6j1xEmZVrR3XQj0HRkoOHUjJobuuSyW3vJtqql2ZSiyvTzW91xNXN4osrI/vcOH65I5+9ckd/TY1vtfu/cNWVFcW7rGxPNJzizdWoldjRaQyWRbpaWXhikhxuKwsYsU9whbuDdbb0gqhIB07fBLXbL6RjXWb+dcbczlyyCG7uh3eN3oqz7/7SncrDnYGHSBTzrkPHcBjF7B7uv9MvPeZ+f5ttx1ArChwPnBvK+fJqvZaDu4FHgFuBGJp129zzrX/8aAwqOVACsrU0Ost+m2n1jccEk00za8tLpoGsKa3Dbv46vDAb/4xOeeQtzkRoKx+/bAjX7plWFO4ZNuyUR+e886Q6VEXioxo7fjpQuGqIaHwEUMo2f0GlkpuXJlK1K5KJWobU8k1Vbido4BWC45sSbpE+famTeXbmzYNy+DuqZJQ+QZ/rMS2ikhVnT9WwpVFeoZKQ+UlRaGSskioqMoI9TGzHtnMunzTKqK9hmJmLH5vCQ3JBL3LqhhSOYD7Fs2iKfVJnIOnV77IRZPPyeapC0HWxniZ2TeBC4G1wEpgoZmNAX6J1+JVB3zeOfe6md0JzHLOPeg/drtzrvn3XmlmcWAs8DheN3rKzGqByc659a2dyzn3EzObjdfysMDM+gELnHPR5hYJ4ArgUiBpZp8CrgROxm/l8B//DPA+oBdwkXNurt9C8Ht2z+64wm95qAEOMrMX8bY0eME//+lm1ge4AxjtP/dLnHMv+a0qI/zrRwA3O+d+3t7r296Ygy3AFjP7X2Cjc26b/8JWmtlU59wz7Z2gAKg4kIIyzlb12vO6X65ZN6J62OAG/KmKTWEruuGTkRNPW5h6+qJ/pw42qASIJBt6jn/rgRPHvfVg6t3Bxz+9dPSHy5uKKjo06ygU7jM8FO4znNKjAHDOOZfaUJtK1L6bStQmUsm1vXH1o4Gsvul2JGJDqq5vQ2Nd382Na9q9c9giO0tbtEpUNVREqpLlkZ6UhnsUFYdKS72Bl+HeYH2u+Pv3Ik+//QIbd27hmF9+jGumf5ZEyutKv+DIM3lkyRP8+eV/EQlHKI2UcOuZ12NmVE+YyfwVz3Pqbz+DmTFj1FROHXt8rl+LfJOVlgMzOxo4D5iE9z72PLAQ+DVwqXPuTTObircez0ntHG4KcDCwAvgn8FHgwQzO1S7nXK2Z3UZal4eZnbzH3SLOuSlm9iHgu8ApeEXIqc65ejMbh7ddwWS8D+m7ukH8IqTZDcALzrmzzOwk4G4/M8BEvAKkJ7DEzH7V3uaJmY45+BVwVNrl7a1cV6hUHEgBca6SulF7XjuiqWnY9J31s58sL5uZfv2/jw4d+3LUVtT8LvluaYKJzdcbLjR09ZPHDl39JJuqxr66ZPx5m+rKB03FLNO/CbuYmVm4XzQU7heldLKf0qVcct3SVGL5e8mm2iaXXNcX1zgGKOvwU86xpGsq29G0eeiOps1D17Gyvbu7U47ovenDR5/ZPB10Z0WkKlEeqXTl4Z6h7YnNxRcf87GyL0w9rypEqLeZVTY/MBwKU/OB63L7ZPLftiwd5wTgIedcHYCZPQyUAtOAB9Jm4Gayrsezzrll/nHuA6aTVhy0ca5s+ov/fSFetwF42xPcYmaT8AZxjm/lcXuaDnwMwDn3XzPrm/bvL+6vV9RgZmuBgcCqfR0s0z8E5pzb1ZTpN7l0+I9IPqqtqW6IxuJJtKynFIBRtnqlGa12B9y0bv2R00cM2+DM+qZf/25fG3nR1eH66+9Jzhn3rtfNkK73lrcOPva577OzpM/qN8afu2RDn0MmYbZX60RHmFnIIgPGhCIDxkSYCoBzqSaXXPNGMrF8bSqxwrnk+r6QGEth7YxqjamdvRsbd/be3Li23TuHCDeURio2locrt1REKrdXFPVqqIhUNpWHKymN9IiUhMpKi0LFFSGL9PIXqeoqe9a0JVvFQWtCwGbn3KRWbmvyb8efJZP+b27P6ZUdmW6567h4xcn+aPC/J9n9nvxlYA1whH/8Ax3I2ZD2c/p52pTpG/wyM7sKr7UAvEGKyzqWLa/twG92Fcln00KvrobWi4PKlKu6YOu2OXdXVe5VACQiVvrNCyMnnvF0at6nHk8dYa00+Zc1bBx8xOJfDU6GincsG1U9Z9XQmSNcKBLNVnazUMQig8eHIoPHUzYNAOeSja5p9evJxPJ1qaa3cckNA6BpDJn/bcprKZIldU1bB9c1bR28vqH9+xeHSrd4Ay8rt1ZEeu2sKKpqrIhUurJwTysJlxcXh0rLIqGiyhDhPtbGwNI8l63iYA5wp5ndiPdv5Qzg/4DlZnaOc+4BfwGvw51zi4BavF2E/wR8mJYbB04xs1F43Qrn4nVNZHIu0o77LHB2G1m30fH3lypglf9B/EJ2f3jdhtc10Jq5ePse/T+/u2G9c27r/q5jlul/wEuBnwPfwquqHgMu2a8z5icVB1IQjg+9vM8+2y9v3Dztj5U9lzWajW7t9r8fGzp+0Whb9oO7kqtLmhjX2n3CqcaKcUsfOnHs0ofc6kHHPrt09FlFieKeOVnGzyxcbEXDJoaKhu3q8nCuqT7V9O6SVGL5hlTT2yGX3DQQmkaTB6179z+7iFdXr6VHSTHXfWDGXrfvbExw7zMvsrluJynnmDFhNFNGDeedTVv4y/MvU59oImTGyQeNZdKIIXs9vjFVX9WYqq/akljfbpYQoURpuGJDmTdWYps/VqJpj6Wze/hLZ/fJk6Wzt2TjIM65583sfmARXv/8c/5NnwR+ZWbfwisA/ujf53bgb2a2CG9cQXp38nPALewekPhQhucC+AnwJzO7BIi3EffvwINmdibegMRM3Ar82cw+vUfel/AGNy4C7sQbkNjseuAOf2ZhHd4Ayv1mab0F3VY0Fn8T7x+GSF57suSqZ4bZ+qn7us9DPSqe/U7/vlP2dZ/ihKv7wd3J50euZXom591SOWrJ6+M/sX5HxZBjMOv0bgDnEnWpplVvpRLLNqcSqyIutXkwJKN08qZTS9dtoCQS4b5nXmy1OHjs1bfYmUhw+hEHsb2+gZv++QTfPeMUNtXVAUb/nhVs2VnPzY8+yVc/MIOy4s7rRUhbOnuLP1aicY+ls8sioeLKEOHe5G7p7NHDak5YnoPjdpr9XVOh0GTUcuAvi3oRcAhp/SrOuc/lKFdny2U/mEjWDGTT0Pbu85HtO6b8rE+vFzaFw21+2m8ssvLrLopMP2du8smzn3RHWzsDBau2Lp8wdcEPJ9QX91rzxrhzXlvf7/DDsFDffT0mm8yKysNFow4PF+0ei+lcw7ZUYuWyVGL55lTTqmKX2jI0fR+JXBjTvy8bd+xjNp5BQ1MTzjkampKUFxcRChn9e+7uxakqK6VHSTHbGxo7tThIpBoqE6mGyq2JDe3et+XS2btaJRJ7L51d1LyhV6b97esO7FlIZ8m0W+H3wOvA+4Hv4TXdvJarUAF4F+hWu59I4enJji1Flsxknj8/X7Ou7ILBA117W/49cEJ4+vNj3Zvf+30yUpRkr1kQeypt3Dzw8FduH5gMFe2sHfnBuSuHnzQkFSoak+lzyCazkp7h4rFHhIt3N/p5+0isXJ5KLNuaanqnxKW2DYdUuwVVthw/NsrvnnyO7/39MRqamvjUsUcS2uNX8PaGzSRTKfr2yN9FHw9g6ewtFUVVO71iosXS2aURKyqN/uikgl90zjl3fdAZOkOmxcFY59w5Znamc+4uM7sXb/BDV9Hu/CWRoE0OvVGLN3q5XZMaGieOSySefLO4uN1ug6WDbdxFV4e333hncv7QDUzL5PjhVKJszPKHTxi9/GG3ZsDkBW+N/Viosbgy8KnN3j4S448MF++e+eVSdRtSTStqk4nl21NN75aR2rbXPhLZsuS9dQzpVcWlM49lw/Y6/m/OM4zu34fSIq+FYOvOeu579kXOm3LEXkVDIWuxdHbb4+rfvqbdJQckX2RaHDQvlrDZzA4F3gMG5CZSIN4OOoBIe6aHXu7QGu+3rFk35v3DhuzErN21BeqLrceXL4lM++R/k3M//IybYpnND8fABq1dMHnQ2gVs7TH8zSUTzn9vW4/hU8iPwW8AWKi8b7j4oL7h4uztI9GW52pXctLEsZgZ/XpW0KeinLVbdzCiby/qEwl+O/c5PnDoBEb27Xa7MQK03wQheSPT4uDXZtYbb7bCw3jToL6ds1SdTy0HkvemhF7v0Gj9IU3JwSfV7Zz934rymZk+5p6TwicsGOde++69yYpIqvUpk22p3L5y3DELbxrXUNRz3Zvjznllbf8jD8FCB/yGmwtt7COxOtVU+3YqUVufalrdw99Hok9Hjtu7vIw316xndP8+bKtvYN227fTtUU5TMsWd8xZydHQYRwwfnO2nUyja30RD8ka7sxX8BSPOds79qXMidb5oLH4i8ETQOUT25eWSz73aw+oP7shjdphtnzZyWF3KrEMtfeX1bstNdyRfG7iFYzuWcreURRpqR5723NvDTx2YChe3Om0y36WSm1Z5+0gsb0gl11TePe/JQ5ev31S0o6GRnqUlnHbIOJIp72/otLEj2bKznvufXcTW+gacc5x00BiOHjmMhStWcf+zLzGoavcU9XOPOZyhvQtxqYL9dts198/6YtAhJDMZTWU0swXOucmdkCcQ0Vh8FF1rUSfpYkKkkktLPpUw6/gqbD/vXTX39l5VJ+zPeT/3r+Sc9z/vjrOWi8Z02Nr+Rz7/xtizU43FVUe3N0gyn3n7SGx8O5VY/o6/j0QvXP0YgttHopBcf839s24IOoRkJtPioAZYD9xP2uIRXWVnxmgsXoy3IUiovfuKBOEgW7H0kZKv79esgCQkp44ctqwhFNqvT++H1qZe+eYfU73CjgMe9b+9Ysiy1yecv2prz+gxmYyFKAT+PhK1qUTt6t37SDTk5T4SAfvsNffPujPoEJKZTIuD1hatcM65VldhK0TRWPxdoNt2Bkp+uyj8j/nfLvpDRjMJWvOPivIFXxvQb79b/3rUuU0/viP5Vt9tHLO/x0jXWFSx8c0xZy9eM3DyRCw0MBvHzCfOpZIuuWZZMrF8TSqxIuWSG/pB4xgyHOjZRZ14zf2zutIsty5NKyT6orH4M3hbd4rknd8W/Xj2yeEXZh7IMd43fOiC9ZHw/ncPOucui6fmzFjspluWljJOWbjx7eEnP1c78gN9U+GSie0/onA5l0y45HtLk4nl61KJFbjkxv6QGMMBdtkUkGHX3D/rnaBDSGYybTkoB74CjHDOXeLvLz3BOTcr1wE7SzQWfxB/u0uRfPN0yeULBtmmAxr380px8ZvnDRk4GrMDemM/6s3Uouv+nBoYdmR1rYB1fQ9b9Ma4jzc0lPSejDcQustzrqkh1bR6aSqxbH2+7SORZfVA+TX3z8r6p9FcL2dsZlcDv07bsnm7cy7jMSZmdicwyzn34D7u8xng3865d/3LvwF+6px79UCyH4hMpzL+Dm+v6eZmzXeAB4AuUxygtQ4kj/Vn8/ADPcYhjY3jDmlsnPtKScl+DU5s9vy40BGXXmHrfnxHcmGvHRx9oLma9d+w+Ij+Gxazo3zgitfHn79iS9WYozGryNbx85FZpCRcNPzgcNHuX6+3j8Q7y1KJZRtSiZXp+0gUcsG0LBeFQSe5GvgD3mZGufIZ4GW81Xpxzl2cw3NlJNN/bGOccz/CXwzJr6AKdsRxG1QcSF7qy5b1YXNZ6Zf/xZp1E3HugJew3dLD+n/hyvCR8yfaEw5S2cjWrKJuzcijX/zZiSfM+2pi8Or5s3HJbrV4jrePRPTQovKTZpRUXXh8ae8vjS7pdfmOooozF4WLD3vCQr3nQ2gF3g65heKNbB7MzL5pZm+Y2ZPABP+6MWb2TzNbaGZzzWyif/2dZvYrM3vazJaZ2Uwzu8PMXvM/1Tcf8zQze8rMnjezB8ysh5ldBQwBHjezx9Pu+wMzW+Qfc6CZ9TSz5WZW5N9emX457XHfMbPnzOxlM/u1ec4GJgP3mNmLZlZmZrPNbLL/mE+Y2WL/MTelHWv7njmy+RpnWhw0mjey2PmhxgAZ7E5eULrSXhHShUwNvZ61wrV/MtX/QzvqFmTjWM4sdPNHwjN++pHQiynL/oY6RU11vQ5acs/MmXOu7j/2rb/MDzfVB9bEGjRvH4kxRxRVnDqjpOqz00p7Xz2ypOqyrUUVZ7wQLj7kCQv1ehpCq4LOuQ9LsnUgMzsaOA+YBHwIdg2S/TVwpXPuaOBavG2Pm/UGjgO+jLeQ38/wNhI8zMwmmVk/vEX+TnHOHQUsAL7inPs53qf59znn3ucfqwJ42jl3BDAH+LxzbhswG6j273Me8BfnXPPqws1ucc4d45w7FG82y+l+d8MC4JPOuUnOuV3bspvZEOAm4CT/+R5jZme1laNDL2Q7Mu1WuB5vT+nhZnYPcDzw2WwGyQMvtH8Xkc43PbQ4q7uG3rB+49R/VpSvTpllZXbOMxNDR112ma358R3JF3vuZFI2jpku5FKREasemzZi1WNs6H3QS0vGn1tXX9pvSmeMS0g0NXLzw1fTlEyQdEmOHHUi1cd8ptX7vrBsDr999Aau++itjOw/Ydf1G7et4ft/+hwfmnwhpxzx8axls1BpVbh43JHp60u5VN3GVNPby5OJ5dtd0zulzttHIh9mYb2exWOdADyUNgbgYbzdgqcBD6Qto5E+M+TvzjlnZouBNc65xf5jXwGiwDDgYGCe//hi4Kk2zt/I7i71hcCp/s+/Ab4K/BXv/bG1N+v3mdlXgXK81TdfAf6+j+d6DDDbObfOz3sPcKJ/jrZyZEVGxYFz7t9mthA4Fq874UvOufXZDBK02prqtdFY/D3I7iArkQN1dOiNTIv4jJQ6V3bZpi3P39KnV9beNDZW2sDPXxXud+2fU08c/ZY70XLU7dh302uHT3vmeurK+q98ffwnlm3uNf4ozHq2/8j9EwkXcdUZ/0NJURnJZBM/ffhLHDxiCqMGtlyosr6xjtmL/0J0wEF7HeMvT/2KQ0Z0zkQoC5X3CRdP7BMu3j3xw6W2r00mVqzw9pF4txy3Iwqus5e1zlrLQRtCwGbnXFvFaXNLd4qWrd4pvPfBJPCoc+4TGZwr4XaP5E/6j8c5N8/MomY2Ewg7515Of5C/rfWtwGTn3Ep/IGWHFzVrL0e2ZFR5m9ljzrkNzrm4c26Wc269mT2WzSB54sWgA4jsaYStzfof8ku2bJ1Wlkpl89McqZCFf3ROeMYtZ4QWpiCnC6SV71w3/KhFP59x4pPXuiHvzH3CUsmcNKmbGSVF3lpGyVQTyVQT1krdM+u533HqpPOIhItbXL9o+ZP07TmYQb2juYiXEQv1GBApOeSY4h6nzyjtdckxpb2/3L+k8uL3IuWnPBsqGvMEVrEQ2JDjGNn8tzYHOMvvm+8JnIE3WHC5mZ0D4PflZ7SDqe9p4HgzG+s/vsLMmrf23AZkWoDeDdyLN4h/T82FwHoz6wGcnXZbW+d4FphhZv3Mm2X0CTppqf99FgdmVmpmfYB+ZtbbzPr4X1E48NXS8pCKA8krRTQ1ltI4KtvHNbAb123Y2f49O27uoaHJV34xXL+jhMW5OH66SLK+cuKbf5wxc86XBo9/8/6nIk11L7f/qI5JpZLc+OAlxO7+GBOHHk10YMvWgZXr3mDTjnUcOrLlNhQNiZ08+uIf+dDkT2c70gGzcOWgSMnhU4p7nDmjtNcXji7t/ZW+xZWfeydSdtLTocioJ7CyF4AtWTrd29fcP2tTlo6Fc+55vNV6FwGPAM/5N30SuMjMFuE115/ZgWOuw5sxcJ+ZvYTXpdDc/PJr4J/pAxL34R688Q33tXKOzcDteLMS/pWWG+BO4LbmAYlpj1kNxIDH8Z7vQufc3zJ9Xgdin+scmNmX8KZxDMGbvthcMm8FbnfO3ZLzhJ0oGoufC/wx6BwizSbZW0v+WvKdCe3fc/+cOnzIs+9FIjlp8w4nXeIb96fmH7bCzcjF8duysdf4V5aMP2/LzrIBUzDLWlNrXcN2bv/3dzjn+CsZ0ser11Iuxc//fi0XvO+r9O05iJsf/gofOe4LjOw/gb88dRvRARM5asxM4gvuoqSoLKtjDnLN30diZSpR+04qUduYSq7phasfTeafopv99Zr7Z30kFxnzjT/z4Ezn3AVBZzlQmS6CdKVz7hedkCdQ0Vh8Atlt/hI5IFeEH5p3bdEDx+fq+G8UFS3/2NBBw7P5Jrqnk19IPXPJP1MTDTp1C8KdpX3fWTL+vLc29j5oEmZZOfcjC++mKFK6601+Z8N2rv/jBZREvA97W3dupLykki984P/xl/m3smm7N4ljZ+N2zEJUT/4MMw49q83j57s99pFIuuS63v4+EuX7eNh3r7l/1vc6K2NQzOwXwAeBDznnsjp1MwgZL59sZtPwRnXu+iPinLs7N7GCEY3FQ3itIl164RUpHPcU/eCJ48Ov5PST96cHD5jzQmnpibk8x+AN7u2a3yV3lCXYe8RejjWFS7YvG3XGwneGnBB1ocjIjjx2287NhEMRykt60NjUwC/jX+WUSedx2MjjWr1/estBukJsOciUt4/E2mWpxPI1ycSKlEuu7wuNY9k9W+DD19w/a18j8iUPZfRpwcx+D4zB65NP+lc7vMEXXUZtTXUqGosvhv3fw14kmyaG3q7M9TluXrP+kBkjhm7J1qfr1qzuayMuujrc8N17k3MmvENOC5E9RZINPca/9eCMcW/9OfXu4GnPLB19ZmlTUUVGg9W21m3g94//iJRL4pzjqDEzOGzkccx67neM6D+Bw6P7vRdWl2EWCltk0LhQZNC4SJlXNHn7SKxZkkwsW5tKvJ2VdTWkc2XarfAacLDLtJmhgEVj8V8BlwadQwRgWcknN4bM9cn1eb7Tr8/sh3r2mJnr8wB86NnU/AsfSx1mHe+7zprNVWNee338JzbWlQ+awh6r2ElWvXv5bSd1xcHrXV6mi4i8TPeZ/68ZC5IXhrB+dWcUBgDfWr/xuLBznbLC3j+mhKZdc3F4fUMku0vqdkSvLUsPOva57x8/7elvr++7fvFsnMvaaHpp4ZmgA8j+ybQ46Ae8amb/MrOHm79yGSxAWilR8sLU0GudthxuMZR8ZePmTttfZFV/G3XR1eHhSwfxZGedszWlDZsGH/HybTNnzP1KyYi3H51jqablQebpglQcFKiOLJ/cXSwCduKtey0SmOnhl3d05vk+vXXbtFt7V72yIxQ6pDPO11hkZV//bGT6R+alnjxvTuoo2/eI95wKpxrLxy7764ljlv3VvTdo6nNvjf5IJFHc88ig8nQhzwYdQPZPxrMVupNoLP5f4H3t3lEkh/5b/JWnRofea31YfI7MKytdfOmgAYd15jkBRr3n3vp/dyetOMmYzj53W7b0jC5ZMuET67dXDD0Gs+L2HyF7SAC9L7/tpE4tciU72lsh8Un/+zYz25r2tc3MtnZOxEDMDjqAyFBb3+njfI7fWX/Y8ESirQ1ncmb5IBt70dXhQSv7Ma+zz92Wqm21E6YsuPH445/65ub+616cjUvleonhruYZFQaFa5/FgXNuuv+9p3OuMu2rp3Mu51OsAjQ76ADSvZXRUFdMU4fm5GfLL9esG4JzjZ193oZiq7jm85HjHzrO5jqo7+zzt6WkccuAw165feaMuV+uGLnin3NDycTSoDMViK64/063kfMtTwvUM+TRHyfpfo4IvbXcLJj/n6MSTSOn1jd0eutBs/tmhk/41qfDK5pCrAgqQ2vCqabSMcv/fvaGEFUAACAASURBVMKMuVePPuTVOxYUN2zR/P19+2/QAWT/qThoRW1NdQNt7+UtknPTQy/ndFfD9vzP2vVHWIDT+94cahMu+lK493u98u//oYENXLtw8vSnvjH5mAU1b/XctmIuzunDREt1eDsdSoFScdA2NYlJYKaGXgt0pHBVKtXr3G3bXwoyw85Sq7zqi5Hj4pNtjoNO7+bIRM/tK8ces/BHJ0yf//XtA9YseAKXWhd0pjzx5OW3nZSXvzPJjIqDtv076ADSfY2zd3oFneGrGzZNizgXeNP+XaeGT7zh/PBbTSE6bd2HjipObOt36Gu/mzFzzpcrRy2f9WQo2VjwG+8cIH24KnAqDtq2ENDoZAmAc1XsiAadogiKYhs2rQ46B8CrI+3gS64K91hXmd/z5kOuqWTUikemz5z75fGHvnz78yX1m56je84X13iDAqfioA21NdUp4D9B55DuZ5StXmlGXswGOnfb9mMrk8lFQecA2F5mvS6/PDLlP5PsCQdNQedpz4D1Lx51/NPfOmbKgh/WVm5ZNhfn6oLO1Ek2Ac8HHUIOjIqDfVPXgnS640Kvvht0hnQ3r11flE+ffn/9wfCMH5wbei1p5EWrRnt67Hh31OQX/ueEE+Z9rWHQe8/MxqXeCzpTjj12+W0npYIOIQdGxcG+/SvoANL9HB96Ja9Gvh9T33Dw6ETT/KBzpHtpdOiwL1wZLt5UwX5NJ2xIpTh3RS0fqV3OGcuX8Yv1rY8jfGTrVk5fvowzli/jund312w/WbuWM5Yv4/Tly/jBmjUZ1U5FTTt6H/z63TNnzvlS3zFL/zovnGx4bX+yF4C/BR1ADpyWT25HNBZ/DpgcdA7pPuYWX/XM8ND6qUHnSLcqEn7ng8OG9MWsNOgsLTjnrnw4NWf6q276/2/vvuOkqu7/j78+M1vZpQtIEVZBEEUpIr2JpvwyxhJbLHGJGjWiBo1+s/Eb46pJvqPRmNhiEmNMscSa+HWN5huVYkNUwFlg6UOTsktZtpeZ8/vjXnAXF7bNzJnyeT4e+4C55dz3rrLzmXPPPUfA247TqDaGHI+HBmO4fPMmbu/bj9HZXyypEqyv55bPt/GnYwbT3etld2MjvdPSWFpTzf27SvnL4MEAXL55Ezf36cOELjntjl/W++Tla46/sLY2s9dpiCTDh7VGoO/cx2frKpcJLhn+Z4y2v9sOoFLL0bJ3gO0MhxrUGBo4o6Y2/p5bF5GHz/HOvP9bns/Cwq52nEaOx/n112gMjS18SHpx3z4u7dGT7l6n5uid5qxTJwh1JkyDMdQbQ6OB3t62rmHX3FG7A6OnfPjTiROX3LOlx761CzCmskMNxY9FWhgkBy0OWvc8oN0rKiZyqd6fRmiQ7Rwt8e8qGyfGlNnO0ZIlIzxjvz/XK/uz277kesgYzgtuZNq6tUzJyWnWawAQbKgnWF/PZZs28e1NQRZVOe/bY7KzmdAlh5nr1zFz/Tqm5uQwNDOzU/lzqncOGbfs1zOnv3dbqP/29+ZjQnE17qQd/mE7gIoMLQ5aEfT7NqNrkqsYGe9ZExRBbOdoSVdjuuWXV6y0neNw9naVPtfc5D1l8XBZYNpQ0HtFeCXvWN4ZOoxATS1r6+qa7Q8Zw6aGep4aPJj7+w/gzh072B8Ksam+ng31dbw9dBjvDB3G4uoqPq6OzIMI6Y013UeufmbWrIXz+g5b99IH3saaFRFpODYM8IrtECoytDhoG721oGJimiewz3aGI5m3d9/UjLCJ24WHwh7xPnC+d+ZDZ3s+CbdxnpJuXi8TunQ52DNwQL+0dE7PzSVdhEEZGQzJyGBTfT3/qaxgdFY2OR4POR4P03NyWV5TE9Hvw2PCaYO3vj155ru3njR6+SOB7JrSDzAmFNGLRN7iuY/P3mI7xAEiMkZEvtGG4wpF5NZWjjlXRE5s8vpuETkzEjnjlRYHbfMCemtBxcAET0lc9hoc4AXvHbv3WF33oS3eO8kz/obrvfWVmbQ4BfSexkb2h5z32tpwmPerqzguo/mtgTO65rLE7RHY29jIpvp6jsnIYEBaOktqqmk0hgZjWFJTzXGZGVH7XnrvXXXy5MWFkyd9VLi9597VCzBmf9Qu1jkv2g5wiDFAq8VBG50LHCwOjDE/NcYk9Tw4Why0QdDv2wa8azuHSn7HyfbetjO05tzKqtN6hkJtvrdvS1l36X/1PO+JS4/78m2G0sZG5mzZzLkbN3LRpiBTuuQwKzeXh8tKebuyAoBpXXLo4fVy1sYNzNmyhVv79KWH18tXu3blmPQMzg1u5LzgRk7IzOT03K5R/3661JQNGrv8oZkz3r1VBm5buEDCoXibTjqixYGI/ENEPhGRFSJyjbvt6yLyqYgsF5G33G05IvKkiHwkIktF5BwRyQDuBi4WkWUicrGIrBWRPu45HhFZd+B1k2t+T0SWuO2/JCJdRGQKcDbwS7etoSLylIhc4J5zhnvdgJsj090eFJG73LwBETkhkj+faNNHGdsor6BoLvCI7RwqeXkIh9ZnXl4vQnbrR9u1PDNj9eX9+x2fKI/fzVoe/uj7r4eHC1hfsyJSDBLaNmD6kg3HfrNLY3qXUyzH+WDu47OnRLJBEelljNkjItnAEuAM4GNghjFmY5P9vwBWGmP+JiI9gI+AscCFwHhjzA1ue3cC5caYX4vIV4FrjTHni0ghUGmMuV9EehtjdrvH/wzYaYx5WESeAl4zxrzo7nsKeM39WgucYYxZIyJ/AT51rxEEHnDPvx4YZ4y5OpI/o2hKiH/YceJFIN7v+akENly2bkqEwgBgdF39iBH1DXE1MdKRzB/tmXDTdd7K6gwSaYDfEQnGO+jzhZNmvHfbKWOX/XpFl+od72OMrWml/xSFNm8SkeU4Sz8fA1wDLDTGbAQwxhy4vfVVoEBElgHzgSxgcAvtPQlc4f79ysNkHiUii0QkAFwGnNRKxhHARmPMgYW2/gzMaLL/ZffPT4C8VtqKK1octFHQ79sJLLSdQyWvKZ4VCTWt7iM7S4cl0noBO3vKoKvneY9feUzy/TvuuW/tSZM+umfK5MU/3dVr94r5GFMew8tXA89FskERmQWcCUw2xowGlgLLDnc4cL4xZoz7NdgY86XZJ40xW4CdIjIbmAD8q4W2ngJuMMacDNyFU2h0xoFHYEJAxybDsESLg/bRpxZU1EzxFNfbztAeR4dCR59ZXRPXqyQeqtErGYWXp83441c8HxiI14F9HZZdu2fAmMBjs2YuuiXtmC1vL5BwYyyW3H5p7uOzKyLcZndgrzGm2r1XPwnnjXqGiBwLzm0H99g3gRtFRNztY93tFcChg0GeAP4GvGBafvqjK7BdRNJxeg4OaKktgNVAnogMc19/B1jQ9m8zfmlx0D4vAQn1C1wljlGeYK7tDO3189Ldp3mM2Wk7R3u9Od4z+ZbveffWprPadpZo8Ibrc45f/9LMWQvnHXPC6qc/Sm+oPNyn7kiIxi2FN4A0EVkF+HFuLZTi3Fp42b3dcODD2j1AOvCZiKxwXwO8A5x4YECiu+1VIPcIme/AmdfmPaCkyfbngNvcgYdDD2w0xtQC3wVecG9FhIHHO/5txw8dkNhOeQVFzwCX2M6hks/6zMt2eMUcbTtHez3So/ui3/XsPt12jo5IbzS1hX8LLTl+OwmZvz32dTu2ZPWIS3dXdek/AeeTcSRsBIbOfXx2QryRiMh44EFjTNL/9+4s7Tlov0dtB1DJpxfluxOxMAC4fl/51KxweE3rR8afhjTJ+u85adP/drrnPQNVtvNEU4/9G0+YuOTnU6d8+JPdR5V9Np8vBvR1xp8TqDAowOn9/bHtLIlAi4N2Cvp970Hb529Xqi0meEpicW84KjzguadsT6TvOcfUq5M8U//rSu+O+jTW2c4SbVl1+44+pfh3s2Yuujl78OZ/L5Jww8YONmVwRucnBGOM3xgzxBijc9a0gRYHHaO9ByqipnmKE/rN9etV1af2aWz82HaOztjUT4ZeOc87YFPf1JjwzBtuyB624Z/TZy2clzdy1Z+XpNfv/7SdTbwz9/HZwWhkU/ZpcdAxzwC6LKmKmPGeNV7bGTrr0Z2lPRNg/v8jqk+XLrddlTbthWnyroHILpgQpwSk/86PTpv+/o/Hjf/kvjW5FVvexZi61s/kt1EPp6zR4qADgn5fDc6EGkpFxGDZ2af1o+LbyPqGoSfX1b9nO0ckvDDdO+32Od6tDV462uWekLpVbBo+4RP/tKkf3L6/z66lCzDhwy3RvQVdgTGp6dMKHZRXUHQczrSZWmCpTkmnsWFN5hWIEKkR5NaUej2ls48ZmIVI9BcbiIHsOlPxi6dCgYF7iOjUwIki5Emr3TT4a0s2H3Nm/7A3Y1iTXQVzH599r7VgKur0ja2Dgn7fBpxncZXqlJMkuCEZCgOAPqFwH19V9Se2c0RKTaZ0vfnatCmvTpSF5ovZ7lKGN9yYdVywaPqsRTcPO2nFk59k1O372J0V8w+2s6no0p6DTsgrKPp/wOu2c6jENtf7j3dvS39+mu0ckVIrUjNxyKB9YZH+trNE0ogtZtWdz4Ry0sItztufMqqy+z0wfun8W23nUNGlPQed8wYk/6NPKrome1Ym9CC+Q2UZk33D3vINtnNE2upjZOTVP/B239mdD21nscjk1Oz8ve0QKvq0OOiEoN9ngMds51CJ7QTP5qS4P9/U1eX7p3QJh7+0+E2iq86S7jdenzbpzXGywECD7TwW/O/IklUJOeGVah8tDjrvCWC37RAqcfWiYojtDJEmIPeW7k7ae/R//Jp35s++7VkdEj63nSXG7rcdQMWGjjmIgLyCogLgf2znUImnP7t3fJB1Y0JOm9wWXx00YPH29LSJnW0nVBVi25+2Ubu1FhFh4FUD6TKsy8H9lasq2fzQZjKOygCg2/hu9D2nLwBlb5axd8FeEMgalMXAqwbiyYjM56Ku1WbPfX8Mre9dyWkRaTC+LR5ZsmqS7RAqNhJqfek49jBwC5Dwz6qr2JroWbUVSNri4LGdpX3PG3h0Q2cX+tn+zHZyT85l8A2DCTeGMXVf/lCTMzyHITc374Rp2NvA7v/bzfG/OB5PhofNj26mfHE5Paf37Eycgyq6SK/v3+DteX1ReP7MgJkukPCTWR3B3bYDqNjR2woREPT7qoD7bOdQiWe6N5DUi/0Ma2g49tTauvc700aoOkTV6ip6znDe0D1pHrw5bX8PNmFDuD6MCRlMvSGtZ4Q/E4nIY2d5Z917gac4JOyIbONx44ORJav0yawUosVB5DwGJNy69squsbIuKeY3OJIHd5WdjDHlHT2/vrSetK5pbHtiG+t+uo5tT24jXBf+0nHV66pZd8c6gg8Eqd1WC0B6z3SO+vpRrPnhGkrmleDJ9tB1VHTGf356vGf0dTd4vfu60N41ChLBHbYDqNjS4iBCgn5fNaAzhql2GSilSXtL4YCe4XCv8yuqlnW4gTDUbKqh1+xeDLt7GJ5MD6WvlTY7JDsvm+EPDGfYPcPofWZvNj+0GXDGKlQsrWD4L4dzwoMnEK4Ls+/9fZ36fo6kPFf6XHuTd8z7J8h8A1+uYBLT/JElq96yHULFlhYHkfVbYLvtECoxZFFXk0Fj0j2p0JLbd++ZlGbMlo6cm9YzjfSe6XQZ6gxA7Da+GzWbmq+J5M324s1ybjV0Hd0V02horGikckUl6Uelk9YtDUkTuo3vRvW66k5+N0dmRDy/Ps8768FzPcvCQmnrZ8Q97TVIQVocRFDQ76sF/LZzqMQwWtZvFEnqAWwHZUDmD/fs29qRc9N7pJPeO5267c6TkZUrK8kakNXsmIZ9DRx48qp6QzUY8OZ6Se+dTs36GsJ1YYwxVK2sIrN/Zie/m7b5cKRn3PXXe8MVWSyPyQWj498jS1alxBLWqjl9lDHC8gqKMoH1wEDbWVR8+2Ha84tuTPvHdNs5Ymny4EGBSq/n5PaeV7Ophm1/2oZpNGT0yWDQ1YMoX+wMY+g1uxe7/7ObPW/vQbyCpAv9L+lPl+Odnoadr+ykfHE54hWyBmcx8MqBeNJj97nIEzah214KvztunZkhIDG7cGRMGFmyaontECr2tDiIgryCouuBR23nUPHt+Yy7FkzwrJ5pO0csvZ+VFbi2f992FwfJYEYgvGTua+FhApF5jjL6/ndkyaqzbYdQduhtheh4AthsO4SKb8Nla6K8SUTMlNrakwc3NHxgO4cNC0/2nHbj973VVZkU287SBgb4qe0Qyh4tDqIg6PfVAz+ynUPFM2O6U5VnO4UNj+4oHYgx9bZz2LCrhwy8+gfeEcVDZIHtLK3488iSVR1/wkQlPC0OoiTo9z0HzLedQ8WnPNmxVYRutnPYkNfYOHhybW1K9h4AhLySfvel3pm//5rnQwMdnv8hiiqAH9sOoezS4iC6bgAabYdQ8WeyZ2WqLdjTzC93lY0RY/bYzmHTf8Z5Js27xltek068rV75i5Elq5J1pkfVRlocRFHQ71sBPGQ7h4o/Uz3FNa0flby6h033S/ZXBmznsG17bxl81TzvcasHstB2Ftd64EHbIZR9WhxEXyE6MZI6xCmyIav1o5LbrXv2Tkk3Jmg7h22NaZJ5xxVpM546w/O+cbr0bbplZMmqpF1qW7WdFgdRFvT7KoBbbedQ8aW/7BlgO4Nt6ZD+4917dD0S1+sTPFN+eLW3rC6NNZYivDayZNWrlq6t4owWBzEQ9PueAeJ9dLKKkVyq96cROsZ2jnhwYUXVxO6hUCLPIBhRW/vIsVfN8x6zoR+xnpWwFvhBjK+p4pgWB7GjgxMVAOM9a4IiCTdTXtT8ZmdZBjob20H16ZJdcGXatOdmeN41EN2FIL5w78iSVRtidC2VALQ4iJGg31cMPGI7h7Jvmqc4essCJqBT6+pGDm1oeN92jnjz8lTPtILvej9v8BLtN+116Jow6hBaHMTWnYA+IpTiTvOUaK/BIR7dWXosxqT0Exwt2Xi0DLtynrfflqN4L0qXCAPfHVmyqjZK7QMgIvNFZHwL288WkYJOtPuEiJzo/v32Q/Z1uOAUkTkiMqDJ64PXSRVaHMRQ0O/bD9xsO4ey6zjZ3st2hngzsDE0YFZ1zWLbOeJRXYbk/PB7aVNfmSyLjDM2IJIesrnqojHmVWNMh3stjDFXG2NWui9vP2TflE5EmwMcLA4OuU5K0OIgxtyZE5+znUPZIYTDudQcaztHPPqf0t2nijGltnPEq2dneaf/5ArvpkYPmyLU5BoOeUPtLBHJE5HiJq9vFZFC9+V3RGSZiBSLyAR3/xwRecT9+7Ei8oGIBETkZyJS6W6fJSKvNWnzERGZ4/59voiMFxE/kO22/7S7r+n580XkRREpEZGnRUTcfT8VkSVupt+L4wJgPPC02152054PEbnEzVgsIvc2yVUpIj8XkeUi8qGI9IvkzzbWtDiw43qgQ2vbq8Q2XLZuEqGL7RzxKNeYrnPKK+JttsC4snagjLjqB96eO3rQ2emnD9xOiOWtnC7GmDE4v/+ebGH/b4DfGmNOpp1zwxhjCoAaY8wYY8xlLRwyFpgHnAgcB0x1tz9ijDnNGDMKyAbOMsa8CHwMXOa2d/Bn5N5quBeYDYwBThORc93dOcCHxpjRwELge+35HuKNFgcWBP2+vTjdVjpCO8VM8azQMSdH8IO9+6ZmhM162zniWU2WdLvp+2mTi8bLQgMdXcDqwZElq2I9CPRZAGPMQqCbiPQ4ZP/UA8cAf43wtT8yxmw1xoSBZUCeu/10EVksIgGcN/yTWmnnNGC+MabUGNMIPA3McPfVAwd6OD5pco2EpMWBJUG/7y2cSlmlkKmeFSm5GmFbecF75+7dKb3mQlv9+SveGXdd6l3X6Gl3L+Rq4CfRyITzuHbT95WmM4Ee+mGopQ9HLW07Uptt1XTWxxCQJiJZwGPABW5vxR862PYBDeaLR3JDQFon2rJOiwO7fgyssB1Cxc4oz8ao3VK48p819P1lBaMeqzy47YUVDZz0WCWeu/bz8eehw577xrpGRjxSybCHKvC/+8Xv0Y17w0x8wtl+8YvV1Iei39l1dmX1ab1CoU+jfqEksHKInHjNTd7csm581MZTwsCcKD6dsBPoKyK9RSQTOKvJvosBRGQaUG6MOXRFyveAb7t/b3prYBNwoohkur0NZxzm2g0ikt6OrAcKgTIRyQUuaLKvAujawjkfATNF5CgR8QKXkKQT3GlxYFHQ76vF+UegnyZTRB/KB0Wr7Tlj0nnj8ua1x6i+Hl6+KJsZQ7yHPS8UNsx9vYZ/XdaFlXNzeba4gZWlTiHxo//UcvOkTNbd1JWeWcIfP22IVvxmHtlRmovTBaxaUZktPa6/3nvaW6NlgWl9orUHRpas+jBaWYwxDcDdOG+i/weUNNldKyJLgceBq1o4/QfAXLeLf2CTNrcAzwPF7p9LD3P53wOfHRiQ2Ias+3B6C4qBN4ElTXY/BTx+YEBik3O2AwXAO8By4BNjzD/bcr1EIzoxmX15BUX/hTPIRSWxnuzfszTruqg+xhjcF+asZ6opvj632fZZT1Vx/1ezGD/gy0XCB1saKVxQx5uX5wDwP4ucnoOCaRn0+WUlO27NJc0jXzou2i4acPSiVZkZ02NysSQxen34s4IXwn28hv4t7P4YmDqyZFVCfBgRkUpjTG7rR6po0J6D+HA/xM2SrSpKJnhKIvUIWkRtqzAc0+2LXwWDugnbKsLsrjH0yII0j7jbPWzbH7sPEw/vLB2OMVUxu2ASWD7Uc8q1N3oz9ubw8SG79gMXJ0phoOzT4iAOBP2+MHAFzj9glaSmeYr1v2879AuF+n2tqnpJ60eqpvbnSO/rbvSOe/dEmW+cgXEAVyfa2gnaa2CXFgdxIuj3bQKus51DRc94z5rD3/i3aGBXYcv+L27vb91vGNjVQ+9sYV8tNIaNuz3MwG6xnfn5nrI9EzzG6OOf7WREPA+d4511/7c8n1Vm8quRJatesJ1JJRYtDuJI0O97FnjQdg4VHUNkR1/bGVpy2kAva3eH2bg3TH3I8NyKBs4ekYaIcPqxXl5c6Yxx+/PyBs4Z0Z7B4J2XbUyX6/aVr4vpRZPIkhEec+UtaRGdBVGlBh2QGGfyCoq8wBvAmbazqMhJo7FhbeYVRoSMaF3jkpeqmR8MUVZt6Jcj3DUrk17Zwo3/qqW02tAjSxhztIc3L8/h84owV79ay+uXOU83vL62gXlv1BEyhivHZPDfMzIB2LA3zLdfrGZPjWFsfy9/Oy+bzLTY9h6EITxxyKC1tR7PiJheOPHtBU4N5Ac22g6iEo8WB3Eor6CoF85jNcfZzqIiY7SsW/PPzJ8Ot50jUf1fl+xPb+nXZ5ztHAnEAGcH8gOvtXqkUi3Q2wpxKOj37QHOASpbO1YlhqmeFbqgUCd8pbpmXL/GRh2c2HY/08JAdYYWB3Eq6PcVA/no+gtJYbJnZWuT06hWPLKztBfGHH6aR3XAi8CdtkOoxKbFQRwL+n0vAz+znUN13kjPppamYlXtcEJ9w9BT6urfs50jzn0MXBHID+iHCtUpWhzEvzuBV22HUJ3Ti4rBtjMkg9/sKh2JMRW2c8SprTjjDGK5DLNKUlocxLmg32eAy4GVtrOojunP7p0eMUfZzpEMjgqF+3yzsuoT2zniUBVOYbDddhCVHLQ4SABBv68COBfYZzuLar+JnlVbbGdIJnfu3jPJa8w22zniiAEuD+QHDrcgkVLtpsVBggj6fWtxCoRoLbWqomSat1ifOomgTEPWTXv3BW3niCM/DuQH/mE7hEouWhwkkKDftwC4kNaXZVVxZKysjdrER6nqu+UVU3LCYb3VBr8P5Ad0RVcVcVocJJig3/caziOOutZ9ghgkZf1sZ0g2AnLfrrIG2zks+zvwfdshVHLS4iABBf2+Z4AbbOdQrcukvjaDhjzbOZLRjJra0QMbGj+0ncOSfwHfCeQH9EOCigotDhJU0O/7LfDftnOoIxst6zeIEJerMSaDR3fuOhpjUq0HYRFwfiA/kGrft4ohLQ4SWNDv+wVwv+0c6vCmeot3286QzIY2NOadVlv3vu0cMbQU+KbOZaCiTYuDBBf0+24DnrCdQ7VssmelzlQXZb/aVXaKGJMKj/muBr4WyA+U2w6ikp8WB8nhWuAF2yHUlw2Xrd1tZ0h2PcLhnhdUVC63nSPKNgNfCeQHdAEvFRNaHCSBoN8XxplF8Q3bWVRz3anKs50hFRTs3js5zZjNtnNEyUZgZiA/oJNpqZjR4iBJBP2+euBbaIEQN4bIjq0iaM9BDGRAxq179ibjrIlrgBmB/EDQdhCVWrQ4SCJBv68GOAd42XYWBZM9K5PxzSpuXba/cnLXUDhgO0cErcDpMdhqO4hKPVocJBm3B+Ei4K+2s6S6qZ5iHVEeY7/aVSq2M0TIUmBWID+ww3YQlZq0OEhCQb8vhDOL4uO2s6Sy0bIhy3aGVDOptm7UkIaGRH+08SNgdiA/UGY7iEpdYow+aZXM8gqK/MCPbOdIRWszv7M5XUKDbedINZvT0rb6BvXvg0im7Swd8C7wjUB+oMJ2EJXatOcgyQX9vgLgFpxlXVWM5FBTkUboGNs5UtHgxsZBU2tqP7CdowOKcOYx0MJAWafFQQoI+n0PAt8BdLrVGDnVs2ajCMly/zvh3FdaNlaMSaTZKf8AnBPID1TbDqIUaHGQMoJ+39PAN4FK21lSwTRPIBVm7Itb3cKm+2X7K4pt52ijnwbyA9cE8gMh20GUOkCLgxQS9PveBGYD221nSXYTPKu118CyH+7ZNzXdmI22cxxBPZAfyA/cYzuIUofS4iDFBP2+JcB4YLHtLMlsqHzey3aGVJcGaT8p2xOv0w3vwZkO+S+2gyjVEi0OUlDQ7/scmAn80XaWZCSEw7nUHGs7h4JvVVZN6BEKLbOd4xBrgUmB/MBC20GUOhwtDlJU0O+rC/p9VwM3oAMVI2q4bN0khaZa+AAADs1JREFUQhfbOZTjNztLM4mfZ7b/BUwM5AfW2g6i1JFocZDign7fo8CZwC7bWZLFFM8KndUujoyrqx95fEPDe5ZjGOAuwBfID+y1nEWpVmlxoAj6fQtxxiF8bDtLMpjiWVFnO4Nq7pGdpUMxxtZ01nuBswL5gcJAfiBeejCUOiItDhQAQb9vCzAdXZOh00Z5gjm2M6jmBjSG+p9eXWNjEO5yYHwgP/C6hWsr1WE6fbL6kryConnAL4E021kS0brMy7enSbi/7RyquSqRyslDBtUYkT4xuuRfgWsD+QFdgEslHO05UF8S9Pt+DZwBbLKdJdH0oGKvFgbxKceY3KvK95fE4FK1wNxAfuAKLQxUotLiQLXIHYdwCvBn21kSyQRPSdB2BnV4N+wtn5IZDq+L4iWW4dxGeCyK1+gwERkjIt9o8rpQRG5tx/l5InLEmSfdYy5t8nq8iDzUscTKFi0O1GEF/b79Qb9vDnA+oMvHtsE0T/F+2xnU4XnBe1fZnmhMbR3GuRU3MZAfWBGF9iNlDPCNVo/qnDzgYHFgjPnYGHNTlK+pIkyLA9WqoN/3MnAyzqpx6gjGe1brOI0456uqHn9UY+iTCDa5BTgjkB/4r0B+oD6C7bbI/WReIiJPicgaEXlaRM4UkfdEZK2ITBCRHBF5UkQ+EpGlInKOiGQAdwMXi8gyEbnYbfJEEZkvIhtE5Cb3GneLyLwm1/y5iPyghRyLRORT92uKu8sPTHevcbOIzBKR19xzeonIP0TkMxH5UEROcbcXunmb5VD26IBE1S55BUXXAg8AOiK/BSszv7u6i9SNsJ1DHVlxRsbaSwb0G4pIZz8gPQtcH8iP3UJbIpIHrAPGAiuAJThPRVwFnA18F1gJrDTG/E1EegAfucdfCIw3xtzgtlUIfBU4HegKrAaOBgYCLxtjxonzM1oLTHCPec0YM0pEugBhY0ytiBwPPGuMGS8is4BbjTFnudc4+FpEHgbKjDF3ichs4FfGmDGHy2GM0QnaLNGeA9UuQb/vdzhdkx/YzhJv0mhsyKZOp01OAKPq648/sb6+MxMj7QUuC+QHLo1lYdDERmNMwBgTxikQ3jLOJ70ATrf+V4ECEVkGzAeygMGHaavIGFNnjCnDmQytnzEmCOwWkbFuW0vNl5fATgf+ICIB4AXgxDbknob7uLQx5m2gt4h0O1yONrSnokSLA9VuQb9vHc6cCD9Bp14+6ETZFBQhw3YO1TYP7ywbgTEdWcL8WWBkID/wTKQztUPTibbCTV6HcR5BFuB8Y8wY92uwMWZVG9oK8cUjzE8Ac3B6Ip5s4bybgZ3AaJxJ1Dr7//7hcigLtDhQHRL0+0JBv+/nOF2N2osATPGs0CmoE0jfUKjv/6uqbs+soBuAr7u9BTujlStC3gRuFBEBcHsAACpwuu3b4hXg68BpbnuH6g5sd3svvgN423CNRcBlbqZZOLcYdBBvHNLiQHVK0O9bBkzF+YQR778wo2qKZ0Wj7Qyqfe4q2zPBY8z2Vg5rBO4FRgXyAy29Scaje3C6/T8TkRXua4B3cAYgNh2Q2CJjTL17/PPGmFALhzwG5IvIcuAEoMrd/hkQEpHlInLzIecUAqeKyGc4Axfz2/+tqVjQAYkqYvIKirrhLC5zAynYJbgk8/uf9JHyU23nUO3zux7d3n2kZ49ph9m9GLgmkB/4LJaZ4oE7EPFT4EJjjK4imWK0OFARl1dQdBLwCDDLcpSY2pB5WalHTKym5lUREobwpCGD1tR4PCc02bwHuAN4PJAfCFuKZo2InAi8BrxijPmh7Twq9rQ4UFGTV1B0MXA/MMh2lmg7mj07P8y6QUdXJ6j/dMleenO/PmNxBtg+BtylSyurVKZjDlTUBP2+v+Pci/QDUZ8cxqaJnlVbbGdQHXdmdc3YE+rqfwecHMgPzNPCQKU67TlQMZFXUHQ8zqCuc3Ees0oq96U9Pv+itIWzbOdQHbIY+BGF5QtsB1EqXmhxoGIqr6BoDHAnTpGQNP6Tcev7wzyfT2n9SBVH1gC3U1j+ku0gSsUbLQ6UFXkFRWNxioRzbGeJhJLM/PVZ0jDUdg7VJjtwnqp5gsJyffxUqRZocaCsyisoGodTJJxtO0tHZVJfW5I5J13k4CQwKj5tBR4CHqWwvNp2GKXimRYHKi64RUIh8E3LUdptgqxa9XzmPSNt51CHtRRnsbDnKSzX6b6VaoOUm6hGxaeg3/cpcHZeQdGpOEXCWXYTtd1Ub3GZ7QzqSwzwOvAAheXv2A6jVKLRngMVl/IKikYB1+PM2Z5rOc4R/T3j7gUTPSUzbedQANTirPr3IIXlh1toSCnVCi0OVFzLKyjqClyBUyi0ZUnYmFuaec3ynlI52naOFFeGM3nRoxSW6wJYSnWSFgcqYeQVFM0C5uI8Bhk3t8Q2Zl5aLkJ32zlS1BrgV8BfKCyvsR1GqWShxYFKOHkFRQOAa9yv/jazDJadWxdm3pz000PHmXrgDeAJ4DUKy/WXmFIRpsWBSlh5BUVpwHnAdTiLPMV8OvCLvO98dF/6HybE+ropKAwsAJ4BXqKwXKc3ViqKtDhQSSGvoOho4HzgImAaMSoUHkp/eP7Z3g9mxeJaKWoJ8CzwdwrLP7cdRqlUocWBSjp5BUX9gQtwCoWpRHEthwUZ8z4c4tk1KVrtp6hVOAXBsxSWr7MdRqlUpMWBSmp5BUUDcQqFi4FJRLhQWJv5nU3pEhoSyTZT1GbgOZyCYJntMEqlOi0OVMrIKyg6BqdQOBuYDGR2pr0caiqKM6/KFUm+VSZjIAwsA94B/gm8qwMLlYofWhyolJRXUJSNc8thNnAGcCq0b22E6Z7PAn/N8J8chXjJyADFOMXAO8ACHVSoVPyKm2fFlYqloN9XA/zH/SKvoKgbMBOnWJgNnEwrtyCmeQL65nZkq3EKgbeB+RSWl1rOo5RqI+05UKoFeQVFfYDTcQqFqcBIDulZeCXjjoVjPetnWIgXrzbwRc/AO/p0gVKJS4sDpdrAvQ0xGhiHcwti3GeZV0k3qUnFaZPDwHrgsyZfn1JYvtlqKqVUxGhxoFRHFXZPB44HTnK/Rrl/DiM5btmFgCDOFMWrgZXAcqCYwvJqi7mUUlGmxYFSkVbYPQMYDgzEmd75aPfPpn8/GrurTYaBPTgLFpUBu4FdwDqcQmANsJ7C8nprCZVS1mhxoJQthd1z+XLB0B/oC2TgzPLowRnr0Na/A+zFebMvo/mbf9PX+ygsD0f7W1RKJSYtDpRSSinVTMwXqlFKKaVUfNPiQCmllFLNaHGglFJKqWa0OFBKKaVUM1ocKKWUUqoZLQ6UUkop1YwWB0oppZRqRosDpZRSSjWjxYFSSimlmtHiQCnVaSJSKCK3duC8OSLySDQyue13KFcb265sZX8PEbm+yesBIvJiNLIoFWlaHCilVAvE0ZnfkT2Ag8WBMeZzY8wFnU+mVPRpcaCU6hAR+W8RWSMi7wIj3G1DReQNEflERBaJyAnu9qdE5HER+dg956wmTQ1wz1krIvc1af8SEQmISLGI3Otu87ptFbv7bna3zxeR34jIMnffhCbtn+ju3yAiNzVp/xb32GIRmeduyxOR1SLyF6AYuENEft3knO+JyIOH/BxyReQtEfnUzXSOu8sPDHUz/dJtu9g9J0tE/uQev1RETne3zxGRl1v6eSgVS8mw5rxSKsZE5FTg28AYnN8jnwKfAL8HrjPGrBWRicBjwGz3tDxgAjAUeEdEhrnbxwBjgTpgtYg8DISAe4FTcVaZ/LeInAtsAQYaY0a5OXo0idXFGDNGRGYATwKj3O0nAKcDXd32fwucAnwXmAgIsFhEFrjXOh7IN8Z8KCK5wHIRuc0Y0+Cec+0hP45a4DxjzH4ROQr4UEReBQqAUcaYMW7WvCbnzAWMMeZkt4D6t4gMP9zPwxiz5bD/MZSKAi0OlFIdMR14xRhTDeC+GWYBU4AXROTAcZlNznneGBMG1orIBpw3bYC3jDHlbjsrgSFAb2C+MabU3f40MAO4BzjOLSCKgH83af9ZAGPMQhHp1qRwKDLG1AF1IrIL6AdMc/NXue2/7H5PrwKbjDEfum1VisjbwFkisgpIN8YEDvlZCPALtygJAwPdaxzJNOBh9xolIrIJOFActPTz0OJAxZQWB0qpSPEA+w58Um7BoevDH3hd12RbiCP8XjLG7BWR0cDXgOuAi4ArI9W+q+qQ108AtwMlwJ9aOP4yoA9wqjGmQUSCOIVSR7U3r1IRp2MOlFIdsRA4V0SyRaQr8E2gGtgoIhfCwQF9o5ucc6GIeERkKHAcsPoI7X8EzBSRo0TEC1wCLHC77T3GmJeAnwDjmpxzsXvdaUD5gU/fh7HIzd9FRHKA89xtX2KMWQwcA1yK2ztxiO7ALrcwOB3nkz5ABc6tjMNd/zI373BgMEf+eSgVU1qRKqXazRjzqYj8HVgO7AKWuLsuA34rIj8B0oHn3GMANuO86XfDGZdQ2+T2w6HtbxeRAuAdnG77ImPMP91i409NniL4cZPTakVkqXvdKzkCN/9Tbh6AJ4wxSw8ZF9DU88AYY8zeFvY9DfyviASAj3F6GDDG7BaR99xBiP8CHm1yzmM4P6cA0AjMMcbUHe7noVSsiTGH9sQppVRkuW/ErxljovKcv4jMB241xnwcpfZfAx40xrwVjfaVijd6W0EppQ5DnImM1gA1WhioVKI9B0oppZRqRnsOlFJKKdWMFgdKKaWUakaLA6WUUko1o8WBUkoppZrR4kAppZRSzWhxoJRSSqlmtDhQSimlVDNaHCillFKqGS0OlFJKKdWMFgdKKaWUakaLA6WUUko1o8WBUkoppZrR4kAppZRSzWhxoJRSSqlmtDhQSimlVDNaHCillFKqGS0OlFJKKdWMFgdKKaWUakaLA6WUUko1o8WBUkoppZrR4kAppZRSzWhxoJRSSqlmtDhQSimlVDNaHCillFKqGS0OlFJKKdWMFgdKKaWUakaLA6WUUko1o8WBUkoppZrR4kAppZRSzWhxoJRSSqlmtDhQSimlVDNaHCillFKqGS0OlFJKKdXM/wevRvki++5emgAAAABJRU5ErkJggg==\n",
      "text/plain": [
       "<Figure size 576x576 with 1 Axes>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    }
   ],
   "source": [
    "data.interactionType.value_counts().plot.pie(autopct='%.2f',figsize=(8, 8))\n",
    "plt.title('Interaction Type Distribution')\n",
    "plt.savefig(\"Interactiontype.svg\")\n",
    "plt.show()"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 17,
   "metadata": {},
   "outputs": [
    {
     "data": {
      "text/html": [
       "<div>\n",
       "<style scoped>\n",
       "    .dataframe tbody tr th:only-of-type {\n",
       "        vertical-align: middle;\n",
       "    }\n",
       "\n",
       "    .dataframe tbody tr th {\n",
       "        vertical-align: top;\n",
       "    }\n",
       "\n",
       "    .dataframe thead th {\n",
       "        text-align: right;\n",
       "    }\n",
       "</style>\n",
       "<table border=\"1\" class=\"dataframe\">\n",
       "  <thead>\n",
       "    <tr style=\"text-align: right;\">\n",
       "      <th></th>\n",
       "      <th>interactionType</th>\n",
       "    </tr>\n",
       "  </thead>\n",
       "  <tbody>\n",
       "    <tr>\n",
       "      <th>phosphorylation</th>\n",
       "      <td>1468</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>dephosphorylation</th>\n",
       "      <td>224</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>methylation</th>\n",
       "      <td>134</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>ubiquitination</th>\n",
       "      <td>75</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>acetylation</th>\n",
       "      <td>70</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>demethylation</th>\n",
       "      <td>37</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>deubiquitination</th>\n",
       "      <td>28</td>\n",
       "    </tr>\n",
       "  </tbody>\n",
       "</table>\n",
       "</div>"
      ],
      "text/plain": [
       "                   interactionType\n",
       "phosphorylation               1468\n",
       "dephosphorylation              224\n",
       "methylation                    134\n",
       "ubiquitination                  75\n",
       "acetylation                     70\n",
       "demethylation                   37\n",
       "deubiquitination                28"
      ]
     },
     "execution_count": 17,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "data.interactionType.value_counts().to_frame()"
   ]
  },
  {
   "cell_type": "markdown",
   "metadata": {},
   "source": [
    "### Distinct interaction types per paper"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 18,
   "metadata": {},
   "outputs": [
    {
     "data": {
      "image/png": "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\n",
      "text/plain": [
       "<Figure size 432x288 with 1 Axes>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    }
   ],
   "source": [
    "distinct_no_papers = data['pubmedId'].nunique()\n",
    "data.groupby('pubmedId')['interactionType'].nunique().hist(bins=100)\n",
    "plt.title(\"Number of unique interactions per paper\")\n",
    "plt.xlabel('Number of interactions')\n",
    "plt.ylabel('Number of papers (total is {})'.format(distinct_no_papers))\n",
    "plt.show()"
   ]
  },
  {
   "cell_type": "markdown",
   "metadata": {},
   "source": [
    "### Postive vs Negative Relationships"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 19,
   "metadata": {},
   "outputs": [
    {
     "data": {
      "image/png": "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\n",
      "text/plain": [
       "<Figure size 360x360 with 1 Axes>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    }
   ],
   "source": [
    "data.isNegative.value_counts().plot.pie(autopct='%.2f',figsize=(5, 5))\n",
    "plt.title('Is Negtive relationship')\n",
    "plt.show()"
   ]
  },
  {
   "cell_type": "markdown",
   "metadata": {},
   "source": [
    "### Number of participants per interaction"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 20,
   "metadata": {},
   "outputs": [
    {
     "data": {
      "image/png": "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\n",
      "text/plain": [
       "<Figure size 360x360 with 1 Axes>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    }
   ],
   "source": [
    "data[\"participants\"].apply(lambda x: len(x)).hist (bins=50, figsize=(5,5), color = 'green')\n",
    "plt.title(\"Participants count per interaction\")\n",
    "plt.show()"
   ]
  },
  {
   "cell_type": "markdown",
   "metadata": {},
   "source": [
    "### Explore if the abstract contains the trigger word"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 21,
   "metadata": {},
   "outputs": [],
   "source": [
    "data[\"hasTriggerWord\"] = data.apply(lambda r: r[\"interactionType\"].lower() in r[\"pubmedabstract\"].lower() , 1)"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 22,
   "metadata": {},
   "outputs": [
    {
     "data": {
      "image/png": "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\n",
      "text/plain": [
       "<Figure size 360x360 with 1 Axes>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    }
   ],
   "source": [
    "data.hasTriggerWord.value_counts().plot.pie(autopct='%.2f',figsize=(5, 5))\n",
    "plt.title('Has trigger word')\n",
    "plt.show()"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 23,
   "metadata": {},
   "outputs": [
    {
     "data": {
      "image/png": "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\n",
      "text/plain": [
       "<Figure size 3240x2160 with 7 Axes>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    }
   ],
   "source": [
    "fig, ax = plt.subplots( 7,1, figsize=(45,30))\n",
    "data.groupby(['hasTriggerWord', 'interactionType']).size().unstack().plot(kind='pie', subplots='True',autopct='%.2f', ax=ax)\n",
    "plt.show()"
   ]
  },
  {
   "cell_type": "markdown",
   "metadata": {},
   "source": [
    "### Explore how many of the entity alias are mentioned in the abstract"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 24,
   "metadata": {},
   "outputs": [
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "CPU times: user 17.3 s, sys: 154 ms, total: 17.4 s\n",
      "Wall time: 19.5 s\n"
     ]
    }
   ],
   "source": [
    "%%time \n",
    "\n",
    "from difflib import SequenceMatcher\n",
    "def getEntityMentionsCount(r):\n",
    "    count = 0\n",
    "    abstract = r[\"pubmedabstract\"].lower()\n",
    "    abstract_len= len(abstract)\n",
    "    for p in r[\"participants\"]:\n",
    "        if p is None or p['alias'] is None : continue\n",
    "        \n",
    "        for a in p['alias']:\n",
    "            alias = a[0].lower()\n",
    "            s = SequenceMatcher(None, abstract, alias)\n",
    "            _,_,match_size = s.find_longest_match(0, len(abstract), 0, len(alias))\n",
    "            if match_size >= 3 and match_size >= len(alias)/2 :\n",
    "                count += 1\n",
    "        \n",
    "    return count\n",
    "        \n",
    "\n",
    "data[\"entityMentionsCount\"] = data.apply(lambda r: getEntityMentionsCount(r)  , 1)"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 25,
   "metadata": {},
   "outputs": [
    {
     "data": {
      "image/png": "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\n",
      "text/plain": [
       "<Figure size 1080x360 with 1 Axes>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    }
   ],
   "source": [
    "data['entityMentionsCount'].hist ( bins=150, figsize=(15,5), color = 'red')\n",
    "plt.title('Entity mentions count distribution')\n",
    "plt.xlabel('Entity name mentions count in abstract')\n",
    "plt.ylabel('Total number of interactions')\n",
    "\n",
    "plt.show()"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 26,
   "metadata": {},
   "outputs": [
    {
     "data": {
      "image/png": "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\n",
      "text/plain": [
       "<Figure size 432x288 with 1 Axes>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    }
   ],
   "source": [
    "(data['entityMentionsCount'] > 0).value_counts().plot.pie(autopct='%.2f')\n",
    "plt.title(\"Percentage of interactions with entity mentions \")\n",
    "plt.ylabel(\"Entity mentions > 0\")\n",
    "plt.show()"
   ]
  },
  {
   "cell_type": "markdown",
   "metadata": {},
   "source": [
    "### Randomly eye ball interactions with no entity mentions"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 27,
   "metadata": {},
   "outputs": [
    {
     "data": {
      "text/html": [
       "<div>\n",
       "<style scoped>\n",
       "    .dataframe tbody tr th:only-of-type {\n",
       "        vertical-align: middle;\n",
       "    }\n",
       "\n",
       "    .dataframe tbody tr th {\n",
       "        vertical-align: top;\n",
       "    }\n",
       "\n",
       "    .dataframe thead th {\n",
       "        text-align: right;\n",
       "    }\n",
       "</style>\n",
       "<table border=\"1\" class=\"dataframe\">\n",
       "  <thead>\n",
       "    <tr style=\"text-align: right;\">\n",
       "      <th></th>\n",
       "      <th>participants</th>\n",
       "      <th>pubmedabstract</th>\n",
       "    </tr>\n",
       "  </thead>\n",
       "  <tbody>\n",
       "    <tr>\n",
       "      <th>1683</th>\n",
       "      <td>[{'uniprotid': 'Q5VYA9', 'alias': [['zic2_human'], ['Zinc finger protein ZIC 2'], ['ZIC2'], ['Zinc finger protein of the cerebellum 2']]}, {'uniprotid': 'Q9UME3', 'alias': [['prkdc_human'], ['DNA-dependent protein kinase catalytic subunit'], ['PRKDC'], ['HYRC'], ['HYRC1'], ['DNPK1'], ['p460']]}]</td>\n",
       "      <td>Signal transducers and activators of transcription (STATs) play a pleomorphic role in signal transduction, similarly to an oncogene. Suppressors of cytokine signaling (SOCS) inhibit STAT pathways. In breast cancer, little is known about the correlation among STATs, SOCS, and clinicopathological/biological features. Therefore, we investigated p-STAT3 (activated form of STAT3) and SOCS-1/3 expression, and clarified their correlation. Immunohistochemical staining for p-STAT3 antigen was performed in 74 surgically resected primary breast cancers. Real-time RT-PCR was used to measure mRNA expression of SOCS-1 and SOCS-3. There were no significant correlations between p-STAT3 expression and clinicopathological/biological features. SOCS-3 mRNA expression in the lymph node-positive group was significantly lower than that in the negative group (p=0.013). Among three groups divided based on the number of involved lymph nodes (node-negative group, 1-3 involved nodes group, 4 or more involved nodes group), the group with 4 or more involved nodes had the lowest expression of SOCS-3 (p=0.043). Correlations were not seen between SOCS-1 and SOCS-3 expression and other clinicopathological/biological features, except for blood vessel invasion. There were no statistical correlations between either SOCS-1 or SOCS-3 mRNA expression and p-STAT3 expression. Reduced expression of SOCS-3 is closely related to lymph node metastasis. Therefore, SOCS-3 may be a good predictor for lymph node metastasis.</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>2461</th>\n",
       "      <td>[{'uniprotid': 'D4AA09', 'alias': [['a4gw50_rat'], ['Non-specific serine/threonine protein kinase'], ['Stk38l'], ['rCG_29601']]}]</td>\n",
       "      <td>MICALs (molecules interacting with CasL) are atypical multidomain flavoenzymes with diverse cellular functions. The molecular pathways employed by MICAL proteins to exert their cellular effects remain largely uncharacterized. Via an unbiased proteomics approach, we identify MICAL-1 as a binding partner of NDR (nuclear Dbf2-related) kinases. NDR1/2 kinases are known to mediate apoptosis downstream of the mammalian Ste-20-like kinase MST1, and ablation of NDR1 in mice predisposes the mice to cancer as a result of compromised apoptosis. MST1 phosphorylates NDR1/2 kinases at their hydrophobic motif, thereby facilitating full NDR kinase activity and function. However, if and how this key phosphorylation event is regulated are unknown. Here we show that MICAL-1 interacts with the hydrophobic motif of NDR1/2 and that overexpression or knockdown of MICAL-1 reduces or augments NDR kinase activation or activity, respectively. Surprisingly, MICAL-1 is a phosphoprotein but not an NDR or MST1 substrate. Rather, MICAL-1 competes with MST1 for NDR binding and thereby antagonizes MST1-induced NDR activation. In line with this inhibitory effect, overexpression or knockdown of MICAL-1 inhibits or enhances, respectively, NDR-dependent proapoptotic signaling induced by extrinsic stimuli. Our findings unveil a previously unknown biological role for MICAL-1 in apoptosis and define a novel negative regulatory mechanism of MST-NDR signaling.</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>1899</th>\n",
       "      <td>[{'uniprotid': 'Q81755', 'alias': [['polg_hcvja'], ['Genome polyprotein']]}, {'uniprotid': 'P97634', 'alias': [['kc1a_rat'], ['Casein kinase I isoform alpha'], ['Csnk1a1'], ['CK1']]}]</td>\n",
       "      <td>Hepatitis C virus (HCV) NS5A phosphoprotein is a component of virus replicase. Here we demonstrate that in vitro unphosphorylated NS5A protein inhibits HCV RNA-dependent RNA polymerase (RdRp) activity in polyA-oligoU system but has little effect on synthesis of viral RNA. The phosphorylated casein kinase (CK) II NS5A protein causes the opposite effect on RdRp in each of these systems. The phosphorylation of NS5A protein with CKII does not affect its affinity to the HCV RdRp and RNA. The NS5A phosphorylation with CKI does not change the RdRp activity. Herein we report evidence that the NS5A prevents template binding to the RdRp.</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>3144</th>\n",
       "      <td>[{'uniprotid': 'Q9R1J6', 'alias': [['ikkb_mouse'], ['Inhibitor of nuclear factor kappa-B kinase subunit beta'], ['I-kappa-B kinase 2'], ['Nuclear factor NF-kappa-B inhibitor kinase beta'], ['Ikbkb'], ['Ikkb']]}, {'uniprotid': 'B2R8L6', 'alias': [['ikba_human'], ['NF-kappa-B inhibitor alpha'], ['NFKBIA'], ['IKBA'], ['MAD3'], ['NFKBI'], ['I-kappa-B-alpha'], ['Major histocompatibility complex enhancer-binding protein MAD3']]}]</td>\n",
       "      <td>Tpl2/Cot is a serine/threonine kinase that plays a key physiological role in the regulation of immune responses to pro-inflammatory stimuli, including tumor necrosis factor-alpha (TNF-alpha). TNF-alpha stimulates the JNK, ERK, and p38 mitogen-activated protein kinases and the NF-kappaB pathway by recruiting RIP1 and TRAF2 to the TNF receptor 1. Here we showed that Tpl2 activation by TNF-alpha signals depends on the integrity of the Tpl2-interacting proteins RIP1 and TRAF2, which are required for the engagement of the ERK mitogen-activated protein kinase pathway. However, neither RIP1 nor TRAF2 overexpression was sufficient to activate Tpl2 and ERK. We also showed that Tpl2 activation by TNF-alpha depends on a tyrosine kinase activity that is detected in TNF-alpha-stimulated cells. Based on both genetic and biochemical evidence, we concluded that in a variety of cell types, Syk is the tyrosine kinase that plays an important role in the activation of Tpl2 upstream of ERK. These data therefore dissect the TNF receptor 1 proximal events that regulate Tpl2 and ERK and highlight a role for RIP1, TRAF2, and Syk in this pathway.</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>943</th>\n",
       "      <td>[{'uniprotid': 'Q2V575', 'alias': [['plcg1_human'], ['1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase gamma-1'], ['PLC-148'], ['PLC1'], ['Phospholipase C-II'], ['PLCG1'], ['Phosphoinositide phospholipase C-gamma-1'], ['Phospholipase C-gamma-1']]}]</td>\n",
       "      <td>The tyrosine phosphatase r-PTPeta is able to suppress the malignant phenotype of rat thyroid tumorigenic cell lines. To identify r-PTPeta interacting proteins, a yeast two-hybrid screening was performed and an insert corresponding to the full-length syntenin cDNA was isolated. It encodes a protein containing two PDZ domains that mediates the binding of syntenin to proteins such as syndecan, proTGF-alpha, beta-ephrins and neurofascin. We show that r-PTPeta is able to interact with syntenin also in mammalian cells, and although syntenin is a tyrosine-phosphorylated protein it is not a substrate of r-PTPeta. The integrity of both PDZ domains of syntenin and the carboxy-terminal region of r-PTPeta are required for the interaction between syntenin and r-PTPeta.</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>158</th>\n",
       "      <td>[{'uniprotid': 'Q9H2Y1', 'alias': [['hipk2_human'], ['Homeodomain-interacting protein kinase 2'], ['HIPK2']]}]</td>\n",
       "      <td>The function of many protein kinases is controlled by the phosphorylation of a critical tyrosine residue in the activation loop. Dual specificity tyrosine-phosphorylation-regulated kinases (DYRKs) autophosphorylate on this tyrosine residue but phosphorylate substrates on aliphatic amino acids. This study addresses the mechanism of dual specificity kinase activity in DYRK1A and related kinases. Tyrosine autophosphorylation of DYRK1A occurred rapidly during in vitro translation and did not depend on the non-catalytic domains or other proteins. Expression in bacteria as well as in mammalian cells revealed that tyrosine kinase activity of DYRK1A is not restricted to the co-translational autophosphorylation in the activation loop. Moreover, mature DYRK1A was still capable of tyrosine autophosphorylation. Point mutants of DYRK1A and DYRK2 lacking the activation loop tyrosine showed enhanced tyrosine kinase activity. A series of structurally diverse DYRK1A inhibitors was used to pharmacologically distinguish different conformational states of the catalytic domain that are hypothesized to account for the dual specificity kinase activity. All tested compounds inhibited substrate phosphorylation with higher potency than autophosphorylation but none of the tested inhibitors differentially inhibited threonine and tyrosine kinase activity. Finally, the related cyclin-dependent kinase-like kinases (CLKs), which lack the activation loop tyrosine, autophosphorylated on tyrosine both in vitro and in living cells. We propose a model of DYRK autoactivation in which tyrosine autophosphorylation in the activation loop stabilizes a conformation of the catalytic domain with enhanced serine/threonine kinase activity without disabling tyrosine phosphorylation. The mechanism of dual specificity kinase activity probably applies to related serine/threonine kinases that depend on tyrosine autophosphorylation for maturation.</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>1093</th>\n",
       "      <td>[{'uniprotid': 'Q8IYV3', 'alias': [['tbk1_human'], ['Serine/threonine-protein kinase TBK1'], ['TBK1'], ['NAK'], ['TANK-binding kinase 1'], ['T2K'], ['NF-kappa-B-activating kinase']]}]</td>\n",
       "      <td>Caspase activation has been extensively studied in the context of apoptosis. However, caspases also control other cellular functions, although the mechanisms regulating caspases in nonapoptotic contexts remain obscure. Drosophila IAP1 (DIAP1) is an endogenous caspase inhibitor that is crucial for regulating cell death during development. Here we describe Drosophila IKK-related kinase (DmIKKvarepsilon) as a regulator of caspase activation in a nonapoptotic context. We show that DmIKKvarepsilon promotes degradation of DIAP1 through direct phosphorylation. Knockdown of DmIKKvarepsilon in the proneural clusters of the wing imaginal disc, in which nonapoptotic caspase activity is required for proper sensory organ precursor (SOP) development, stabilizes endogenous DIAP1 and affects Drosophila SOP development. Our results demonstrate that DmIKKvarepsilon is a determinant of DIAP1 protein levels and that it establishes the threshold of activity required for the execution of nonapoptotic caspase functions.</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>2147</th>\n",
       "      <td>[{'uniprotid': 'P02686-1', 'alias': [['p02686-1'], ['Myelin basic protein'], ['MBP'], ['Myelin A1 protein'], ['Myelin membrane encephalitogenic protein'], ['Golli-MBP1'], ['HOG7']]}, {'uniprotid': 'Q8I629', 'alias': [['q8i629_plaf7'], ['PF3D7_1201600']]}]</td>\n",
       "      <td>The canonical mitogen-activated protein kinase (MAPK) signal cascade was previously suggested to be atypical in the malaria parasite. This raises queries on the existence of alternative mediators of plasmodial MAPK pathways. This study describes, Pfnek3, a malarial protein kinase belonging to the NIMA (Never in Mitosis, Aspergillus) family. Endogenous Pfnek3 is expressed during late asexual to gametocyte stages and lacks some classical protein kinase sequence motifs. Moreover, Pfnek3 is phylogenetically distant from mammalian NIMA-kinases. Recombinant Pfnek3 was able to phosphorylate and stimulate a malarial MAPK (Pfmap2). Contrastingly, this was not observed with two other kinases, Pfmap1 and human MAPK1, suggesting that the Pfnek3-Pfmap2 interaction may be specific for Pfmap2 regulation. In summary, our data reveal a malarial NIMA-kinase with the potential to regulate a MAPK. Possessing biochemical properties divergent from classical mammalian NIMA-kinases, Pfnek3 could potentially be an attractive target for parasite-selective anti-malarials.</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>3153</th>\n",
       "      <td>[{'uniprotid': 'Q9BTT9', 'alias': [['gys1_human'], ['Glycogen [starch] synthase, muscle'], ['GYS1'], ['GYS']]}, {'uniprotid': 'Q9UL47', 'alias': [['gsk3b_human'], ['Glycogen synthase kinase-3 beta'], ['GSK3B'], ['Serine/threonine-protein kinase GSK3B']]}]</td>\n",
       "      <td>Bim, the Bcl-2 interacting mediator of cell death, is a member of the BH3-only family of pro-apoptotic proteins. Recent studies have demonstrated that the apoptotic activity of Bim can be regulated through a post-translational mechanism whereby ERK phosphorylation serves as a signal for Bim ubiquitination and proteasomal degradation. In this report, we investigated the signaling pathways leading to Bim phosphorylation in Ba/F3 cells, an interleukin-3 (IL-3)-dependent B-cell line. IL-3 stimulation induced phosphorylation of Bim(EL), one of the predominant isoforms of Bim expressed in cells, at multiple sites, as evidenced by the formation of at least three to four bands by Western blotting that were sensitive to phosphatase digestion. The appearance of multiple, phosphorylated species of Bim(EL) correlated with Akt, and not ERK, activation. The PI3K inhibitor, LY294002, blocked IL-3-stimulated Akt activity and partially blocked Bim(EL) phosphorylation. In vitro kinase assays showed that recombinant Akt could directly phosphorylate a GST-Bim(EL) fusion protein and identified the Akt phosphorylation site in the Bim(EL) domain as Ser(87). Further, we demonstrated that cytokine stimulation promotes Bim(EL) binding to 14-3-3 proteins. Finally, we show that mutation of Ser(87) dramatically increases the apoptotic potency of Bim(EL). We propose that Ser(87) of Bim(EL) is an important regulatory site that is targeted by Akt to attenuate the pro-apoptotic function of Bim(EL), thereby promoting cell survival.</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>465</th>\n",
       "      <td>[{'uniprotid': 'Q15153', 'alias': [['plk1_human'], ['Serine/threonine-protein kinase PLK1'], ['Polo-like kinase 1'], ['Serine/threonine-protein kinase 13'], ['PLK1'], ['PLK']]}]</td>\n",
       "      <td>During interphase in Drosophila neuroblasts, the Centrobin (CNB)-positive daughter centriole retains pericentriolar material (PCM) and organizes an aster that is a key determinant of the orientation of cell division. Here we show that daughter centrioles depleted of CNB cannot fulfil this function whereas mother centrioles that carry ectopic CNB can. CNB co-precipitates with a set of centrosomal proteins that include γ-TUB, ANA2, CNN, SAS-4, ASL, DGRIP71, POLO and SAS-6. Following chemical inhibition of POLO or removal of three POLO phosphorylation sites present in CNB, the interphase microtubule aster is lost. These results demonstrate that centriolar CNB localization is both necessary and sufficient to enable centrioles to retain PCM and organize the interphase aster in Drosophila neuroblasts. They also reveal an interphase function for POLO in this process that seems to have co-opted part of the protein network involved in mitotic centrosome maturation.</td>\n",
       "    </tr>\n",
       "  </tbody>\n",
       "</table>\n",
       "</div>"
      ],
      "text/plain": [
       "                                                                                                                                                                                                                                                                                                                                                                                                                                     participants  \\\n",
       "1683                                                                                                                                     [{'uniprotid': 'Q5VYA9', 'alias': [['zic2_human'], ['Zinc finger protein ZIC 2'], ['ZIC2'], ['Zinc finger protein of the cerebellum 2']]}, {'uniprotid': 'Q9UME3', 'alias': [['prkdc_human'], ['DNA-dependent protein kinase catalytic subunit'], ['PRKDC'], ['HYRC'], ['HYRC1'], ['DNPK1'], ['p460']]}]   \n",
       "2461                                                                                                                                                                                                                                                                                                            [{'uniprotid': 'D4AA09', 'alias': [['a4gw50_rat'], ['Non-specific serine/threonine protein kinase'], ['Stk38l'], ['rCG_29601']]}]   \n",
       "1899                                                                                                                                                                                                                                                      [{'uniprotid': 'Q81755', 'alias': [['polg_hcvja'], ['Genome polyprotein']]}, {'uniprotid': 'P97634', 'alias': [['kc1a_rat'], ['Casein kinase I isoform alpha'], ['Csnk1a1'], ['CK1']]}]   \n",
       "3144  [{'uniprotid': 'Q9R1J6', 'alias': [['ikkb_mouse'], ['Inhibitor of nuclear factor kappa-B kinase subunit beta'], ['I-kappa-B kinase 2'], ['Nuclear factor NF-kappa-B inhibitor kinase beta'], ['Ikbkb'], ['Ikkb']]}, {'uniprotid': 'B2R8L6', 'alias': [['ikba_human'], ['NF-kappa-B inhibitor alpha'], ['NFKBIA'], ['IKBA'], ['MAD3'], ['NFKBI'], ['I-kappa-B-alpha'], ['Major histocompatibility complex enhancer-binding protein MAD3']]}]   \n",
       "943                                                                                                                                                                             [{'uniprotid': 'Q2V575', 'alias': [['plcg1_human'], ['1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase gamma-1'], ['PLC-148'], ['PLC1'], ['Phospholipase C-II'], ['PLCG1'], ['Phosphoinositide phospholipase C-gamma-1'], ['Phospholipase C-gamma-1']]}]   \n",
       "158                                                                                                                                                                                                                                                                                                                                [{'uniprotid': 'Q9H2Y1', 'alias': [['hipk2_human'], ['Homeodomain-interacting protein kinase 2'], ['HIPK2']]}]   \n",
       "1093                                                                                                                                                                                                                                                      [{'uniprotid': 'Q8IYV3', 'alias': [['tbk1_human'], ['Serine/threonine-protein kinase TBK1'], ['TBK1'], ['NAK'], ['TANK-binding kinase 1'], ['T2K'], ['NF-kappa-B-activating kinase']]}]   \n",
       "2147                                                                                                                                                                              [{'uniprotid': 'P02686-1', 'alias': [['p02686-1'], ['Myelin basic protein'], ['MBP'], ['Myelin A1 protein'], ['Myelin membrane encephalitogenic protein'], ['Golli-MBP1'], ['HOG7']]}, {'uniprotid': 'Q8I629', 'alias': [['q8i629_plaf7'], ['PF3D7_1201600']]}]   \n",
       "3153                                                                                                                                                                              [{'uniprotid': 'Q9BTT9', 'alias': [['gys1_human'], ['Glycogen [starch] synthase, muscle'], ['GYS1'], ['GYS']]}, {'uniprotid': 'Q9UL47', 'alias': [['gsk3b_human'], ['Glycogen synthase kinase-3 beta'], ['GSK3B'], ['Serine/threonine-protein kinase GSK3B']]}]   \n",
       "465                                                                                                                                                                                                                                                             [{'uniprotid': 'Q15153', 'alias': [['plk1_human'], ['Serine/threonine-protein kinase PLK1'], ['Polo-like kinase 1'], ['Serine/threonine-protein kinase 13'], ['PLK1'], ['PLK']]}]   \n",
       "\n",
       "                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                pubmedabstract  \n",
       "1683                                                                                                                                                                                                                                                                                                                                                                                                                                               Signal transducers and activators of transcription (STATs) play a pleomorphic role in signal transduction, similarly to an oncogene. Suppressors of cytokine signaling (SOCS) inhibit STAT pathways. In breast cancer, little is known about the correlation among STATs, SOCS, and clinicopathological/biological features. Therefore, we investigated p-STAT3 (activated form of STAT3) and SOCS-1/3 expression, and clarified their correlation. Immunohistochemical staining for p-STAT3 antigen was performed in 74 surgically resected primary breast cancers. Real-time RT-PCR was used to measure mRNA expression of SOCS-1 and SOCS-3. There were no significant correlations between p-STAT3 expression and clinicopathological/biological features. SOCS-3 mRNA expression in the lymph node-positive group was significantly lower than that in the negative group (p=0.013). Among three groups divided based on the number of involved lymph nodes (node-negative group, 1-3 involved nodes group, 4 or more involved nodes group), the group with 4 or more involved nodes had the lowest expression of SOCS-3 (p=0.043). Correlations were not seen between SOCS-1 and SOCS-3 expression and other clinicopathological/biological features, except for blood vessel invasion. There were no statistical correlations between either SOCS-1 or SOCS-3 mRNA expression and p-STAT3 expression. Reduced expression of SOCS-3 is closely related to lymph node metastasis. Therefore, SOCS-3 may be a good predictor for lymph node metastasis.  \n",
       "2461                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                         MICALs (molecules interacting with CasL) are atypical multidomain flavoenzymes with diverse cellular functions. The molecular pathways employed by MICAL proteins to exert their cellular effects remain largely uncharacterized. Via an unbiased proteomics approach, we identify MICAL-1 as a binding partner of NDR (nuclear Dbf2-related) kinases. NDR1/2 kinases are known to mediate apoptosis downstream of the mammalian Ste-20-like kinase MST1, and ablation of NDR1 in mice predisposes the mice to cancer as a result of compromised apoptosis. MST1 phosphorylates NDR1/2 kinases at their hydrophobic motif, thereby facilitating full NDR kinase activity and function. However, if and how this key phosphorylation event is regulated are unknown. Here we show that MICAL-1 interacts with the hydrophobic motif of NDR1/2 and that overexpression or knockdown of MICAL-1 reduces or augments NDR kinase activation or activity, respectively. Surprisingly, MICAL-1 is a phosphoprotein but not an NDR or MST1 substrate. Rather, MICAL-1 competes with MST1 for NDR binding and thereby antagonizes MST1-induced NDR activation. In line with this inhibitory effect, overexpression or knockdown of MICAL-1 inhibits or enhances, respectively, NDR-dependent proapoptotic signaling induced by extrinsic stimuli. Our findings unveil a previously unknown biological role for MICAL-1 in apoptosis and define a novel negative regulatory mechanism of MST-NDR signaling.  \n",
       "1899                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                               Hepatitis C virus (HCV) NS5A phosphoprotein is a component of virus replicase. Here we demonstrate that in vitro unphosphorylated NS5A protein inhibits HCV RNA-dependent RNA polymerase (RdRp) activity in polyA-oligoU system but has little effect on synthesis of viral RNA. The phosphorylated casein kinase (CK) II NS5A protein causes the opposite effect on RdRp in each of these systems. The phosphorylation of NS5A protein with CKII does not affect its affinity to the HCV RdRp and RNA. The NS5A phosphorylation with CKI does not change the RdRp activity. Herein we report evidence that the NS5A prevents template binding to the RdRp.  \n",
       "3144                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                        Tpl2/Cot is a serine/threonine kinase that plays a key physiological role in the regulation of immune responses to pro-inflammatory stimuli, including tumor necrosis factor-alpha (TNF-alpha). TNF-alpha stimulates the JNK, ERK, and p38 mitogen-activated protein kinases and the NF-kappaB pathway by recruiting RIP1 and TRAF2 to the TNF receptor 1. Here we showed that Tpl2 activation by TNF-alpha signals depends on the integrity of the Tpl2-interacting proteins RIP1 and TRAF2, which are required for the engagement of the ERK mitogen-activated protein kinase pathway. However, neither RIP1 nor TRAF2 overexpression was sufficient to activate Tpl2 and ERK. We also showed that Tpl2 activation by TNF-alpha depends on a tyrosine kinase activity that is detected in TNF-alpha-stimulated cells. Based on both genetic and biochemical evidence, we concluded that in a variety of cell types, Syk is the tyrosine kinase that plays an important role in the activation of Tpl2 upstream of ERK. These data therefore dissect the TNF receptor 1 proximal events that regulate Tpl2 and ERK and highlight a role for RIP1, TRAF2, and Syk in this pathway.  \n",
       "943                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                             The tyrosine phosphatase r-PTPeta is able to suppress the malignant phenotype of rat thyroid tumorigenic cell lines. To identify r-PTPeta interacting proteins, a yeast two-hybrid screening was performed and an insert corresponding to the full-length syntenin cDNA was isolated. It encodes a protein containing two PDZ domains that mediates the binding of syntenin to proteins such as syndecan, proTGF-alpha, beta-ephrins and neurofascin. We show that r-PTPeta is able to interact with syntenin also in mammalian cells, and although syntenin is a tyrosine-phosphorylated protein it is not a substrate of r-PTPeta. The integrity of both PDZ domains of syntenin and the carboxy-terminal region of r-PTPeta are required for the interaction between syntenin and r-PTPeta.  \n",
       "158   The function of many protein kinases is controlled by the phosphorylation of a critical tyrosine residue in the activation loop. Dual specificity tyrosine-phosphorylation-regulated kinases (DYRKs) autophosphorylate on this tyrosine residue but phosphorylate substrates on aliphatic amino acids. This study addresses the mechanism of dual specificity kinase activity in DYRK1A and related kinases. Tyrosine autophosphorylation of DYRK1A occurred rapidly during in vitro translation and did not depend on the non-catalytic domains or other proteins. Expression in bacteria as well as in mammalian cells revealed that tyrosine kinase activity of DYRK1A is not restricted to the co-translational autophosphorylation in the activation loop. Moreover, mature DYRK1A was still capable of tyrosine autophosphorylation. Point mutants of DYRK1A and DYRK2 lacking the activation loop tyrosine showed enhanced tyrosine kinase activity. A series of structurally diverse DYRK1A inhibitors was used to pharmacologically distinguish different conformational states of the catalytic domain that are hypothesized to account for the dual specificity kinase activity. All tested compounds inhibited substrate phosphorylation with higher potency than autophosphorylation but none of the tested inhibitors differentially inhibited threonine and tyrosine kinase activity. Finally, the related cyclin-dependent kinase-like kinases (CLKs), which lack the activation loop tyrosine, autophosphorylated on tyrosine both in vitro and in living cells. We propose a model of DYRK autoactivation in which tyrosine autophosphorylation in the activation loop stabilizes a conformation of the catalytic domain with enhanced serine/threonine kinase activity without disabling tyrosine phosphorylation. The mechanism of dual specificity kinase activity probably applies to related serine/threonine kinases that depend on tyrosine autophosphorylation for maturation.  \n",
       "1093                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                      Caspase activation has been extensively studied in the context of apoptosis. However, caspases also control other cellular functions, although the mechanisms regulating caspases in nonapoptotic contexts remain obscure. Drosophila IAP1 (DIAP1) is an endogenous caspase inhibitor that is crucial for regulating cell death during development. Here we describe Drosophila IKK-related kinase (DmIKKvarepsilon) as a regulator of caspase activation in a nonapoptotic context. We show that DmIKKvarepsilon promotes degradation of DIAP1 through direct phosphorylation. Knockdown of DmIKKvarepsilon in the proneural clusters of the wing imaginal disc, in which nonapoptotic caspase activity is required for proper sensory organ precursor (SOP) development, stabilizes endogenous DIAP1 and affects Drosophila SOP development. Our results demonstrate that DmIKKvarepsilon is a determinant of DIAP1 protein levels and that it establishes the threshold of activity required for the execution of nonapoptotic caspase functions.  \n",
       "2147                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                     The canonical mitogen-activated protein kinase (MAPK) signal cascade was previously suggested to be atypical in the malaria parasite. This raises queries on the existence of alternative mediators of plasmodial MAPK pathways. This study describes, Pfnek3, a malarial protein kinase belonging to the NIMA (Never in Mitosis, Aspergillus) family. Endogenous Pfnek3 is expressed during late asexual to gametocyte stages and lacks some classical protein kinase sequence motifs. Moreover, Pfnek3 is phylogenetically distant from mammalian NIMA-kinases. Recombinant Pfnek3 was able to phosphorylate and stimulate a malarial MAPK (Pfmap2). Contrastingly, this was not observed with two other kinases, Pfmap1 and human MAPK1, suggesting that the Pfnek3-Pfmap2 interaction may be specific for Pfmap2 regulation. In summary, our data reveal a malarial NIMA-kinase with the potential to regulate a MAPK. Possessing biochemical properties divergent from classical mammalian NIMA-kinases, Pfnek3 could potentially be an attractive target for parasite-selective anti-malarials.  \n",
       "3153                                                                                                                                                                                                                                                                                                                                                                                                                       Bim, the Bcl-2 interacting mediator of cell death, is a member of the BH3-only family of pro-apoptotic proteins. Recent studies have demonstrated that the apoptotic activity of Bim can be regulated through a post-translational mechanism whereby ERK phosphorylation serves as a signal for Bim ubiquitination and proteasomal degradation. In this report, we investigated the signaling pathways leading to Bim phosphorylation in Ba/F3 cells, an interleukin-3 (IL-3)-dependent B-cell line. IL-3 stimulation induced phosphorylation of Bim(EL), one of the predominant isoforms of Bim expressed in cells, at multiple sites, as evidenced by the formation of at least three to four bands by Western blotting that were sensitive to phosphatase digestion. The appearance of multiple, phosphorylated species of Bim(EL) correlated with Akt, and not ERK, activation. The PI3K inhibitor, LY294002, blocked IL-3-stimulated Akt activity and partially blocked Bim(EL) phosphorylation. In vitro kinase assays showed that recombinant Akt could directly phosphorylate a GST-Bim(EL) fusion protein and identified the Akt phosphorylation site in the Bim(EL) domain as Ser(87). Further, we demonstrated that cytokine stimulation promotes Bim(EL) binding to 14-3-3 proteins. Finally, we show that mutation of Ser(87) dramatically increases the apoptotic potency of Bim(EL). We propose that Ser(87) of Bim(EL) is an important regulatory site that is targeted by Akt to attenuate the pro-apoptotic function of Bim(EL), thereby promoting cell survival.  \n",
       "465                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                 During interphase in Drosophila neuroblasts, the Centrobin (CNB)-positive daughter centriole retains pericentriolar material (PCM) and organizes an aster that is a key determinant of the orientation of cell division. Here we show that daughter centrioles depleted of CNB cannot fulfil this function whereas mother centrioles that carry ectopic CNB can. CNB co-precipitates with a set of centrosomal proteins that include γ-TUB, ANA2, CNN, SAS-4, ASL, DGRIP71, POLO and SAS-6. Following chemical inhibition of POLO or removal of three POLO phosphorylation sites present in CNB, the interphase microtubule aster is lost. These results demonstrate that centriolar CNB localization is both necessary and sufficient to enable centrioles to retain PCM and organize the interphase aster in Drosophila neuroblasts. They also reveal an interphase function for POLO in this process that seems to have co-opted part of the protein network involved in mitotic centrosome maturation.  "
      ]
     },
     "execution_count": 27,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "\n",
    "data.query('entityMentionsCount == 0')[['participants','pubmedabstract' ]].sample(n=10)\n"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 28,
   "metadata": {},
   "outputs": [
    {
     "data": {
      "text/html": [
       "<div>\n",
       "<style scoped>\n",
       "    .dataframe tbody tr th:only-of-type {\n",
       "        vertical-align: middle;\n",
       "    }\n",
       "\n",
       "    .dataframe tbody tr th {\n",
       "        vertical-align: top;\n",
       "    }\n",
       "\n",
       "    .dataframe thead th {\n",
       "        text-align: right;\n",
       "    }\n",
       "</style>\n",
       "<table border=\"1\" class=\"dataframe\">\n",
       "  <thead>\n",
       "    <tr style=\"text-align: right;\">\n",
       "      <th></th>\n",
       "      <th>interactionId</th>\n",
       "      <th>interactionType</th>\n",
       "      <th>isNegative</th>\n",
       "      <th>participants</th>\n",
       "      <th>pubmedId</th>\n",
       "      <th>pubmedTitle</th>\n",
       "      <th>pubmedabstract</th>\n",
       "      <th>lessThanThreshold</th>\n",
       "      <th>hasTriggerWord</th>\n",
       "      <th>entityMentionsCount</th>\n",
       "    </tr>\n",
       "  </thead>\n",
       "  <tbody>\n",
       "    <tr>\n",
       "      <th>0</th>\n",
       "      <td>2503510</td>\n",
       "      <td>phosphorylation</td>\n",
       "      <td>False</td>\n",
       "      <td>[{'uniprotid': 'P43405', 'alias': [['ksyk_human'], ['Tyrosine-protein kinase SYK'], ['SYK'], ['Spleen tyrosine kinase'], ['p72-Syk']]}]</td>\n",
       "      <td>25605870</td>\n",
       "      <td>None</td>\n",
       "      <td>NLRP3 is the most crucial member of the NLR family, as it detects the existence of pathogen invasion and self-derived molecules associated with cellular damage. Several studies have reported that excessive NLRP3 inflammasome-mediated caspase-1 activation is a key factor in the development of diseases. Recent studies have reported that Syk is involved in pathogen-induced NLRP3 inflammasome activation; however, the detailed mechanism linking Syk to NLRP3 inflammasome remains unclear. In this study, we showed that Syk mediates NLRP3 stimuli-induced processing of procaspase-1 and the consequent activation of caspase-1. Moreover, the kinase activity of Syk is required to potentiate caspase-1 activation in a reconstituted NLRP3 inflammasome system in HEK293T cells. The adaptor protein ASC bridges NLRP3 with the effector protein caspase-1. Herein, we find that Syk can associate directly with ASC and NLRP3 by its kinase domain but interact indirectly with procaspase-1. Syk can phosphorylate ASC at Y146 and Y187 residues, and the phosphorylation of both residues is critical to enhance ASC oligomerization and the recruitment of procaspase-1. Together, our results reveal a new molecular pathway through which Syk promotes NLRP3 inflammasome formation, resulting from the phosphorylation of ASC. Thus, the control of Syk activity might be effective to modulate NLRP3 inflammasome activation and treat NLRP3-related immune diseases.</td>\n",
       "      <td>True</td>\n",
       "      <td>True</td>\n",
       "      <td>1</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>1</th>\n",
       "      <td>2503513</td>\n",
       "      <td>phosphorylation</td>\n",
       "      <td>False</td>\n",
       "      <td>[{'uniprotid': 'P43405', 'alias': [['ksyk_human'], ['Tyrosine-protein kinase SYK'], ['SYK'], ['Spleen tyrosine kinase'], ['p72-Syk']]}, {'uniprotid': 'Q9BSZ5', 'alias': [['asc_human'], ['Apoptosis-associated speck-like protein containing a CARD'], ['PYD and CARD domain-containing protein'], ['Target of methylation-induced silencing 1'], ['Caspase recruitment domain-containing protein 5'], ['ASC'], ['CARD5'], ['TMS1'], ['PYCARD']]}]</td>\n",
       "      <td>25605870</td>\n",
       "      <td>None</td>\n",
       "      <td>NLRP3 is the most crucial member of the NLR family, as it detects the existence of pathogen invasion and self-derived molecules associated with cellular damage. Several studies have reported that excessive NLRP3 inflammasome-mediated caspase-1 activation is a key factor in the development of diseases. Recent studies have reported that Syk is involved in pathogen-induced NLRP3 inflammasome activation; however, the detailed mechanism linking Syk to NLRP3 inflammasome remains unclear. In this study, we showed that Syk mediates NLRP3 stimuli-induced processing of procaspase-1 and the consequent activation of caspase-1. Moreover, the kinase activity of Syk is required to potentiate caspase-1 activation in a reconstituted NLRP3 inflammasome system in HEK293T cells. The adaptor protein ASC bridges NLRP3 with the effector protein caspase-1. Herein, we find that Syk can associate directly with ASC and NLRP3 by its kinase domain but interact indirectly with procaspase-1. Syk can phosphorylate ASC at Y146 and Y187 residues, and the phosphorylation of both residues is critical to enhance ASC oligomerization and the recruitment of procaspase-1. Together, our results reveal a new molecular pathway through which Syk promotes NLRP3 inflammasome formation, resulting from the phosphorylation of ASC. Thus, the control of Syk activity might be effective to modulate NLRP3 inflammasome activation and treat NLRP3-related immune diseases.</td>\n",
       "      <td>True</td>\n",
       "      <td>True</td>\n",
       "      <td>2</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>10</th>\n",
       "      <td>1796163</td>\n",
       "      <td>phosphorylation</td>\n",
       "      <td>False</td>\n",
       "      <td>[{'uniprotid': 'Q8WUB1', 'alias': [['kc1g2_human'], ['Casein kinase I isoform gamma-2'], ['CK1G2'], ['CSNK1G2']]}, {'uniprotid': 'Q6ZS50', 'alias': [['lrrk2_human'], ['Leucine-rich repeat serine/threonine-protein kinase 2'], ['LRRK2'], ['PARK8'], ['Dardarin']]}]</td>\n",
       "      <td>25500533</td>\n",
       "      <td>None</td>\n",
       "      <td>LRRK2, a gene relevant to Parkinson's disease, encodes a scaffolding protein with both GTPase and kinase activities. LRRK2 protein is itself phosphorylated and therefore is subject to regulation by cell signalling; however, the kinase(s) responsible for this event have not been definitively identified. Here using an unbiased siRNA kinome screen, we identify and validate casein kinase 1α (CK1α) as being responsible for LRRK2 phosphorylation, including in the adult mouse striatum. We further show that LRRK2 recruitment to TGN46-positive Golgi-derived vesicles is modulated by constitutive LRRK2 phosphorylation by CK1α. These effects are mediated by differential protein interactions of LRRK2 with a guanine nucleotide exchange factor, ARHGEF7. These pathways are therefore likely involved in the physiological maintenance of the Golgi in cells, which may play a role in the pathogenesis of Parkinson's disease.</td>\n",
       "      <td>True</td>\n",
       "      <td>True</td>\n",
       "      <td>3</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>1000</th>\n",
       "      <td>1160297</td>\n",
       "      <td>phosphorylation</td>\n",
       "      <td>False</td>\n",
       "      <td>[{'uniprotid': None, 'alias': None}, {'uniprotid': 'Q05BV0', 'alias': [['akt2_human'], ['RAC-beta serine/threonine-protein kinase'], ['AKT2'], ['RAC-PK-beta'], ['Protein kinase Akt-2'], ['Protein kinase B beta']]}]</td>\n",
       "      <td>20856200</td>\n",
       "      <td>None</td>\n",
       "      <td>The PI3K/AKT signaling pathway is aberrant in a wide variety of cancers. Downstream effectors of AKT are involved in survival, growth and metabolic-related pathways. In contrast, contradictory data relating to AKT effects on cell motility and invasion, crucial prometastatic processes, have been reported pointing to a potential cell type and isoform type-specific AKT-driven function. By implication, study of AKT signaling should optimally be conducted in an appropriate intracellular environment. Prognosis in soft-tissue sarcoma (STS), the aggressive malignancies of mesenchymal origin, is poor, reflecting our modest ability to control metastasis, an effort hampered by lack of insight into molecular mechanisms driving STS progression and dissemination. We examined the impact of the cancer progression-relevant AKT pathway on the mesenchymal tumor cell internal milieu. We demonstrate that AKT1 activation induces STS cell motility and invasiveness at least partially through a novel interaction with the intermediate filament vimentin (Vim). The binding of AKT (tail region) to Vim (head region) results in Vim Ser39 phosphorylation enhancing the ability of Vim to induce motility and invasion while protecting Vim from caspase-induced proteolysis. Moreover, vimentin phosphorylation was shown to enhance tumor and metastasis growth in vivo. Insights into this mesenchymal-related molecular mechanism may facilitate the development of critically lacking therapeutic options for these devastating malignancies.</td>\n",
       "      <td>True</td>\n",
       "      <td>True</td>\n",
       "      <td>1</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>1001</th>\n",
       "      <td>1160335</td>\n",
       "      <td>phosphorylation</td>\n",
       "      <td>False</td>\n",
       "      <td>[{'uniprotid': 'B7Z5R1', 'alias': [['akt1_human'], ['RAC-alpha serine/threonine-protein kinase'], ['AKT1'], ['PKB'], ['RAC'], ['RAC-PK-alpha'], ['Protein kinase B'], ['Proto-oncogene c-Akt'], ['Protein kinase B alpha']]}, {'uniprotid': 'Q9NTM3', 'alias': [['vime_human'], ['Vimentin'], ['VIM']]}]</td>\n",
       "      <td>20856200</td>\n",
       "      <td>None</td>\n",
       "      <td>The PI3K/AKT signaling pathway is aberrant in a wide variety of cancers. Downstream effectors of AKT are involved in survival, growth and metabolic-related pathways. In contrast, contradictory data relating to AKT effects on cell motility and invasion, crucial prometastatic processes, have been reported pointing to a potential cell type and isoform type-specific AKT-driven function. By implication, study of AKT signaling should optimally be conducted in an appropriate intracellular environment. Prognosis in soft-tissue sarcoma (STS), the aggressive malignancies of mesenchymal origin, is poor, reflecting our modest ability to control metastasis, an effort hampered by lack of insight into molecular mechanisms driving STS progression and dissemination. We examined the impact of the cancer progression-relevant AKT pathway on the mesenchymal tumor cell internal milieu. We demonstrate that AKT1 activation induces STS cell motility and invasiveness at least partially through a novel interaction with the intermediate filament vimentin (Vim). The binding of AKT (tail region) to Vim (head region) results in Vim Ser39 phosphorylation enhancing the ability of Vim to induce motility and invasion while protecting Vim from caspase-induced proteolysis. Moreover, vimentin phosphorylation was shown to enhance tumor and metastasis growth in vivo. Insights into this mesenchymal-related molecular mechanism may facilitate the development of critically lacking therapeutic options for these devastating malignancies.</td>\n",
       "      <td>True</td>\n",
       "      <td>True</td>\n",
       "      <td>4</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>1002</th>\n",
       "      <td>1160459</td>\n",
       "      <td>phosphorylation</td>\n",
       "      <td>False</td>\n",
       "      <td>[{'uniprotid': 'Q15153', 'alias': [['plk1_human'], ['Serine/threonine-protein kinase PLK1'], ['Polo-like kinase 1'], ['Serine/threonine-protein kinase 13'], ['PLK1'], ['PLK']]}, {'uniprotid': 'Q6IBR4', 'alias': [['fadd_human'], ['FAS-associated death domain protein'], ['FAS-associating death domain-containing protein'], ['Mediator of receptor induced toxicity'], ['FADD'], ['MORT1'], ['Protein FADD'], ['GIG3'], ['Growth-inhibiting gene 3 protein']]}]</td>\n",
       "      <td>20890306</td>\n",
       "      <td>None</td>\n",
       "      <td>Phosphorylation of the Fas-associated death domain (FADD) protein sensitizes cancer cells to various chemotherapeutics. However, the molecular mechanism underlying chemosensitization by phosphorylated FADD (P-FADD) is poorly understood. In this study, we describe the physical interactions and functional interplay between Polo-like kinase 1 (Plk1) and FADD. Plk1 phosphorylates FADD at Ser-194 in response to treatment with taxol. Overexpression of a phosphorylation-mimicking mutant, FADD S194D, caused degradation of Plk1 in an ubiquitin-independent manner, and delayed cytokinesis, consistent with the expected cellular phenotype of Plk1 deficiency. This demonstrates that Plk1 is regulated via a negative feedback loop by its substrate, FADD. Overexpression of FADD S194D sensitized HeLa cells to a low dose of taxol independently of caspase activation, whereas overexpression of FADD S194D resulted in caspase activation in response to a high dose of taxol. Therefore, we examined whether the death potential of P-FADD affected Plk1-mediated tumorigenesis. Transfection of FADD S194D inhibited colony formation by Plk1-overexpressing HeLa cells (HeLa-Plk1). Moreover, overexpression of FADD S194D suppressed tumorigenesis in nude mice xenografted with HeLa-Plk1. Therefore, this study reports the first in vivo validation of tumor-suppressing activity of P-FADD. Collectively, our data demonstrate that in response to taxol, Plk1 endows death-promoting and tumor-suppressor functions to its substrate, FADD.</td>\n",
       "      <td>True</td>\n",
       "      <td>True</td>\n",
       "      <td>7</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>1003</th>\n",
       "      <td>1160465</td>\n",
       "      <td>phosphorylation</td>\n",
       "      <td>False</td>\n",
       "      <td>[{'uniprotid': 'Q15153', 'alias': [['plk1_human'], ['Serine/threonine-protein kinase PLK1'], ['Polo-like kinase 1'], ['Serine/threonine-protein kinase 13'], ['PLK1'], ['PLK']]}, {'uniprotid': 'Q6IBR4', 'alias': [['fadd_human'], ['FAS-associated death domain protein'], ['FAS-associating death domain-containing protein'], ['Mediator of receptor induced toxicity'], ['FADD'], ['MORT1'], ['Protein FADD'], ['GIG3'], ['Growth-inhibiting gene 3 protein']]}]</td>\n",
       "      <td>20890306</td>\n",
       "      <td>None</td>\n",
       "      <td>Phosphorylation of the Fas-associated death domain (FADD) protein sensitizes cancer cells to various chemotherapeutics. However, the molecular mechanism underlying chemosensitization by phosphorylated FADD (P-FADD) is poorly understood. In this study, we describe the physical interactions and functional interplay between Polo-like kinase 1 (Plk1) and FADD. Plk1 phosphorylates FADD at Ser-194 in response to treatment with taxol. Overexpression of a phosphorylation-mimicking mutant, FADD S194D, caused degradation of Plk1 in an ubiquitin-independent manner, and delayed cytokinesis, consistent with the expected cellular phenotype of Plk1 deficiency. This demonstrates that Plk1 is regulated via a negative feedback loop by its substrate, FADD. Overexpression of FADD S194D sensitized HeLa cells to a low dose of taxol independently of caspase activation, whereas overexpression of FADD S194D resulted in caspase activation in response to a high dose of taxol. Therefore, we examined whether the death potential of P-FADD affected Plk1-mediated tumorigenesis. Transfection of FADD S194D inhibited colony formation by Plk1-overexpressing HeLa cells (HeLa-Plk1). Moreover, overexpression of FADD S194D suppressed tumorigenesis in nude mice xenografted with HeLa-Plk1. Therefore, this study reports the first in vivo validation of tumor-suppressing activity of P-FADD. Collectively, our data demonstrate that in response to taxol, Plk1 endows death-promoting and tumor-suppressor functions to its substrate, FADD.</td>\n",
       "      <td>True</td>\n",
       "      <td>True</td>\n",
       "      <td>7</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>1004</th>\n",
       "      <td>1160473</td>\n",
       "      <td>phosphorylation</td>\n",
       "      <td>False</td>\n",
       "      <td>[{'uniprotid': 'Q15153', 'alias': [['plk1_human'], ['Serine/threonine-protein kinase PLK1'], ['Polo-like kinase 1'], ['Serine/threonine-protein kinase 13'], ['PLK1'], ['PLK']]}, {'uniprotid': 'Q6IBR4', 'alias': [['fadd_human'], ['FAS-associated death domain protein'], ['FAS-associating death domain-containing protein'], ['Mediator of receptor induced toxicity'], ['FADD'], ['MORT1'], ['Protein FADD'], ['GIG3'], ['Growth-inhibiting gene 3 protein']]}]</td>\n",
       "      <td>20890306</td>\n",
       "      <td>None</td>\n",
       "      <td>Phosphorylation of the Fas-associated death domain (FADD) protein sensitizes cancer cells to various chemotherapeutics. However, the molecular mechanism underlying chemosensitization by phosphorylated FADD (P-FADD) is poorly understood. In this study, we describe the physical interactions and functional interplay between Polo-like kinase 1 (Plk1) and FADD. Plk1 phosphorylates FADD at Ser-194 in response to treatment with taxol. Overexpression of a phosphorylation-mimicking mutant, FADD S194D, caused degradation of Plk1 in an ubiquitin-independent manner, and delayed cytokinesis, consistent with the expected cellular phenotype of Plk1 deficiency. This demonstrates that Plk1 is regulated via a negative feedback loop by its substrate, FADD. Overexpression of FADD S194D sensitized HeLa cells to a low dose of taxol independently of caspase activation, whereas overexpression of FADD S194D resulted in caspase activation in response to a high dose of taxol. Therefore, we examined whether the death potential of P-FADD affected Plk1-mediated tumorigenesis. Transfection of FADD S194D inhibited colony formation by Plk1-overexpressing HeLa cells (HeLa-Plk1). Moreover, overexpression of FADD S194D suppressed tumorigenesis in nude mice xenografted with HeLa-Plk1. Therefore, this study reports the first in vivo validation of tumor-suppressing activity of P-FADD. Collectively, our data demonstrate that in response to taxol, Plk1 endows death-promoting and tumor-suppressor functions to its substrate, FADD.</td>\n",
       "      <td>True</td>\n",
       "      <td>True</td>\n",
       "      <td>7</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>1005</th>\n",
       "      <td>2665902</td>\n",
       "      <td>dephosphorylation</td>\n",
       "      <td>False</td>\n",
       "      <td>[{'uniprotid': 'Q5F298', 'alias': [['rpb1_mouse'], ['DNA-directed RNA polymerase II subunit RPB1'], ['Polr2a'], ['Rpii215'], ['Rpo2-1'], ['DNA-directed RNA polymerase II subunit A'], ['DNA-directed RNA polymerase III largest subunit']]}, {'uniprotid': 'Q9NP77-1', 'alias': [['q9np77-1'], ['RNA polymerase II subunit A C-terminal domain phosphatase SSU72'], ['SSU72'], ['HSPC182'], ['PNAS-120']]}]</td>\n",
       "      <td>20861839</td>\n",
       "      <td>Crystal structure of the human symplekin-Ssu72-CTD phosphopeptide complex.</td>\n",
       "      <td>Symplekin (Pta1 in yeast) is a scaffold in the large protein complex that is required for 3'-end cleavage and polyadenylation of eukaryotic messenger RNA precursors (pre-mRNAs); it also participates in transcription initiation and termination by RNA polymerase II (Pol II). Symplekin mediates interactions between many different proteins in this machinery, although the molecular basis for its function is not known. Here we report the crystal structure at 2.4 Å resolution of the amino-terminal domain (residues 30-340) of human symplekin in a ternary complex with the Pol II carboxy-terminal domain (CTD) Ser 5 phosphatase Ssu72 (refs 7, 10-17) and a CTD Ser 5 phosphopeptide. The N-terminal domain of symplekin has the ARM or HEAT fold, with seven pairs of antiparallel α-helices arranged in the shape of an arc. The structure of Ssu72 has some similarity to that of low-molecular-mass phosphotyrosine protein phosphatase, although Ssu72 has a unique active-site landscape as well as extra structural features at the C terminus that are important for interaction with symplekin. Ssu72 is bound to the concave face of symplekin, and engineered mutations in this interface can abolish interactions between the two proteins. The CTD peptide is bound in the active site of Ssu72, with the pSer 5-Pro 6 peptide bond in the cis configuration, which contrasts with all other known CTD peptide conformations. Although the active site of Ssu72 is about 25 Å from the interface with symplekin, we found that the symplekin N-terminal domain stimulates Ssu72 CTD phosphatase activity in vitro. Furthermore, the N-terminal domain of symplekin inhibits polyadenylation in vitro, but only when coupled to transcription. Because catalytically active Ssu72 overcomes this inhibition, our results show a role for mammalian Ssu72 in transcription-coupled pre-mRNA 3'-end processing.</td>\n",
       "      <td>True</td>\n",
       "      <td>False</td>\n",
       "      <td>2</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>1006</th>\n",
       "      <td>2665906</td>\n",
       "      <td>dephosphorylation</td>\n",
       "      <td>False</td>\n",
       "      <td>[{'uniprotid': None, 'alias': None}, {'uniprotid': 'Q9NP77-1', 'alias': [['q9np77-1'], ['RNA polymerase II subunit A C-terminal domain phosphatase SSU72'], ['SSU72'], ['HSPC182'], ['PNAS-120']]}]</td>\n",
       "      <td>20861839</td>\n",
       "      <td>Crystal structure of the human symplekin-Ssu72-CTD phosphopeptide complex.</td>\n",
       "      <td>Symplekin (Pta1 in yeast) is a scaffold in the large protein complex that is required for 3'-end cleavage and polyadenylation of eukaryotic messenger RNA precursors (pre-mRNAs); it also participates in transcription initiation and termination by RNA polymerase II (Pol II). Symplekin mediates interactions between many different proteins in this machinery, although the molecular basis for its function is not known. Here we report the crystal structure at 2.4 Å resolution of the amino-terminal domain (residues 30-340) of human symplekin in a ternary complex with the Pol II carboxy-terminal domain (CTD) Ser 5 phosphatase Ssu72 (refs 7, 10-17) and a CTD Ser 5 phosphopeptide. The N-terminal domain of symplekin has the ARM or HEAT fold, with seven pairs of antiparallel α-helices arranged in the shape of an arc. The structure of Ssu72 has some similarity to that of low-molecular-mass phosphotyrosine protein phosphatase, although Ssu72 has a unique active-site landscape as well as extra structural features at the C terminus that are important for interaction with symplekin. Ssu72 is bound to the concave face of symplekin, and engineered mutations in this interface can abolish interactions between the two proteins. The CTD peptide is bound in the active site of Ssu72, with the pSer 5-Pro 6 peptide bond in the cis configuration, which contrasts with all other known CTD peptide conformations. Although the active site of Ssu72 is about 25 Å from the interface with symplekin, we found that the symplekin N-terminal domain stimulates Ssu72 CTD phosphatase activity in vitro. Furthermore, the N-terminal domain of symplekin inhibits polyadenylation in vitro, but only when coupled to transcription. Because catalytically active Ssu72 overcomes this inhibition, our results show a role for mammalian Ssu72 in transcription-coupled pre-mRNA 3'-end processing.</td>\n",
       "      <td>True</td>\n",
       "      <td>False</td>\n",
       "      <td>1</td>\n",
       "    </tr>\n",
       "  </tbody>\n",
       "</table>\n",
       "</div>"
      ],
      "text/plain": [
       "     interactionId    interactionType  isNegative  \\\n",
       "0          2503510    phosphorylation       False   \n",
       "1          2503513    phosphorylation       False   \n",
       "10         1796163    phosphorylation       False   \n",
       "1000       1160297    phosphorylation       False   \n",
       "1001       1160335    phosphorylation       False   \n",
       "1002       1160459    phosphorylation       False   \n",
       "1003       1160465    phosphorylation       False   \n",
       "1004       1160473    phosphorylation       False   \n",
       "1005       2665902  dephosphorylation       False   \n",
       "1006       2665906  dephosphorylation       False   \n",
       "\n",
       "                                                                                                                                                                                                                                                                                                                                                                                                                                                               participants  \\\n",
       "0                                                                                                                                                                                                                                                                                                                                   [{'uniprotid': 'P43405', 'alias': [['ksyk_human'], ['Tyrosine-protein kinase SYK'], ['SYK'], ['Spleen tyrosine kinase'], ['p72-Syk']]}]   \n",
       "1                       [{'uniprotid': 'P43405', 'alias': [['ksyk_human'], ['Tyrosine-protein kinase SYK'], ['SYK'], ['Spleen tyrosine kinase'], ['p72-Syk']]}, {'uniprotid': 'Q9BSZ5', 'alias': [['asc_human'], ['Apoptosis-associated speck-like protein containing a CARD'], ['PYD and CARD domain-containing protein'], ['Target of methylation-induced silencing 1'], ['Caspase recruitment domain-containing protein 5'], ['ASC'], ['CARD5'], ['TMS1'], ['PYCARD']]}]   \n",
       "10                                                                                                                                                                                                   [{'uniprotid': 'Q8WUB1', 'alias': [['kc1g2_human'], ['Casein kinase I isoform gamma-2'], ['CK1G2'], ['CSNK1G2']]}, {'uniprotid': 'Q6ZS50', 'alias': [['lrrk2_human'], ['Leucine-rich repeat serine/threonine-protein kinase 2'], ['LRRK2'], ['PARK8'], ['Dardarin']]}]   \n",
       "1000                                                                                                                                                                                                                                                 [{'uniprotid': None, 'alias': None}, {'uniprotid': 'Q05BV0', 'alias': [['akt2_human'], ['RAC-beta serine/threonine-protein kinase'], ['AKT2'], ['RAC-PK-beta'], ['Protein kinase Akt-2'], ['Protein kinase B beta']]}]   \n",
       "1001                                                                                                                                                               [{'uniprotid': 'B7Z5R1', 'alias': [['akt1_human'], ['RAC-alpha serine/threonine-protein kinase'], ['AKT1'], ['PKB'], ['RAC'], ['RAC-PK-alpha'], ['Protein kinase B'], ['Proto-oncogene c-Akt'], ['Protein kinase B alpha']]}, {'uniprotid': 'Q9NTM3', 'alias': [['vime_human'], ['Vimentin'], ['VIM']]}]   \n",
       "1002  [{'uniprotid': 'Q15153', 'alias': [['plk1_human'], ['Serine/threonine-protein kinase PLK1'], ['Polo-like kinase 1'], ['Serine/threonine-protein kinase 13'], ['PLK1'], ['PLK']]}, {'uniprotid': 'Q6IBR4', 'alias': [['fadd_human'], ['FAS-associated death domain protein'], ['FAS-associating death domain-containing protein'], ['Mediator of receptor induced toxicity'], ['FADD'], ['MORT1'], ['Protein FADD'], ['GIG3'], ['Growth-inhibiting gene 3 protein']]}]   \n",
       "1003  [{'uniprotid': 'Q15153', 'alias': [['plk1_human'], ['Serine/threonine-protein kinase PLK1'], ['Polo-like kinase 1'], ['Serine/threonine-protein kinase 13'], ['PLK1'], ['PLK']]}, {'uniprotid': 'Q6IBR4', 'alias': [['fadd_human'], ['FAS-associated death domain protein'], ['FAS-associating death domain-containing protein'], ['Mediator of receptor induced toxicity'], ['FADD'], ['MORT1'], ['Protein FADD'], ['GIG3'], ['Growth-inhibiting gene 3 protein']]}]   \n",
       "1004  [{'uniprotid': 'Q15153', 'alias': [['plk1_human'], ['Serine/threonine-protein kinase PLK1'], ['Polo-like kinase 1'], ['Serine/threonine-protein kinase 13'], ['PLK1'], ['PLK']]}, {'uniprotid': 'Q6IBR4', 'alias': [['fadd_human'], ['FAS-associated death domain protein'], ['FAS-associating death domain-containing protein'], ['Mediator of receptor induced toxicity'], ['FADD'], ['MORT1'], ['Protein FADD'], ['GIG3'], ['Growth-inhibiting gene 3 protein']]}]   \n",
       "1005                                                           [{'uniprotid': 'Q5F298', 'alias': [['rpb1_mouse'], ['DNA-directed RNA polymerase II subunit RPB1'], ['Polr2a'], ['Rpii215'], ['Rpo2-1'], ['DNA-directed RNA polymerase II subunit A'], ['DNA-directed RNA polymerase III largest subunit']]}, {'uniprotid': 'Q9NP77-1', 'alias': [['q9np77-1'], ['RNA polymerase II subunit A C-terminal domain phosphatase SSU72'], ['SSU72'], ['HSPC182'], ['PNAS-120']]}]   \n",
       "1006                                                                                                                                                                                                                                                                    [{'uniprotid': None, 'alias': None}, {'uniprotid': 'Q9NP77-1', 'alias': [['q9np77-1'], ['RNA polymerase II subunit A C-terminal domain phosphatase SSU72'], ['SSU72'], ['HSPC182'], ['PNAS-120']]}]   \n",
       "\n",
       "      pubmedId  \\\n",
       "0     25605870   \n",
       "1     25605870   \n",
       "10    25500533   \n",
       "1000  20856200   \n",
       "1001  20856200   \n",
       "1002  20890306   \n",
       "1003  20890306   \n",
       "1004  20890306   \n",
       "1005  20861839   \n",
       "1006  20861839   \n",
       "\n",
       "                                                                     pubmedTitle  \\\n",
       "0                                                                           None   \n",
       "1                                                                           None   \n",
       "10                                                                          None   \n",
       "1000                                                                        None   \n",
       "1001                                                                        None   \n",
       "1002                                                                        None   \n",
       "1003                                                                        None   \n",
       "1004                                                                        None   \n",
       "1005  Crystal structure of the human symplekin-Ssu72-CTD phosphopeptide complex.   \n",
       "1006  Crystal structure of the human symplekin-Ssu72-CTD phosphopeptide complex.   \n",
       "\n",
       "                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                  pubmedabstract  \\\n",
       "0                                                                                                                                                                                                                                                                                                                                                                                                                                                 NLRP3 is the most crucial member of the NLR family, as it detects the existence of pathogen invasion and self-derived molecules associated with cellular damage. Several studies have reported that excessive NLRP3 inflammasome-mediated caspase-1 activation is a key factor in the development of diseases. Recent studies have reported that Syk is involved in pathogen-induced NLRP3 inflammasome activation; however, the detailed mechanism linking Syk to NLRP3 inflammasome remains unclear. In this study, we showed that Syk mediates NLRP3 stimuli-induced processing of procaspase-1 and the consequent activation of caspase-1. Moreover, the kinase activity of Syk is required to potentiate caspase-1 activation in a reconstituted NLRP3 inflammasome system in HEK293T cells. The adaptor protein ASC bridges NLRP3 with the effector protein caspase-1. Herein, we find that Syk can associate directly with ASC and NLRP3 by its kinase domain but interact indirectly with procaspase-1. Syk can phosphorylate ASC at Y146 and Y187 residues, and the phosphorylation of both residues is critical to enhance ASC oligomerization and the recruitment of procaspase-1. Together, our results reveal a new molecular pathway through which Syk promotes NLRP3 inflammasome formation, resulting from the phosphorylation of ASC. Thus, the control of Syk activity might be effective to modulate NLRP3 inflammasome activation and treat NLRP3-related immune diseases.   \n",
       "1                                                                                                                                                                                                                                                                                                                                                                                                                                                 NLRP3 is the most crucial member of the NLR family, as it detects the existence of pathogen invasion and self-derived molecules associated with cellular damage. Several studies have reported that excessive NLRP3 inflammasome-mediated caspase-1 activation is a key factor in the development of diseases. Recent studies have reported that Syk is involved in pathogen-induced NLRP3 inflammasome activation; however, the detailed mechanism linking Syk to NLRP3 inflammasome remains unclear. In this study, we showed that Syk mediates NLRP3 stimuli-induced processing of procaspase-1 and the consequent activation of caspase-1. Moreover, the kinase activity of Syk is required to potentiate caspase-1 activation in a reconstituted NLRP3 inflammasome system in HEK293T cells. The adaptor protein ASC bridges NLRP3 with the effector protein caspase-1. Herein, we find that Syk can associate directly with ASC and NLRP3 by its kinase domain but interact indirectly with procaspase-1. Syk can phosphorylate ASC at Y146 and Y187 residues, and the phosphorylation of both residues is critical to enhance ASC oligomerization and the recruitment of procaspase-1. Together, our results reveal a new molecular pathway through which Syk promotes NLRP3 inflammasome formation, resulting from the phosphorylation of ASC. Thus, the control of Syk activity might be effective to modulate NLRP3 inflammasome activation and treat NLRP3-related immune diseases.   \n",
       "10                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                          LRRK2, a gene relevant to Parkinson's disease, encodes a scaffolding protein with both GTPase and kinase activities. LRRK2 protein is itself phosphorylated and therefore is subject to regulation by cell signalling; however, the kinase(s) responsible for this event have not been definitively identified. Here using an unbiased siRNA kinome screen, we identify and validate casein kinase 1α (CK1α) as being responsible for LRRK2 phosphorylation, including in the adult mouse striatum. We further show that LRRK2 recruitment to TGN46-positive Golgi-derived vesicles is modulated by constitutive LRRK2 phosphorylation by CK1α. These effects are mediated by differential protein interactions of LRRK2 with a guanine nucleotide exchange factor, ARHGEF7. These pathways are therefore likely involved in the physiological maintenance of the Golgi in cells, which may play a role in the pathogenesis of Parkinson's disease.    \n",
       "1000                                                                                                                                                                                                                                                                                                                                                               The PI3K/AKT signaling pathway is aberrant in a wide variety of cancers. Downstream effectors of AKT are involved in survival, growth and metabolic-related pathways. In contrast, contradictory data relating to AKT effects on cell motility and invasion, crucial prometastatic processes, have been reported pointing to a potential cell type and isoform type-specific AKT-driven function. By implication, study of AKT signaling should optimally be conducted in an appropriate intracellular environment. Prognosis in soft-tissue sarcoma (STS), the aggressive malignancies of mesenchymal origin, is poor, reflecting our modest ability to control metastasis, an effort hampered by lack of insight into molecular mechanisms driving STS progression and dissemination. We examined the impact of the cancer progression-relevant AKT pathway on the mesenchymal tumor cell internal milieu. We demonstrate that AKT1 activation induces STS cell motility and invasiveness at least partially through a novel interaction with the intermediate filament vimentin (Vim). The binding of AKT (tail region) to Vim (head region) results in Vim Ser39 phosphorylation enhancing the ability of Vim to induce motility and invasion while protecting Vim from caspase-induced proteolysis. Moreover, vimentin phosphorylation was shown to enhance tumor and metastasis growth in vivo. Insights into this mesenchymal-related molecular mechanism may facilitate the development of critically lacking therapeutic options for these devastating malignancies.   \n",
       "1001                                                                                                                                                                                                                                                                                                                                                               The PI3K/AKT signaling pathway is aberrant in a wide variety of cancers. Downstream effectors of AKT are involved in survival, growth and metabolic-related pathways. In contrast, contradictory data relating to AKT effects on cell motility and invasion, crucial prometastatic processes, have been reported pointing to a potential cell type and isoform type-specific AKT-driven function. By implication, study of AKT signaling should optimally be conducted in an appropriate intracellular environment. Prognosis in soft-tissue sarcoma (STS), the aggressive malignancies of mesenchymal origin, is poor, reflecting our modest ability to control metastasis, an effort hampered by lack of insight into molecular mechanisms driving STS progression and dissemination. We examined the impact of the cancer progression-relevant AKT pathway on the mesenchymal tumor cell internal milieu. We demonstrate that AKT1 activation induces STS cell motility and invasiveness at least partially through a novel interaction with the intermediate filament vimentin (Vim). The binding of AKT (tail region) to Vim (head region) results in Vim Ser39 phosphorylation enhancing the ability of Vim to induce motility and invasion while protecting Vim from caspase-induced proteolysis. Moreover, vimentin phosphorylation was shown to enhance tumor and metastasis growth in vivo. Insights into this mesenchymal-related molecular mechanism may facilitate the development of critically lacking therapeutic options for these devastating malignancies.   \n",
       "1002                                                                                                                                                                                                                                                                                                                                                                   Phosphorylation of the Fas-associated death domain (FADD) protein sensitizes cancer cells to various chemotherapeutics. However, the molecular mechanism underlying chemosensitization by phosphorylated FADD (P-FADD) is poorly understood. In this study, we describe the physical interactions and functional interplay between Polo-like kinase 1 (Plk1) and FADD. Plk1 phosphorylates FADD at Ser-194 in response to treatment with taxol. Overexpression of a phosphorylation-mimicking mutant, FADD S194D, caused degradation of Plk1 in an ubiquitin-independent manner, and delayed cytokinesis, consistent with the expected cellular phenotype of Plk1 deficiency. This demonstrates that Plk1 is regulated via a negative feedback loop by its substrate, FADD. Overexpression of FADD S194D sensitized HeLa cells to a low dose of taxol independently of caspase activation, whereas overexpression of FADD S194D resulted in caspase activation in response to a high dose of taxol. Therefore, we examined whether the death potential of P-FADD affected Plk1-mediated tumorigenesis. Transfection of FADD S194D inhibited colony formation by Plk1-overexpressing HeLa cells (HeLa-Plk1). Moreover, overexpression of FADD S194D suppressed tumorigenesis in nude mice xenografted with HeLa-Plk1. Therefore, this study reports the first in vivo validation of tumor-suppressing activity of P-FADD. Collectively, our data demonstrate that in response to taxol, Plk1 endows death-promoting and tumor-suppressor functions to its substrate, FADD.   \n",
       "1003                                                                                                                                                                                                                                                                                                                                                                   Phosphorylation of the Fas-associated death domain (FADD) protein sensitizes cancer cells to various chemotherapeutics. However, the molecular mechanism underlying chemosensitization by phosphorylated FADD (P-FADD) is poorly understood. In this study, we describe the physical interactions and functional interplay between Polo-like kinase 1 (Plk1) and FADD. Plk1 phosphorylates FADD at Ser-194 in response to treatment with taxol. Overexpression of a phosphorylation-mimicking mutant, FADD S194D, caused degradation of Plk1 in an ubiquitin-independent manner, and delayed cytokinesis, consistent with the expected cellular phenotype of Plk1 deficiency. This demonstrates that Plk1 is regulated via a negative feedback loop by its substrate, FADD. Overexpression of FADD S194D sensitized HeLa cells to a low dose of taxol independently of caspase activation, whereas overexpression of FADD S194D resulted in caspase activation in response to a high dose of taxol. Therefore, we examined whether the death potential of P-FADD affected Plk1-mediated tumorigenesis. Transfection of FADD S194D inhibited colony formation by Plk1-overexpressing HeLa cells (HeLa-Plk1). Moreover, overexpression of FADD S194D suppressed tumorigenesis in nude mice xenografted with HeLa-Plk1. Therefore, this study reports the first in vivo validation of tumor-suppressing activity of P-FADD. Collectively, our data demonstrate that in response to taxol, Plk1 endows death-promoting and tumor-suppressor functions to its substrate, FADD.   \n",
       "1004                                                                                                                                                                                                                                                                                                                                                                   Phosphorylation of the Fas-associated death domain (FADD) protein sensitizes cancer cells to various chemotherapeutics. However, the molecular mechanism underlying chemosensitization by phosphorylated FADD (P-FADD) is poorly understood. In this study, we describe the physical interactions and functional interplay between Polo-like kinase 1 (Plk1) and FADD. Plk1 phosphorylates FADD at Ser-194 in response to treatment with taxol. Overexpression of a phosphorylation-mimicking mutant, FADD S194D, caused degradation of Plk1 in an ubiquitin-independent manner, and delayed cytokinesis, consistent with the expected cellular phenotype of Plk1 deficiency. This demonstrates that Plk1 is regulated via a negative feedback loop by its substrate, FADD. Overexpression of FADD S194D sensitized HeLa cells to a low dose of taxol independently of caspase activation, whereas overexpression of FADD S194D resulted in caspase activation in response to a high dose of taxol. Therefore, we examined whether the death potential of P-FADD affected Plk1-mediated tumorigenesis. Transfection of FADD S194D inhibited colony formation by Plk1-overexpressing HeLa cells (HeLa-Plk1). Moreover, overexpression of FADD S194D suppressed tumorigenesis in nude mice xenografted with HeLa-Plk1. Therefore, this study reports the first in vivo validation of tumor-suppressing activity of P-FADD. Collectively, our data demonstrate that in response to taxol, Plk1 endows death-promoting and tumor-suppressor functions to its substrate, FADD.   \n",
       "1005  Symplekin (Pta1 in yeast) is a scaffold in the large protein complex that is required for 3'-end cleavage and polyadenylation of eukaryotic messenger RNA precursors (pre-mRNAs); it also participates in transcription initiation and termination by RNA polymerase II (Pol II). Symplekin mediates interactions between many different proteins in this machinery, although the molecular basis for its function is not known. Here we report the crystal structure at 2.4 Å resolution of the amino-terminal domain (residues 30-340) of human symplekin in a ternary complex with the Pol II carboxy-terminal domain (CTD) Ser 5 phosphatase Ssu72 (refs 7, 10-17) and a CTD Ser 5 phosphopeptide. The N-terminal domain of symplekin has the ARM or HEAT fold, with seven pairs of antiparallel α-helices arranged in the shape of an arc. The structure of Ssu72 has some similarity to that of low-molecular-mass phosphotyrosine protein phosphatase, although Ssu72 has a unique active-site landscape as well as extra structural features at the C terminus that are important for interaction with symplekin. Ssu72 is bound to the concave face of symplekin, and engineered mutations in this interface can abolish interactions between the two proteins. The CTD peptide is bound in the active site of Ssu72, with the pSer 5-Pro 6 peptide bond in the cis configuration, which contrasts with all other known CTD peptide conformations. Although the active site of Ssu72 is about 25 Å from the interface with symplekin, we found that the symplekin N-terminal domain stimulates Ssu72 CTD phosphatase activity in vitro. Furthermore, the N-terminal domain of symplekin inhibits polyadenylation in vitro, but only when coupled to transcription. Because catalytically active Ssu72 overcomes this inhibition, our results show a role for mammalian Ssu72 in transcription-coupled pre-mRNA 3'-end processing.   \n",
       "1006  Symplekin (Pta1 in yeast) is a scaffold in the large protein complex that is required for 3'-end cleavage and polyadenylation of eukaryotic messenger RNA precursors (pre-mRNAs); it also participates in transcription initiation and termination by RNA polymerase II (Pol II). Symplekin mediates interactions between many different proteins in this machinery, although the molecular basis for its function is not known. Here we report the crystal structure at 2.4 Å resolution of the amino-terminal domain (residues 30-340) of human symplekin in a ternary complex with the Pol II carboxy-terminal domain (CTD) Ser 5 phosphatase Ssu72 (refs 7, 10-17) and a CTD Ser 5 phosphopeptide. The N-terminal domain of symplekin has the ARM or HEAT fold, with seven pairs of antiparallel α-helices arranged in the shape of an arc. The structure of Ssu72 has some similarity to that of low-molecular-mass phosphotyrosine protein phosphatase, although Ssu72 has a unique active-site landscape as well as extra structural features at the C terminus that are important for interaction with symplekin. Ssu72 is bound to the concave face of symplekin, and engineered mutations in this interface can abolish interactions between the two proteins. The CTD peptide is bound in the active site of Ssu72, with the pSer 5-Pro 6 peptide bond in the cis configuration, which contrasts with all other known CTD peptide conformations. Although the active site of Ssu72 is about 25 Å from the interface with symplekin, we found that the symplekin N-terminal domain stimulates Ssu72 CTD phosphatase activity in vitro. Furthermore, the N-terminal domain of symplekin inhibits polyadenylation in vitro, but only when coupled to transcription. Because catalytically active Ssu72 overcomes this inhibition, our results show a role for mammalian Ssu72 in transcription-coupled pre-mRNA 3'-end processing.   \n",
       "\n",
       "      lessThanThreshold  hasTriggerWord  entityMentionsCount  \n",
       "0                  True            True                    1  \n",
       "1                  True            True                    2  \n",
       "10                 True            True                    3  \n",
       "1000               True            True                    1  \n",
       "1001               True            True                    4  \n",
       "1002               True            True                    7  \n",
       "1003               True            True                    7  \n",
       "1004               True            True                    7  \n",
       "1005               True           False                    2  \n",
       "1006               True           False                    1  "
      ]
     },
     "execution_count": 28,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "data.head(n=10)"
   ]
  },
  {
   "cell_type": "markdown",
   "metadata": {},
   "source": [
    "### Data Transformation"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 29,
   "metadata": {},
   "outputs": [],
   "source": [
    "from datatransformer.jsonPPIFlattenTransformer import IntactJsonPpiFlattenTransformer\n",
    " \n",
    "\n",
    "sut = IntactJsonPpiFlattenTransformer()\n",
    "\n",
    "data_transformed = sut.transform(data)\n"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 30,
   "metadata": {
    "scrolled": true
   },
   "outputs": [
    {
     "data": {
      "text/html": [
       "<div>\n",
       "<style scoped>\n",
       "    .dataframe tbody tr th:only-of-type {\n",
       "        vertical-align: middle;\n",
       "    }\n",
       "\n",
       "    .dataframe tbody tr th {\n",
       "        vertical-align: top;\n",
       "    }\n",
       "\n",
       "    .dataframe thead th {\n",
       "        text-align: right;\n",
       "    }\n",
       "</style>\n",
       "<table border=\"1\" class=\"dataframe\">\n",
       "  <thead>\n",
       "    <tr style=\"text-align: right;\">\n",
       "      <th></th>\n",
       "      <th>entityMentionsCount</th>\n",
       "      <th>hasTriggerWord</th>\n",
       "      <th>interactionId</th>\n",
       "      <th>interactionType</th>\n",
       "      <th>isNegative</th>\n",
       "      <th>lessThanThreshold</th>\n",
       "      <th>participant1Alias</th>\n",
       "      <th>participant1Id</th>\n",
       "      <th>participant2Alias</th>\n",
       "      <th>participant2Id</th>\n",
       "      <th>pubmedId</th>\n",
       "      <th>pubmedTitle</th>\n",
       "      <th>pubmedabstract</th>\n",
       "    </tr>\n",
       "  </thead>\n",
       "  <tbody>\n",
       "    <tr>\n",
       "      <th>0</th>\n",
       "      <td>1</td>\n",
       "      <td>True</td>\n",
       "      <td>2503510</td>\n",
       "      <td>phosphorylation</td>\n",
       "      <td>False</td>\n",
       "      <td>True</td>\n",
       "      <td>[[ksyk_human], [Tyrosine-protein kinase SYK], [SYK], [Spleen tyrosine kinase], [p72-Syk]]</td>\n",
       "      <td>P43405</td>\n",
       "      <td>[[ksyk_human], [Tyrosine-protein kinase SYK], [SYK], [Spleen tyrosine kinase], [p72-Syk]]</td>\n",
       "      <td>P43405</td>\n",
       "      <td>25605870</td>\n",
       "      <td>None</td>\n",
       "      <td>NLRP3 is the most crucial member of the NLR family, as it detects the existence of pathogen invasion and self-derived molecules associated with cellular damage. Several studies have reported that excessive NLRP3 inflammasome-mediated caspase-1 activation is a key factor in the development of diseases. Recent studies have reported that Syk is involved in pathogen-induced NLRP3 inflammasome activation; however, the detailed mechanism linking Syk to NLRP3 inflammasome remains unclear. In this study, we showed that Syk mediates NLRP3 stimuli-induced processing of procaspase-1 and the consequent activation of caspase-1. Moreover, the kinase activity of Syk is required to potentiate caspase-1 activation in a reconstituted NLRP3 inflammasome system in HEK293T cells. The adaptor protein ASC bridges NLRP3 with the effector protein caspase-1. Herein, we find that Syk can associate directly with ASC and NLRP3 by its kinase domain but interact indirectly with procaspase-1. Syk can phosphorylate ASC at Y146 and Y187 residues, and the phosphorylation of both residues is critical to enhance ASC oligomerization and the recruitment of procaspase-1. Together, our results reveal a new molecular pathway through which Syk promotes NLRP3 inflammasome formation, resulting from the phosphorylation of ASC. Thus, the control of Syk activity might be effective to modulate NLRP3 inflammasome activation and treat NLRP3-related immune diseases.</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>1</th>\n",
       "      <td>2</td>\n",
       "      <td>True</td>\n",
       "      <td>2503513</td>\n",
       "      <td>phosphorylation</td>\n",
       "      <td>False</td>\n",
       "      <td>True</td>\n",
       "      <td>[[ksyk_human], [Tyrosine-protein kinase SYK], [SYK], [Spleen tyrosine kinase], [p72-Syk]]</td>\n",
       "      <td>P43405</td>\n",
       "      <td>[[asc_human], [Apoptosis-associated speck-like protein containing a CARD], [PYD and CARD domain-containing protein], [Target of methylation-induced silencing 1], [Caspase recruitment domain-containing protein 5], [ASC], [CARD5], [TMS1], [PYCARD]]</td>\n",
       "      <td>Q9BSZ5</td>\n",
       "      <td>25605870</td>\n",
       "      <td>None</td>\n",
       "      <td>NLRP3 is the most crucial member of the NLR family, as it detects the existence of pathogen invasion and self-derived molecules associated with cellular damage. Several studies have reported that excessive NLRP3 inflammasome-mediated caspase-1 activation is a key factor in the development of diseases. Recent studies have reported that Syk is involved in pathogen-induced NLRP3 inflammasome activation; however, the detailed mechanism linking Syk to NLRP3 inflammasome remains unclear. In this study, we showed that Syk mediates NLRP3 stimuli-induced processing of procaspase-1 and the consequent activation of caspase-1. Moreover, the kinase activity of Syk is required to potentiate caspase-1 activation in a reconstituted NLRP3 inflammasome system in HEK293T cells. The adaptor protein ASC bridges NLRP3 with the effector protein caspase-1. Herein, we find that Syk can associate directly with ASC and NLRP3 by its kinase domain but interact indirectly with procaspase-1. Syk can phosphorylate ASC at Y146 and Y187 residues, and the phosphorylation of both residues is critical to enhance ASC oligomerization and the recruitment of procaspase-1. Together, our results reveal a new molecular pathway through which Syk promotes NLRP3 inflammasome formation, resulting from the phosphorylation of ASC. Thus, the control of Syk activity might be effective to modulate NLRP3 inflammasome activation and treat NLRP3-related immune diseases.</td>\n",
       "    </tr>\n",
       "  </tbody>\n",
       "</table>\n",
       "</div>"
      ],
      "text/plain": [
       "   entityMentionsCount  hasTriggerWord interactionId  interactionType  \\\n",
       "0                    1            True       2503510  phosphorylation   \n",
       "1                    2            True       2503513  phosphorylation   \n",
       "\n",
       "   isNegative  lessThanThreshold  \\\n",
       "0       False               True   \n",
       "1       False               True   \n",
       "\n",
       "                                                                           participant1Alias  \\\n",
       "0  [[ksyk_human], [Tyrosine-protein kinase SYK], [SYK], [Spleen tyrosine kinase], [p72-Syk]]   \n",
       "1  [[ksyk_human], [Tyrosine-protein kinase SYK], [SYK], [Spleen tyrosine kinase], [p72-Syk]]   \n",
       "\n",
       "  participant1Id  \\\n",
       "0         P43405   \n",
       "1         P43405   \n",
       "\n",
       "                                                                                                                                                                                                                                        participant2Alias  \\\n",
       "0                                                                                                                                                               [[ksyk_human], [Tyrosine-protein kinase SYK], [SYK], [Spleen tyrosine kinase], [p72-Syk]]   \n",
       "1  [[asc_human], [Apoptosis-associated speck-like protein containing a CARD], [PYD and CARD domain-containing protein], [Target of methylation-induced silencing 1], [Caspase recruitment domain-containing protein 5], [ASC], [CARD5], [TMS1], [PYCARD]]   \n",
       "\n",
       "  participant2Id  pubmedId pubmedTitle  \\\n",
       "0         P43405  25605870        None   \n",
       "1         Q9BSZ5  25605870        None   \n",
       "\n",
       "                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                   pubmedabstract  \n",
       "0  NLRP3 is the most crucial member of the NLR family, as it detects the existence of pathogen invasion and self-derived molecules associated with cellular damage. Several studies have reported that excessive NLRP3 inflammasome-mediated caspase-1 activation is a key factor in the development of diseases. Recent studies have reported that Syk is involved in pathogen-induced NLRP3 inflammasome activation; however, the detailed mechanism linking Syk to NLRP3 inflammasome remains unclear. In this study, we showed that Syk mediates NLRP3 stimuli-induced processing of procaspase-1 and the consequent activation of caspase-1. Moreover, the kinase activity of Syk is required to potentiate caspase-1 activation in a reconstituted NLRP3 inflammasome system in HEK293T cells. The adaptor protein ASC bridges NLRP3 with the effector protein caspase-1. Herein, we find that Syk can associate directly with ASC and NLRP3 by its kinase domain but interact indirectly with procaspase-1. Syk can phosphorylate ASC at Y146 and Y187 residues, and the phosphorylation of both residues is critical to enhance ASC oligomerization and the recruitment of procaspase-1. Together, our results reveal a new molecular pathway through which Syk promotes NLRP3 inflammasome formation, resulting from the phosphorylation of ASC. Thus, the control of Syk activity might be effective to modulate NLRP3 inflammasome activation and treat NLRP3-related immune diseases.  \n",
       "1  NLRP3 is the most crucial member of the NLR family, as it detects the existence of pathogen invasion and self-derived molecules associated with cellular damage. Several studies have reported that excessive NLRP3 inflammasome-mediated caspase-1 activation is a key factor in the development of diseases. Recent studies have reported that Syk is involved in pathogen-induced NLRP3 inflammasome activation; however, the detailed mechanism linking Syk to NLRP3 inflammasome remains unclear. In this study, we showed that Syk mediates NLRP3 stimuli-induced processing of procaspase-1 and the consequent activation of caspase-1. Moreover, the kinase activity of Syk is required to potentiate caspase-1 activation in a reconstituted NLRP3 inflammasome system in HEK293T cells. The adaptor protein ASC bridges NLRP3 with the effector protein caspase-1. Herein, we find that Syk can associate directly with ASC and NLRP3 by its kinase domain but interact indirectly with procaspase-1. Syk can phosphorylate ASC at Y146 and Y187 residues, and the phosphorylation of both residues is critical to enhance ASC oligomerization and the recruitment of procaspase-1. Together, our results reveal a new molecular pathway through which Syk promotes NLRP3 inflammasome formation, resulting from the phosphorylation of ASC. Thus, the control of Syk activity might be effective to modulate NLRP3 inflammasome activation and treat NLRP3-related immune diseases.  "
      ]
     },
     "execution_count": 30,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "data_transformed.head(n=2)"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 31,
   "metadata": {},
   "outputs": [
    {
     "data": {
      "text/plain": [
       "(2749, 13)"
      ]
     },
     "execution_count": 31,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "data_transformed.shape"
   ]
  },
  {
   "cell_type": "markdown",
   "metadata": {},
   "source": [
    "Okay.. looks like it is only a case of the names of the participants not matching the names of the alias used in the abstract.. "
   ]
  },
  {
   "cell_type": "markdown",
   "metadata": {},
   "source": [
    "### Data Engineering"
   ]
  },
  {
   "cell_type": "markdown",
   "metadata": {},
   "source": [
    "#### Add more negative samples"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 32,
   "metadata": {},
   "outputs": [],
   "source": [
    "\n",
    "def generate_negative_old(data):\n",
    "    import uuid\n",
    "    unique_pubmeds = data[\"pubmedId\"].unique()\n",
    "    data_fake = pd.DataFrame(columns=data.columns)\n",
    "\n",
    "    num_fake_records = int( .50 * len(data))\n",
    "    #TODO: Randomise this, biased via\n",
    "    for u in unique_pubmeds:\n",
    "        fake_records = pd.DataFrame(data[ data.pubmedId != u]  ).sample(n=1) \n",
    "        fake_records.loc[:, \"interactionId\"] =  fake_records.interactionId.astype(str) + \"_\" + str(uuid.uuid4() ) + \"_\" + \"fake\"\n",
    "        fake_records.loc[:,\"isNegative\"] = 'True' \n",
    "        ## Copy of the pubmeid abtract and the title from a id\n",
    "        fake_records.loc[:,\"pubmedId\"] = u\n",
    "        fake_records.loc[:, \"pubmedTitle\"] =  data[ data.pubmedId == u].iloc[0][\"pubmedTitle\"]\n",
    "        fake_records.loc[:, \"pubmedabstract\"] =  data[ data.pubmedId == u].iloc[0][\"pubmedabstract\"]\n",
    "\n",
    "\n",
    "        data_fake = data_fake.append(fake_records, ignore_index=True)\n",
    "        if len(data_fake) > num_fake_records:\n",
    "            break\n",
    "            \n",
    "    return data_fake\n",
    "  \n",
    "    "
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 33,
   "metadata": {},
   "outputs": [],
   "source": [
    "\n",
    "def generate_negative(data, enity_annotations_file):\n",
    "    from dataformatters.gnormplusPubtatorReader import GnormplusPubtatorReader\n",
    "    from datatransformer.gnormplusNegativeSamplesAugmentor import GnormplusNegativeSamplesAugmentor\n",
    "    from datatransformer.ncbiGeneUniprotLocalDbMapper import NcbiGeneUniprotLocalDbMapper\n",
    "    from datatransformer.interactionTypeNegativeSamplesAugmentor import InteractionTypeNegativeSamplesAugmentor\n",
    "\n",
    "    import os\n",
    "    \n",
    " \n",
    "    localdb = human_idmapping_dat\n",
    "    with open(localdb, \"r\") as dbhandle:\n",
    "        mapper = NcbiGeneUniprotLocalDbMapper(dbhandle, \"GeneID\") \n",
    "            \n",
    "        #Read gnormplus identified entities\n",
    "        reader = GnormplusPubtatorReader()\n",
    "        with open(enity_annotations_file,\"r\") as handle:\n",
    "            annotations_json = list(reader(handle))\n",
    "\n",
    "        negative_samples_generator = GnormplusNegativeSamplesAugmentor(annotations_json, mapper)\n",
    "        result = negative_samples_generator.transform(data)\n",
    "        \n",
    "        negative_samples_generator = InteractionTypeNegativeSamplesAugmentor()\n",
    "        result = negative_samples_generator.transform(result)\n",
    "\n",
    "        return result"
   ]
  },
  {
   "cell_type": "markdown",
   "metadata": {},
   "source": [
    "Remove records where the alias is null"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 34,
   "metadata": {},
   "outputs": [],
   "source": [
    "data_filtered = data_transformed[data_transformed.participant1Alias.notnull()]\n",
    "data_filtered = data_filtered[data_filtered.participant2Alias.notnull()]"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 35,
   "metadata": {},
   "outputs": [],
   "source": [
    "from sklearn.model_selection import train_test_split\n",
    "train, test = train_test_split(data_filtered, test_size=.2,\n",
    "                                                        random_state=777)\n",
    "\n",
    "train, val = train_test_split(train, test_size=.2,\n",
    "                                                        random_state=777)"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 36,
   "metadata": {
    "scrolled": true
   },
   "outputs": [
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "The total number of train records including fake records 9035\n"
     ]
    }
   ],
   "source": [
    "train = generate_negative(train, annotations_file)\n",
    "print(\"The total number of train records including fake records {}\".format(train.shape[0]))\n"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 37,
   "metadata": {},
   "outputs": [
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "The total number of test records including fake records 4108\n",
      "The total number of val records including fake records 3525\n"
     ]
    }
   ],
   "source": [
    "\n",
    "\n",
    "test = generate_negative(test,  annotations_file)\n",
    "print(\"The total number of test records including fake records {}\".format(test.shape[0]))\n",
    "\n",
    "\n",
    "val = generate_negative(val, annotations_file)\n",
    "print(\"The total number of val records including fake records {}\".format(val.shape[0]))"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 38,
   "metadata": {},
   "outputs": [
    {
     "data": {
      "text/html": [
       "<div>\n",
       "<style scoped>\n",
       "    .dataframe tbody tr th:only-of-type {\n",
       "        vertical-align: middle;\n",
       "    }\n",
       "\n",
       "    .dataframe tbody tr th {\n",
       "        vertical-align: top;\n",
       "    }\n",
       "\n",
       "    .dataframe thead th {\n",
       "        text-align: right;\n",
       "    }\n",
       "</style>\n",
       "<table border=\"1\" class=\"dataframe\">\n",
       "  <thead>\n",
       "    <tr style=\"text-align: right;\">\n",
       "      <th></th>\n",
       "      <th>entityMentionsCount</th>\n",
       "      <th>hasTriggerWord</th>\n",
       "      <th>interactionId</th>\n",
       "      <th>interactionType</th>\n",
       "      <th>isNegative</th>\n",
       "      <th>lessThanThreshold</th>\n",
       "      <th>participant1Alias</th>\n",
       "      <th>participant1Id</th>\n",
       "      <th>participant2Alias</th>\n",
       "      <th>participant2Id</th>\n",
       "      <th>pubmedId</th>\n",
       "      <th>pubmedTitle</th>\n",
       "      <th>pubmedabstract</th>\n",
       "    </tr>\n",
       "  </thead>\n",
       "  <tbody>\n",
       "    <tr>\n",
       "      <th>2343</th>\n",
       "      <td>7</td>\n",
       "      <td>True</td>\n",
       "      <td>1215357_5915c8fd-34f9-4f9f-804e-3e69e261b551_fake_annot</td>\n",
       "      <td>ubiquitination</td>\n",
       "      <td>True</td>\n",
       "      <td>True</td>\n",
       "      <td>[[ptprr_mouse], [Receptor-type tyrosine-protein phosphatase R], [Ptprr], [Ptp13], [Phosphotyrosine phosphatase 13], [Protein-tyrosine-phosphatase SL]]</td>\n",
       "      <td>Q9QUH9</td>\n",
       "      <td>[[mk03_human], [Mitogen-activated protein kinase 3], [ERT2], [MAP kinase isoform p44], [Microtubule-associated protein 2 kinase], [Extracellular signal-regulated kinase 1], [Insulin-stimulated MAP2 kinase], [p44-ERK1], [MAPK3], [ERK1], [PRKM3]]</td>\n",
       "      <td>Q8NHX1</td>\n",
       "      <td>10066421</td>\n",
       "      <td>None</td>\n",
       "      <td>Mitogen-activated protein kinase (MAPK) is inactivated through dephosphorylation of tyrosyl and threonyl regulatory sites. In yeast, both dual-specificity and tyrosine-specific phosphatases are involved in dephosphorylation. In mammals, however, no tyrosine-specific phosphatase has been identified molecularly to dephosphorylate MAPK in vivo. Recently, we and others have cloned a murine tyrosine-specific phosphatase, PTPBR7/PTP-SL, which is expressed predominantly in the brain. Here we report inactivation of the extracellular signal-regulated kinase (ERK) family MAPK by PTPBR7. PTPBR7 made complexes with ERK1/ERK2 in vivo and dephosphorylated ERK1 in vitro. When overexpressed in mammalian cells, wild-type PTPBR7 suppressed the phosphorylation and activation of ERK by epidermal growth factor (EGF), nerve growth factor (NGF), and constitutively active MEK1, a mutant MAPK kinase. In contrast, catalytically inactive and ERK-binding-deficient mutants revealed little inhibition on the ERK cascade. These results indicate that PTPBR7 suppresses MAPK directly in vivo.</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>6673</th>\n",
       "      <td>7</td>\n",
       "      <td>True</td>\n",
       "      <td>1215357_990d36fd-8a8a-4af0-9e05-1d3f1a249710_fake_annot</td>\n",
       "      <td>dephosphorylation</td>\n",
       "      <td>True</td>\n",
       "      <td>True</td>\n",
       "      <td>[NGF, nerve growth factor]</td>\n",
       "      <td>P01138</td>\n",
       "      <td>[PTPBR7]</td>\n",
       "      <td>Q7Z2V8</td>\n",
       "      <td>10066421</td>\n",
       "      <td>None</td>\n",
       "      <td>Mitogen-activated protein kinase (MAPK) is inactivated through dephosphorylation of tyrosyl and threonyl regulatory sites. In yeast, both dual-specificity and tyrosine-specific phosphatases are involved in dephosphorylation. In mammals, however, no tyrosine-specific phosphatase has been identified molecularly to dephosphorylate MAPK in vivo. Recently, we and others have cloned a murine tyrosine-specific phosphatase, PTPBR7/PTP-SL, which is expressed predominantly in the brain. Here we report inactivation of the extracellular signal-regulated kinase (ERK) family MAPK by PTPBR7. PTPBR7 made complexes with ERK1/ERK2 in vivo and dephosphorylated ERK1 in vitro. When overexpressed in mammalian cells, wild-type PTPBR7 suppressed the phosphorylation and activation of ERK by epidermal growth factor (EGF), nerve growth factor (NGF), and constitutively active MEK1, a mutant MAPK kinase. In contrast, catalytically inactive and ERK-binding-deficient mutants revealed little inhibition on the ERK cascade. These results indicate that PTPBR7 suppresses MAPK directly in vivo.</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>6672</th>\n",
       "      <td>7</td>\n",
       "      <td>True</td>\n",
       "      <td>1215357_27782e8a-e47c-476b-8a23-16a08a080cf9_fake_annot</td>\n",
       "      <td>dephosphorylation</td>\n",
       "      <td>True</td>\n",
       "      <td>True</td>\n",
       "      <td>[NGF, nerve growth factor]</td>\n",
       "      <td>P01138</td>\n",
       "      <td>[ERK1]</td>\n",
       "      <td>Q9BWJ1</td>\n",
       "      <td>10066421</td>\n",
       "      <td>None</td>\n",
       "      <td>Mitogen-activated protein kinase (MAPK) is inactivated through dephosphorylation of tyrosyl and threonyl regulatory sites. In yeast, both dual-specificity and tyrosine-specific phosphatases are involved in dephosphorylation. In mammals, however, no tyrosine-specific phosphatase has been identified molecularly to dephosphorylate MAPK in vivo. Recently, we and others have cloned a murine tyrosine-specific phosphatase, PTPBR7/PTP-SL, which is expressed predominantly in the brain. Here we report inactivation of the extracellular signal-regulated kinase (ERK) family MAPK by PTPBR7. PTPBR7 made complexes with ERK1/ERK2 in vivo and dephosphorylated ERK1 in vitro. When overexpressed in mammalian cells, wild-type PTPBR7 suppressed the phosphorylation and activation of ERK by epidermal growth factor (EGF), nerve growth factor (NGF), and constitutively active MEK1, a mutant MAPK kinase. In contrast, catalytically inactive and ERK-binding-deficient mutants revealed little inhibition on the ERK cascade. These results indicate that PTPBR7 suppresses MAPK directly in vivo.</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>6671</th>\n",
       "      <td>7</td>\n",
       "      <td>True</td>\n",
       "      <td>1215357_70e03450-225c-4b3c-881e-c6ad9c916d17_fake_annot</td>\n",
       "      <td>dephosphorylation</td>\n",
       "      <td>True</td>\n",
       "      <td>True</td>\n",
       "      <td>[MEK1]</td>\n",
       "      <td>H3BRW9</td>\n",
       "      <td>[PTPBR7]</td>\n",
       "      <td>Q7Z2V8</td>\n",
       "      <td>10066421</td>\n",
       "      <td>None</td>\n",
       "      <td>Mitogen-activated protein kinase (MAPK) is inactivated through dephosphorylation of tyrosyl and threonyl regulatory sites. In yeast, both dual-specificity and tyrosine-specific phosphatases are involved in dephosphorylation. In mammals, however, no tyrosine-specific phosphatase has been identified molecularly to dephosphorylate MAPK in vivo. Recently, we and others have cloned a murine tyrosine-specific phosphatase, PTPBR7/PTP-SL, which is expressed predominantly in the brain. Here we report inactivation of the extracellular signal-regulated kinase (ERK) family MAPK by PTPBR7. PTPBR7 made complexes with ERK1/ERK2 in vivo and dephosphorylated ERK1 in vitro. When overexpressed in mammalian cells, wild-type PTPBR7 suppressed the phosphorylation and activation of ERK by epidermal growth factor (EGF), nerve growth factor (NGF), and constitutively active MEK1, a mutant MAPK kinase. In contrast, catalytically inactive and ERK-binding-deficient mutants revealed little inhibition on the ERK cascade. These results indicate that PTPBR7 suppresses MAPK directly in vivo.</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>6678</th>\n",
       "      <td>7</td>\n",
       "      <td>True</td>\n",
       "      <td>1215357_c27e9df3-32ce-4ae8-9c7c-0d60873f13cf_fake_annot</td>\n",
       "      <td>dephosphorylation</td>\n",
       "      <td>True</td>\n",
       "      <td>True</td>\n",
       "      <td>[MEK1]</td>\n",
       "      <td>H3BRW9</td>\n",
       "      <td>[ERK1]</td>\n",
       "      <td>Q9BWJ1</td>\n",
       "      <td>10066421</td>\n",
       "      <td>None</td>\n",
       "      <td>Mitogen-activated protein kinase (MAPK) is inactivated through dephosphorylation of tyrosyl and threonyl regulatory sites. In yeast, both dual-specificity and tyrosine-specific phosphatases are involved in dephosphorylation. In mammals, however, no tyrosine-specific phosphatase has been identified molecularly to dephosphorylate MAPK in vivo. Recently, we and others have cloned a murine tyrosine-specific phosphatase, PTPBR7/PTP-SL, which is expressed predominantly in the brain. Here we report inactivation of the extracellular signal-regulated kinase (ERK) family MAPK by PTPBR7. PTPBR7 made complexes with ERK1/ERK2 in vivo and dephosphorylated ERK1 in vitro. When overexpressed in mammalian cells, wild-type PTPBR7 suppressed the phosphorylation and activation of ERK by epidermal growth factor (EGF), nerve growth factor (NGF), and constitutively active MEK1, a mutant MAPK kinase. In contrast, catalytically inactive and ERK-binding-deficient mutants revealed little inhibition on the ERK cascade. These results indicate that PTPBR7 suppresses MAPK directly in vivo.</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>6669</th>\n",
       "      <td>7</td>\n",
       "      <td>True</td>\n",
       "      <td>1215357_ac62b930-c6be-4941-b195-19a692180483_fake_annot</td>\n",
       "      <td>dephosphorylation</td>\n",
       "      <td>True</td>\n",
       "      <td>True</td>\n",
       "      <td>[NGF, nerve growth factor]</td>\n",
       "      <td>P01138</td>\n",
       "      <td>[MEK1]</td>\n",
       "      <td>H3BRW9</td>\n",
       "      <td>10066421</td>\n",
       "      <td>None</td>\n",
       "      <td>Mitogen-activated protein kinase (MAPK) is inactivated through dephosphorylation of tyrosyl and threonyl regulatory sites. In yeast, both dual-specificity and tyrosine-specific phosphatases are involved in dephosphorylation. In mammals, however, no tyrosine-specific phosphatase has been identified molecularly to dephosphorylate MAPK in vivo. Recently, we and others have cloned a murine tyrosine-specific phosphatase, PTPBR7/PTP-SL, which is expressed predominantly in the brain. Here we report inactivation of the extracellular signal-regulated kinase (ERK) family MAPK by PTPBR7. PTPBR7 made complexes with ERK1/ERK2 in vivo and dephosphorylated ERK1 in vitro. When overexpressed in mammalian cells, wild-type PTPBR7 suppressed the phosphorylation and activation of ERK by epidermal growth factor (EGF), nerve growth factor (NGF), and constitutively active MEK1, a mutant MAPK kinase. In contrast, catalytically inactive and ERK-binding-deficient mutants revealed little inhibition on the ERK cascade. These results indicate that PTPBR7 suppresses MAPK directly in vivo.</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>6670</th>\n",
       "      <td>7</td>\n",
       "      <td>True</td>\n",
       "      <td>1215357_ced8e4c8-6748-44ea-b926-ff0120160852_fake_annot</td>\n",
       "      <td>dephosphorylation</td>\n",
       "      <td>True</td>\n",
       "      <td>True</td>\n",
       "      <td>[PTPBR7]</td>\n",
       "      <td>Q7Z2V8</td>\n",
       "      <td>[ERK1]</td>\n",
       "      <td>Q9BWJ1</td>\n",
       "      <td>10066421</td>\n",
       "      <td>None</td>\n",
       "      <td>Mitogen-activated protein kinase (MAPK) is inactivated through dephosphorylation of tyrosyl and threonyl regulatory sites. In yeast, both dual-specificity and tyrosine-specific phosphatases are involved in dephosphorylation. In mammals, however, no tyrosine-specific phosphatase has been identified molecularly to dephosphorylate MAPK in vivo. Recently, we and others have cloned a murine tyrosine-specific phosphatase, PTPBR7/PTP-SL, which is expressed predominantly in the brain. Here we report inactivation of the extracellular signal-regulated kinase (ERK) family MAPK by PTPBR7. PTPBR7 made complexes with ERK1/ERK2 in vivo and dephosphorylated ERK1 in vitro. When overexpressed in mammalian cells, wild-type PTPBR7 suppressed the phosphorylation and activation of ERK by epidermal growth factor (EGF), nerve growth factor (NGF), and constitutively active MEK1, a mutant MAPK kinase. In contrast, catalytically inactive and ERK-binding-deficient mutants revealed little inhibition on the ERK cascade. These results indicate that PTPBR7 suppresses MAPK directly in vivo.</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>6675</th>\n",
       "      <td>7</td>\n",
       "      <td>True</td>\n",
       "      <td>1215357_c8f3192e-6335-4f9f-856f-69269404a11d_fake_annot</td>\n",
       "      <td>dephosphorylation</td>\n",
       "      <td>True</td>\n",
       "      <td>True</td>\n",
       "      <td>[PTPBR7]</td>\n",
       "      <td>Q7Z2V8</td>\n",
       "      <td>[extracellular signal-regulated kinase, ERK, ERK2]</td>\n",
       "      <td>Q499G7</td>\n",
       "      <td>10066421</td>\n",
       "      <td>None</td>\n",
       "      <td>Mitogen-activated protein kinase (MAPK) is inactivated through dephosphorylation of tyrosyl and threonyl regulatory sites. In yeast, both dual-specificity and tyrosine-specific phosphatases are involved in dephosphorylation. In mammals, however, no tyrosine-specific phosphatase has been identified molecularly to dephosphorylate MAPK in vivo. Recently, we and others have cloned a murine tyrosine-specific phosphatase, PTPBR7/PTP-SL, which is expressed predominantly in the brain. Here we report inactivation of the extracellular signal-regulated kinase (ERK) family MAPK by PTPBR7. PTPBR7 made complexes with ERK1/ERK2 in vivo and dephosphorylated ERK1 in vitro. When overexpressed in mammalian cells, wild-type PTPBR7 suppressed the phosphorylation and activation of ERK by epidermal growth factor (EGF), nerve growth factor (NGF), and constitutively active MEK1, a mutant MAPK kinase. In contrast, catalytically inactive and ERK-binding-deficient mutants revealed little inhibition on the ERK cascade. These results indicate that PTPBR7 suppresses MAPK directly in vivo.</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>2342</th>\n",
       "      <td>7</td>\n",
       "      <td>True</td>\n",
       "      <td>1215357_90400c1c-3204-425e-8b23-5d6c2768b0b7_fake_annot</td>\n",
       "      <td>demethylation</td>\n",
       "      <td>True</td>\n",
       "      <td>True</td>\n",
       "      <td>[[ptprr_mouse], [Receptor-type tyrosine-protein phosphatase R], [Ptprr], [Ptp13], [Phosphotyrosine phosphatase 13], [Protein-tyrosine-phosphatase SL]]</td>\n",
       "      <td>Q9QUH9</td>\n",
       "      <td>[[mk03_human], [Mitogen-activated protein kinase 3], [ERT2], [MAP kinase isoform p44], [Microtubule-associated protein 2 kinase], [Extracellular signal-regulated kinase 1], [Insulin-stimulated MAP2 kinase], [p44-ERK1], [MAPK3], [ERK1], [PRKM3]]</td>\n",
       "      <td>Q8NHX1</td>\n",
       "      <td>10066421</td>\n",
       "      <td>None</td>\n",
       "      <td>Mitogen-activated protein kinase (MAPK) is inactivated through dephosphorylation of tyrosyl and threonyl regulatory sites. In yeast, both dual-specificity and tyrosine-specific phosphatases are involved in dephosphorylation. In mammals, however, no tyrosine-specific phosphatase has been identified molecularly to dephosphorylate MAPK in vivo. Recently, we and others have cloned a murine tyrosine-specific phosphatase, PTPBR7/PTP-SL, which is expressed predominantly in the brain. Here we report inactivation of the extracellular signal-regulated kinase (ERK) family MAPK by PTPBR7. PTPBR7 made complexes with ERK1/ERK2 in vivo and dephosphorylated ERK1 in vitro. When overexpressed in mammalian cells, wild-type PTPBR7 suppressed the phosphorylation and activation of ERK by epidermal growth factor (EGF), nerve growth factor (NGF), and constitutively active MEK1, a mutant MAPK kinase. In contrast, catalytically inactive and ERK-binding-deficient mutants revealed little inhibition on the ERK cascade. These results indicate that PTPBR7 suppresses MAPK directly in vivo.</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>6674</th>\n",
       "      <td>7</td>\n",
       "      <td>True</td>\n",
       "      <td>1215357_80aa6361-5a08-41ec-8a1d-832851434450_fake_annot</td>\n",
       "      <td>dephosphorylation</td>\n",
       "      <td>True</td>\n",
       "      <td>True</td>\n",
       "      <td>[NGF, nerve growth factor]</td>\n",
       "      <td>P01138</td>\n",
       "      <td>[extracellular signal-regulated kinase, ERK, ERK2]</td>\n",
       "      <td>Q499G7</td>\n",
       "      <td>10066421</td>\n",
       "      <td>None</td>\n",
       "      <td>Mitogen-activated protein kinase (MAPK) is inactivated through dephosphorylation of tyrosyl and threonyl regulatory sites. In yeast, both dual-specificity and tyrosine-specific phosphatases are involved in dephosphorylation. In mammals, however, no tyrosine-specific phosphatase has been identified molecularly to dephosphorylate MAPK in vivo. Recently, we and others have cloned a murine tyrosine-specific phosphatase, PTPBR7/PTP-SL, which is expressed predominantly in the brain. Here we report inactivation of the extracellular signal-regulated kinase (ERK) family MAPK by PTPBR7. PTPBR7 made complexes with ERK1/ERK2 in vivo and dephosphorylated ERK1 in vitro. When overexpressed in mammalian cells, wild-type PTPBR7 suppressed the phosphorylation and activation of ERK by epidermal growth factor (EGF), nerve growth factor (NGF), and constitutively active MEK1, a mutant MAPK kinase. In contrast, catalytically inactive and ERK-binding-deficient mutants revealed little inhibition on the ERK cascade. These results indicate that PTPBR7 suppresses MAPK directly in vivo.</td>\n",
       "    </tr>\n",
       "  </tbody>\n",
       "</table>\n",
       "</div>"
      ],
      "text/plain": [
       "     entityMentionsCount hasTriggerWord  \\\n",
       "2343                   7           True   \n",
       "6673                   7           True   \n",
       "6672                   7           True   \n",
       "6671                   7           True   \n",
       "6678                   7           True   \n",
       "6669                   7           True   \n",
       "6670                   7           True   \n",
       "6675                   7           True   \n",
       "2342                   7           True   \n",
       "6674                   7           True   \n",
       "\n",
       "                                                interactionId  \\\n",
       "2343  1215357_5915c8fd-34f9-4f9f-804e-3e69e261b551_fake_annot   \n",
       "6673  1215357_990d36fd-8a8a-4af0-9e05-1d3f1a249710_fake_annot   \n",
       "6672  1215357_27782e8a-e47c-476b-8a23-16a08a080cf9_fake_annot   \n",
       "6671  1215357_70e03450-225c-4b3c-881e-c6ad9c916d17_fake_annot   \n",
       "6678  1215357_c27e9df3-32ce-4ae8-9c7c-0d60873f13cf_fake_annot   \n",
       "6669  1215357_ac62b930-c6be-4941-b195-19a692180483_fake_annot   \n",
       "6670  1215357_ced8e4c8-6748-44ea-b926-ff0120160852_fake_annot   \n",
       "6675  1215357_c8f3192e-6335-4f9f-856f-69269404a11d_fake_annot   \n",
       "2342  1215357_90400c1c-3204-425e-8b23-5d6c2768b0b7_fake_annot   \n",
       "6674  1215357_80aa6361-5a08-41ec-8a1d-832851434450_fake_annot   \n",
       "\n",
       "        interactionType isNegative lessThanThreshold  \\\n",
       "2343     ubiquitination       True              True   \n",
       "6673  dephosphorylation       True              True   \n",
       "6672  dephosphorylation       True              True   \n",
       "6671  dephosphorylation       True              True   \n",
       "6678  dephosphorylation       True              True   \n",
       "6669  dephosphorylation       True              True   \n",
       "6670  dephosphorylation       True              True   \n",
       "6675  dephosphorylation       True              True   \n",
       "2342      demethylation       True              True   \n",
       "6674  dephosphorylation       True              True   \n",
       "\n",
       "                                                                                                                                           participant1Alias  \\\n",
       "2343  [[ptprr_mouse], [Receptor-type tyrosine-protein phosphatase R], [Ptprr], [Ptp13], [Phosphotyrosine phosphatase 13], [Protein-tyrosine-phosphatase SL]]   \n",
       "6673                                                                                                                              [NGF, nerve growth factor]   \n",
       "6672                                                                                                                              [NGF, nerve growth factor]   \n",
       "6671                                                                                                                                                  [MEK1]   \n",
       "6678                                                                                                                                                  [MEK1]   \n",
       "6669                                                                                                                              [NGF, nerve growth factor]   \n",
       "6670                                                                                                                                                [PTPBR7]   \n",
       "6675                                                                                                                                                [PTPBR7]   \n",
       "2342  [[ptprr_mouse], [Receptor-type tyrosine-protein phosphatase R], [Ptprr], [Ptp13], [Phosphotyrosine phosphatase 13], [Protein-tyrosine-phosphatase SL]]   \n",
       "6674                                                                                                                              [NGF, nerve growth factor]   \n",
       "\n",
       "     participant1Id  \\\n",
       "2343         Q9QUH9   \n",
       "6673         P01138   \n",
       "6672         P01138   \n",
       "6671         H3BRW9   \n",
       "6678         H3BRW9   \n",
       "6669         P01138   \n",
       "6670         Q7Z2V8   \n",
       "6675         Q7Z2V8   \n",
       "2342         Q9QUH9   \n",
       "6674         P01138   \n",
       "\n",
       "                                                                                                                                                                                                                                         participant2Alias  \\\n",
       "2343  [[mk03_human], [Mitogen-activated protein kinase 3], [ERT2], [MAP kinase isoform p44], [Microtubule-associated protein 2 kinase], [Extracellular signal-regulated kinase 1], [Insulin-stimulated MAP2 kinase], [p44-ERK1], [MAPK3], [ERK1], [PRKM3]]   \n",
       "6673                                                                                                                                                                                                                                              [PTPBR7]   \n",
       "6672                                                                                                                                                                                                                                                [ERK1]   \n",
       "6671                                                                                                                                                                                                                                              [PTPBR7]   \n",
       "6678                                                                                                                                                                                                                                                [ERK1]   \n",
       "6669                                                                                                                                                                                                                                                [MEK1]   \n",
       "6670                                                                                                                                                                                                                                                [ERK1]   \n",
       "6675                                                                                                                                                                                                    [extracellular signal-regulated kinase, ERK, ERK2]   \n",
       "2342  [[mk03_human], [Mitogen-activated protein kinase 3], [ERT2], [MAP kinase isoform p44], [Microtubule-associated protein 2 kinase], [Extracellular signal-regulated kinase 1], [Insulin-stimulated MAP2 kinase], [p44-ERK1], [MAPK3], [ERK1], [PRKM3]]   \n",
       "6674                                                                                                                                                                                                    [extracellular signal-regulated kinase, ERK, ERK2]   \n",
       "\n",
       "     participant2Id  pubmedId pubmedTitle  \\\n",
       "2343         Q8NHX1  10066421        None   \n",
       "6673         Q7Z2V8  10066421        None   \n",
       "6672         Q9BWJ1  10066421        None   \n",
       "6671         Q7Z2V8  10066421        None   \n",
       "6678         Q9BWJ1  10066421        None   \n",
       "6669         H3BRW9  10066421        None   \n",
       "6670         Q9BWJ1  10066421        None   \n",
       "6675         Q499G7  10066421        None   \n",
       "2342         Q8NHX1  10066421        None   \n",
       "6674         Q499G7  10066421        None   \n",
       "\n",
       "                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                          pubmedabstract  \n",
       "2343  Mitogen-activated protein kinase (MAPK) is inactivated through dephosphorylation of tyrosyl and threonyl regulatory sites. In yeast, both dual-specificity and tyrosine-specific phosphatases are involved in dephosphorylation. In mammals, however, no tyrosine-specific phosphatase has been identified molecularly to dephosphorylate MAPK in vivo. Recently, we and others have cloned a murine tyrosine-specific phosphatase, PTPBR7/PTP-SL, which is expressed predominantly in the brain. Here we report inactivation of the extracellular signal-regulated kinase (ERK) family MAPK by PTPBR7. PTPBR7 made complexes with ERK1/ERK2 in vivo and dephosphorylated ERK1 in vitro. When overexpressed in mammalian cells, wild-type PTPBR7 suppressed the phosphorylation and activation of ERK by epidermal growth factor (EGF), nerve growth factor (NGF), and constitutively active MEK1, a mutant MAPK kinase. In contrast, catalytically inactive and ERK-binding-deficient mutants revealed little inhibition on the ERK cascade. These results indicate that PTPBR7 suppresses MAPK directly in vivo.  \n",
       "6673  Mitogen-activated protein kinase (MAPK) is inactivated through dephosphorylation of tyrosyl and threonyl regulatory sites. In yeast, both dual-specificity and tyrosine-specific phosphatases are involved in dephosphorylation. In mammals, however, no tyrosine-specific phosphatase has been identified molecularly to dephosphorylate MAPK in vivo. Recently, we and others have cloned a murine tyrosine-specific phosphatase, PTPBR7/PTP-SL, which is expressed predominantly in the brain. Here we report inactivation of the extracellular signal-regulated kinase (ERK) family MAPK by PTPBR7. PTPBR7 made complexes with ERK1/ERK2 in vivo and dephosphorylated ERK1 in vitro. When overexpressed in mammalian cells, wild-type PTPBR7 suppressed the phosphorylation and activation of ERK by epidermal growth factor (EGF), nerve growth factor (NGF), and constitutively active MEK1, a mutant MAPK kinase. In contrast, catalytically inactive and ERK-binding-deficient mutants revealed little inhibition on the ERK cascade. These results indicate that PTPBR7 suppresses MAPK directly in vivo.  \n",
       "6672  Mitogen-activated protein kinase (MAPK) is inactivated through dephosphorylation of tyrosyl and threonyl regulatory sites. In yeast, both dual-specificity and tyrosine-specific phosphatases are involved in dephosphorylation. In mammals, however, no tyrosine-specific phosphatase has been identified molecularly to dephosphorylate MAPK in vivo. Recently, we and others have cloned a murine tyrosine-specific phosphatase, PTPBR7/PTP-SL, which is expressed predominantly in the brain. Here we report inactivation of the extracellular signal-regulated kinase (ERK) family MAPK by PTPBR7. PTPBR7 made complexes with ERK1/ERK2 in vivo and dephosphorylated ERK1 in vitro. When overexpressed in mammalian cells, wild-type PTPBR7 suppressed the phosphorylation and activation of ERK by epidermal growth factor (EGF), nerve growth factor (NGF), and constitutively active MEK1, a mutant MAPK kinase. In contrast, catalytically inactive and ERK-binding-deficient mutants revealed little inhibition on the ERK cascade. These results indicate that PTPBR7 suppresses MAPK directly in vivo.  \n",
       "6671  Mitogen-activated protein kinase (MAPK) is inactivated through dephosphorylation of tyrosyl and threonyl regulatory sites. In yeast, both dual-specificity and tyrosine-specific phosphatases are involved in dephosphorylation. In mammals, however, no tyrosine-specific phosphatase has been identified molecularly to dephosphorylate MAPK in vivo. Recently, we and others have cloned a murine tyrosine-specific phosphatase, PTPBR7/PTP-SL, which is expressed predominantly in the brain. Here we report inactivation of the extracellular signal-regulated kinase (ERK) family MAPK by PTPBR7. PTPBR7 made complexes with ERK1/ERK2 in vivo and dephosphorylated ERK1 in vitro. When overexpressed in mammalian cells, wild-type PTPBR7 suppressed the phosphorylation and activation of ERK by epidermal growth factor (EGF), nerve growth factor (NGF), and constitutively active MEK1, a mutant MAPK kinase. In contrast, catalytically inactive and ERK-binding-deficient mutants revealed little inhibition on the ERK cascade. These results indicate that PTPBR7 suppresses MAPK directly in vivo.  \n",
       "6678  Mitogen-activated protein kinase (MAPK) is inactivated through dephosphorylation of tyrosyl and threonyl regulatory sites. In yeast, both dual-specificity and tyrosine-specific phosphatases are involved in dephosphorylation. In mammals, however, no tyrosine-specific phosphatase has been identified molecularly to dephosphorylate MAPK in vivo. Recently, we and others have cloned a murine tyrosine-specific phosphatase, PTPBR7/PTP-SL, which is expressed predominantly in the brain. Here we report inactivation of the extracellular signal-regulated kinase (ERK) family MAPK by PTPBR7. PTPBR7 made complexes with ERK1/ERK2 in vivo and dephosphorylated ERK1 in vitro. When overexpressed in mammalian cells, wild-type PTPBR7 suppressed the phosphorylation and activation of ERK by epidermal growth factor (EGF), nerve growth factor (NGF), and constitutively active MEK1, a mutant MAPK kinase. In contrast, catalytically inactive and ERK-binding-deficient mutants revealed little inhibition on the ERK cascade. These results indicate that PTPBR7 suppresses MAPK directly in vivo.  \n",
       "6669  Mitogen-activated protein kinase (MAPK) is inactivated through dephosphorylation of tyrosyl and threonyl regulatory sites. In yeast, both dual-specificity and tyrosine-specific phosphatases are involved in dephosphorylation. In mammals, however, no tyrosine-specific phosphatase has been identified molecularly to dephosphorylate MAPK in vivo. Recently, we and others have cloned a murine tyrosine-specific phosphatase, PTPBR7/PTP-SL, which is expressed predominantly in the brain. Here we report inactivation of the extracellular signal-regulated kinase (ERK) family MAPK by PTPBR7. PTPBR7 made complexes with ERK1/ERK2 in vivo and dephosphorylated ERK1 in vitro. When overexpressed in mammalian cells, wild-type PTPBR7 suppressed the phosphorylation and activation of ERK by epidermal growth factor (EGF), nerve growth factor (NGF), and constitutively active MEK1, a mutant MAPK kinase. In contrast, catalytically inactive and ERK-binding-deficient mutants revealed little inhibition on the ERK cascade. These results indicate that PTPBR7 suppresses MAPK directly in vivo.  \n",
       "6670  Mitogen-activated protein kinase (MAPK) is inactivated through dephosphorylation of tyrosyl and threonyl regulatory sites. In yeast, both dual-specificity and tyrosine-specific phosphatases are involved in dephosphorylation. In mammals, however, no tyrosine-specific phosphatase has been identified molecularly to dephosphorylate MAPK in vivo. Recently, we and others have cloned a murine tyrosine-specific phosphatase, PTPBR7/PTP-SL, which is expressed predominantly in the brain. Here we report inactivation of the extracellular signal-regulated kinase (ERK) family MAPK by PTPBR7. PTPBR7 made complexes with ERK1/ERK2 in vivo and dephosphorylated ERK1 in vitro. When overexpressed in mammalian cells, wild-type PTPBR7 suppressed the phosphorylation and activation of ERK by epidermal growth factor (EGF), nerve growth factor (NGF), and constitutively active MEK1, a mutant MAPK kinase. In contrast, catalytically inactive and ERK-binding-deficient mutants revealed little inhibition on the ERK cascade. These results indicate that PTPBR7 suppresses MAPK directly in vivo.  \n",
       "6675  Mitogen-activated protein kinase (MAPK) is inactivated through dephosphorylation of tyrosyl and threonyl regulatory sites. In yeast, both dual-specificity and tyrosine-specific phosphatases are involved in dephosphorylation. In mammals, however, no tyrosine-specific phosphatase has been identified molecularly to dephosphorylate MAPK in vivo. Recently, we and others have cloned a murine tyrosine-specific phosphatase, PTPBR7/PTP-SL, which is expressed predominantly in the brain. Here we report inactivation of the extracellular signal-regulated kinase (ERK) family MAPK by PTPBR7. PTPBR7 made complexes with ERK1/ERK2 in vivo and dephosphorylated ERK1 in vitro. When overexpressed in mammalian cells, wild-type PTPBR7 suppressed the phosphorylation and activation of ERK by epidermal growth factor (EGF), nerve growth factor (NGF), and constitutively active MEK1, a mutant MAPK kinase. In contrast, catalytically inactive and ERK-binding-deficient mutants revealed little inhibition on the ERK cascade. These results indicate that PTPBR7 suppresses MAPK directly in vivo.  \n",
       "2342  Mitogen-activated protein kinase (MAPK) is inactivated through dephosphorylation of tyrosyl and threonyl regulatory sites. In yeast, both dual-specificity and tyrosine-specific phosphatases are involved in dephosphorylation. In mammals, however, no tyrosine-specific phosphatase has been identified molecularly to dephosphorylate MAPK in vivo. Recently, we and others have cloned a murine tyrosine-specific phosphatase, PTPBR7/PTP-SL, which is expressed predominantly in the brain. Here we report inactivation of the extracellular signal-regulated kinase (ERK) family MAPK by PTPBR7. PTPBR7 made complexes with ERK1/ERK2 in vivo and dephosphorylated ERK1 in vitro. When overexpressed in mammalian cells, wild-type PTPBR7 suppressed the phosphorylation and activation of ERK by epidermal growth factor (EGF), nerve growth factor (NGF), and constitutively active MEK1, a mutant MAPK kinase. In contrast, catalytically inactive and ERK-binding-deficient mutants revealed little inhibition on the ERK cascade. These results indicate that PTPBR7 suppresses MAPK directly in vivo.  \n",
       "6674  Mitogen-activated protein kinase (MAPK) is inactivated through dephosphorylation of tyrosyl and threonyl regulatory sites. In yeast, both dual-specificity and tyrosine-specific phosphatases are involved in dephosphorylation. In mammals, however, no tyrosine-specific phosphatase has been identified molecularly to dephosphorylate MAPK in vivo. Recently, we and others have cloned a murine tyrosine-specific phosphatase, PTPBR7/PTP-SL, which is expressed predominantly in the brain. Here we report inactivation of the extracellular signal-regulated kinase (ERK) family MAPK by PTPBR7. PTPBR7 made complexes with ERK1/ERK2 in vivo and dephosphorylated ERK1 in vitro. When overexpressed in mammalian cells, wild-type PTPBR7 suppressed the phosphorylation and activation of ERK by epidermal growth factor (EGF), nerve growth factor (NGF), and constitutively active MEK1, a mutant MAPK kinase. In contrast, catalytically inactive and ERK-binding-deficient mutants revealed little inhibition on the ERK cascade. These results indicate that PTPBR7 suppresses MAPK directly in vivo.  "
      ]
     },
     "execution_count": 38,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "train.sort_values(by=[\"pubmedId\"]).query(\"interactionType != 'phosphorylation'\").head(n=10)"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 39,
   "metadata": {},
   "outputs": [
    {
     "data": {
      "image/png": "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\n",
      "text/plain": [
       "<Figure size 576x216 with 2 Axes>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    }
   ],
   "source": [
    "import matplotlib.pyplot as plt\n",
    "fig, ax = plt.subplots( 1,2, figsize=(8,3))\n",
    "\n",
    "#fig, ax = plt.subplots( 7,1, figsize=(45,30))\n",
    "train.groupby(['interactionType', 'isNegative']).size().unstack().plot.bar(ax=ax[0])\n",
    "ax[0].set_title( \"Training set\")\n",
    "\n",
    "\n",
    "val.groupby(['interactionType', 'isNegative']).size().unstack().plot.bar(ax=ax[1])\n",
    "ax[1].set_title( \"Validation set\")\n",
    "\n",
    "\n",
    "plt.savefig(\"NegativeSample.svg\",bbox_inches = \"tight\")\n",
    "plt.show()"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 40,
   "metadata": {},
   "outputs": [
    {
     "data": {
      "text/plain": [
       "isNegative  interactionType  \n",
       "False       acetylation            14\n",
       "            demethylation           2\n",
       "            dephosphorylation      30\n",
       "            deubiquitination        9\n",
       "            methylation            17\n",
       "            phosphorylation       268\n",
       "            ubiquitination         61\n",
       "True        acetylation           284\n",
       "            demethylation         284\n",
       "            dephosphorylation     404\n",
       "            deubiquitination      275\n",
       "            methylation           310\n",
       "            phosphorylation      1156\n",
       "            ubiquitination        411\n",
       "dtype: int64"
      ]
     },
     "execution_count": 40,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "val.groupby(['isNegative', 'interactionType']).size()"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 50,
   "metadata": {},
   "outputs": [
    {
     "data": {
      "image/png": "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\n",
      "text/plain": [
       "<Figure size 360x360 with 1 Axes>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    }
   ],
   "source": [
    "import matplotlib.pyplot as plt\n",
    "val.isNegative.value_counts().plot.pie(autopct='%.2f',figsize=(5, 5))\n",
    "plt.savefig(\"Interaction.png\")"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": null,
   "metadata": {},
   "outputs": [],
   "source": []
  },
  {
   "cell_type": "code",
   "execution_count": 42,
   "metadata": {},
   "outputs": [],
   "source": [
    "train.to_json(\"train.json\")\n",
    "test.to_json(\"test.json\")\n",
    "val.to_json(\"val.json\")"
   ]
  },
  {
   "cell_type": "markdown",
   "metadata": {},
   "source": [
    "### Train val split such that the pubmedid do not overladp"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 43,
   "metadata": {},
   "outputs": [],
   "source": [
    "from sklearn.model_selection import train_test_split\n",
    "trainpubmed, testpubmed = train_test_split(data_filtered.pubmedId.unique(), test_size=.2,\n",
    "                                                        random_state=777)\n",
    "\n",
    "trainpubmed, valpubmed = train_test_split(trainpubmed, test_size=.2,\n",
    "                                                        random_state=777)"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 44,
   "metadata": {},
   "outputs": [
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "Unique pubmeds in train 521, test 164 and val 131\n"
     ]
    }
   ],
   "source": [
    "print(\"Unique pubmeds in train {}, test {} and val {}\".format(len(trainpubmed), len(testpubmed),len(valpubmed)))"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 45,
   "metadata": {},
   "outputs": [],
   "source": [
    "train = data_filtered[data_filtered['pubmedId'].isin(trainpubmed)]\n",
    "test = data_filtered[data_filtered['pubmedId'].isin(testpubmed)]\n",
    "val = data_filtered[data_filtered['pubmedId'].isin(valpubmed)]\n",
    "\n"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 46,
   "metadata": {},
   "outputs": [
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "The total number of train records including fake records 7261\n",
      "The total number of test records including fake records 2450\n",
      "The total number of val records including fake records 1717\n"
     ]
    }
   ],
   "source": [
    "\n",
    "train = generate_negative(train,  annotations_file)\n",
    "print(\"The total number of train records including fake records {}\".format(train.shape[0]))\n",
    "\n",
    "\n",
    "\n",
    "test = generate_negative(test,  annotations_file)\n",
    "print(\"The total number of test records including fake records {}\".format(test.shape[0]))\n",
    "\n",
    "\n",
    "val = generate_negative(val, annotations_file)\n",
    "print(\"The total number of val records including fake records {}\".format(val.shape[0]))"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 47,
   "metadata": {},
   "outputs": [
    {
     "data": {
      "text/plain": [
       "<matplotlib.axes._subplots.AxesSubplot at 0x1149dd860>"
      ]
     },
     "execution_count": 47,
     "metadata": {},
     "output_type": "execute_result"
    },
    {
     "data": {
      "image/png": "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\n",
      "text/plain": [
       "<Figure size 3600x2160 with 3 Axes>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    }
   ],
   "source": [
    "import matplotlib.pyplot as plt\n",
    "fig, ax = plt.subplots( 3,1, figsize=(50,30))\n",
    "train.isNegative.value_counts().plot.pie(autopct='%.2f',ax=ax[1])\n",
    "\n",
    "\n",
    "val.isNegative.value_counts().plot.pie(autopct='%.2f',ax=ax[0])\n",
    "\n",
    "test.isNegative.value_counts().plot.pie(autopct='%.2f',ax=ax[2])"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 48,
   "metadata": {},
   "outputs": [],
   "source": [
    "train.to_json(\"train_unique_pub.json\")\n",
    "test.to_json(\"test_unique_pub.json\")\n",
    "val.to_json(\"val_unique_pub.json\")"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 49,
   "metadata": {},
   "outputs": [
    {
     "data": {
      "text/html": [
       "<div>\n",
       "<style scoped>\n",
       "    .dataframe tbody tr th:only-of-type {\n",
       "        vertical-align: middle;\n",
       "    }\n",
       "\n",
       "    .dataframe tbody tr th {\n",
       "        vertical-align: top;\n",
       "    }\n",
       "\n",
       "    .dataframe thead th {\n",
       "        text-align: right;\n",
       "    }\n",
       "</style>\n",
       "<table border=\"1\" class=\"dataframe\">\n",
       "  <thead>\n",
       "    <tr style=\"text-align: right;\">\n",
       "      <th></th>\n",
       "      <th>entityMentionsCount</th>\n",
       "      <th>hasTriggerWord</th>\n",
       "      <th>interactionId</th>\n",
       "      <th>interactionType</th>\n",
       "      <th>isNegative</th>\n",
       "      <th>lessThanThreshold</th>\n",
       "      <th>participant1Alias</th>\n",
       "      <th>participant1Id</th>\n",
       "      <th>participant2Alias</th>\n",
       "      <th>participant2Id</th>\n",
       "      <th>pubmedId</th>\n",
       "      <th>pubmedTitle</th>\n",
       "      <th>pubmedabstract</th>\n",
       "    </tr>\n",
       "  </thead>\n",
       "  <tbody>\n",
       "    <tr>\n",
       "      <th>0</th>\n",
       "      <td>4</td>\n",
       "      <td>True</td>\n",
       "      <td>1160335_8d8d2388-d4c6-4281-a673-13b5c23b18eb_fake_annot</td>\n",
       "      <td>acetylation</td>\n",
       "      <td>True</td>\n",
       "      <td>True</td>\n",
       "      <td>[[akt1_human], [RAC-alpha serine/threonine-protein kinase], [AKT1], [PKB], [RAC], [RAC-PK-alpha], [Protein kinase B], [Proto-oncogene c-Akt], [Protein kinase B alpha]]</td>\n",
       "      <td>B7Z5R1</td>\n",
       "      <td>[[vime_human], [Vimentin], [VIM]]</td>\n",
       "      <td>Q9NTM3</td>\n",
       "      <td>20856200</td>\n",
       "      <td>None</td>\n",
       "      <td>The PI3K/AKT signaling pathway is aberrant in a wide variety of cancers. Downstream effectors of AKT are involved in survival, growth and metabolic-related pathways. In contrast, contradictory data relating to AKT effects on cell motility and invasion, crucial prometastatic processes, have been reported pointing to a potential cell type and isoform type-specific AKT-driven function. By implication, study of AKT signaling should optimally be conducted in an appropriate intracellular environment. Prognosis in soft-tissue sarcoma (STS), the aggressive malignancies of mesenchymal origin, is poor, reflecting our modest ability to control metastasis, an effort hampered by lack of insight into molecular mechanisms driving STS progression and dissemination. We examined the impact of the cancer progression-relevant AKT pathway on the mesenchymal tumor cell internal milieu. We demonstrate that AKT1 activation induces STS cell motility and invasiveness at least partially through a novel interaction with the intermediate filament vimentin (Vim). The binding of AKT (tail region) to Vim (head region) results in Vim Ser39 phosphorylation enhancing the ability of Vim to induce motility and invasion while protecting Vim from caspase-induced proteolysis. Moreover, vimentin phosphorylation was shown to enhance tumor and metastasis growth in vivo. Insights into this mesenchymal-related molecular mechanism may facilitate the development of critically lacking therapeutic options for these devastating malignancies.</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>1</th>\n",
       "      <td>4</td>\n",
       "      <td>True</td>\n",
       "      <td>1160335_fc1cf105-2b36-4678-96c4-b9113b2f40da_fake_annot</td>\n",
       "      <td>deubiquitination</td>\n",
       "      <td>True</td>\n",
       "      <td>True</td>\n",
       "      <td>[[akt1_human], [RAC-alpha serine/threonine-protein kinase], [AKT1], [PKB], [RAC], [RAC-PK-alpha], [Protein kinase B], [Proto-oncogene c-Akt], [Protein kinase B alpha]]</td>\n",
       "      <td>B7Z5R1</td>\n",
       "      <td>[[vime_human], [Vimentin], [VIM]]</td>\n",
       "      <td>Q9NTM3</td>\n",
       "      <td>20856200</td>\n",
       "      <td>None</td>\n",
       "      <td>The PI3K/AKT signaling pathway is aberrant in a wide variety of cancers. Downstream effectors of AKT are involved in survival, growth and metabolic-related pathways. In contrast, contradictory data relating to AKT effects on cell motility and invasion, crucial prometastatic processes, have been reported pointing to a potential cell type and isoform type-specific AKT-driven function. By implication, study of AKT signaling should optimally be conducted in an appropriate intracellular environment. Prognosis in soft-tissue sarcoma (STS), the aggressive malignancies of mesenchymal origin, is poor, reflecting our modest ability to control metastasis, an effort hampered by lack of insight into molecular mechanisms driving STS progression and dissemination. We examined the impact of the cancer progression-relevant AKT pathway on the mesenchymal tumor cell internal milieu. We demonstrate that AKT1 activation induces STS cell motility and invasiveness at least partially through a novel interaction with the intermediate filament vimentin (Vim). The binding of AKT (tail region) to Vim (head region) results in Vim Ser39 phosphorylation enhancing the ability of Vim to induce motility and invasion while protecting Vim from caspase-induced proteolysis. Moreover, vimentin phosphorylation was shown to enhance tumor and metastasis growth in vivo. Insights into this mesenchymal-related molecular mechanism may facilitate the development of critically lacking therapeutic options for these devastating malignancies.</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>2</th>\n",
       "      <td>4</td>\n",
       "      <td>True</td>\n",
       "      <td>1160335_5972a1a1-2098-4f55-b30d-aaf258b83517_fake_annot</td>\n",
       "      <td>dephosphorylation</td>\n",
       "      <td>True</td>\n",
       "      <td>True</td>\n",
       "      <td>[[akt1_human], [RAC-alpha serine/threonine-protein kinase], [AKT1], [PKB], [RAC], [RAC-PK-alpha], [Protein kinase B], [Proto-oncogene c-Akt], [Protein kinase B alpha]]</td>\n",
       "      <td>B7Z5R1</td>\n",
       "      <td>[[vime_human], [Vimentin], [VIM]]</td>\n",
       "      <td>Q9NTM3</td>\n",
       "      <td>20856200</td>\n",
       "      <td>None</td>\n",
       "      <td>The PI3K/AKT signaling pathway is aberrant in a wide variety of cancers. Downstream effectors of AKT are involved in survival, growth and metabolic-related pathways. In contrast, contradictory data relating to AKT effects on cell motility and invasion, crucial prometastatic processes, have been reported pointing to a potential cell type and isoform type-specific AKT-driven function. By implication, study of AKT signaling should optimally be conducted in an appropriate intracellular environment. Prognosis in soft-tissue sarcoma (STS), the aggressive malignancies of mesenchymal origin, is poor, reflecting our modest ability to control metastasis, an effort hampered by lack of insight into molecular mechanisms driving STS progression and dissemination. We examined the impact of the cancer progression-relevant AKT pathway on the mesenchymal tumor cell internal milieu. We demonstrate that AKT1 activation induces STS cell motility and invasiveness at least partially through a novel interaction with the intermediate filament vimentin (Vim). The binding of AKT (tail region) to Vim (head region) results in Vim Ser39 phosphorylation enhancing the ability of Vim to induce motility and invasion while protecting Vim from caspase-induced proteolysis. Moreover, vimentin phosphorylation was shown to enhance tumor and metastasis growth in vivo. Insights into this mesenchymal-related molecular mechanism may facilitate the development of critically lacking therapeutic options for these devastating malignancies.</td>\n",
       "    </tr>\n",
       "  </tbody>\n",
       "</table>\n",
       "</div>"
      ],
      "text/plain": [
       "  entityMentionsCount hasTriggerWord  \\\n",
       "0                   4           True   \n",
       "1                   4           True   \n",
       "2                   4           True   \n",
       "\n",
       "                                             interactionId    interactionType  \\\n",
       "0  1160335_8d8d2388-d4c6-4281-a673-13b5c23b18eb_fake_annot        acetylation   \n",
       "1  1160335_fc1cf105-2b36-4678-96c4-b9113b2f40da_fake_annot   deubiquitination   \n",
       "2  1160335_5972a1a1-2098-4f55-b30d-aaf258b83517_fake_annot  dephosphorylation   \n",
       "\n",
       "  isNegative lessThanThreshold  \\\n",
       "0       True              True   \n",
       "1       True              True   \n",
       "2       True              True   \n",
       "\n",
       "                                                                                                                                                         participant1Alias  \\\n",
       "0  [[akt1_human], [RAC-alpha serine/threonine-protein kinase], [AKT1], [PKB], [RAC], [RAC-PK-alpha], [Protein kinase B], [Proto-oncogene c-Akt], [Protein kinase B alpha]]   \n",
       "1  [[akt1_human], [RAC-alpha serine/threonine-protein kinase], [AKT1], [PKB], [RAC], [RAC-PK-alpha], [Protein kinase B], [Proto-oncogene c-Akt], [Protein kinase B alpha]]   \n",
       "2  [[akt1_human], [RAC-alpha serine/threonine-protein kinase], [AKT1], [PKB], [RAC], [RAC-PK-alpha], [Protein kinase B], [Proto-oncogene c-Akt], [Protein kinase B alpha]]   \n",
       "\n",
       "  participant1Id                  participant2Alias participant2Id  pubmedId  \\\n",
       "0         B7Z5R1  [[vime_human], [Vimentin], [VIM]]         Q9NTM3  20856200   \n",
       "1         B7Z5R1  [[vime_human], [Vimentin], [VIM]]         Q9NTM3  20856200   \n",
       "2         B7Z5R1  [[vime_human], [Vimentin], [VIM]]         Q9NTM3  20856200   \n",
       "\n",
       "  pubmedTitle  \\\n",
       "0        None   \n",
       "1        None   \n",
       "2        None   \n",
       "\n",
       "                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                  pubmedabstract  \n",
       "0  The PI3K/AKT signaling pathway is aberrant in a wide variety of cancers. Downstream effectors of AKT are involved in survival, growth and metabolic-related pathways. In contrast, contradictory data relating to AKT effects on cell motility and invasion, crucial prometastatic processes, have been reported pointing to a potential cell type and isoform type-specific AKT-driven function. By implication, study of AKT signaling should optimally be conducted in an appropriate intracellular environment. Prognosis in soft-tissue sarcoma (STS), the aggressive malignancies of mesenchymal origin, is poor, reflecting our modest ability to control metastasis, an effort hampered by lack of insight into molecular mechanisms driving STS progression and dissemination. We examined the impact of the cancer progression-relevant AKT pathway on the mesenchymal tumor cell internal milieu. We demonstrate that AKT1 activation induces STS cell motility and invasiveness at least partially through a novel interaction with the intermediate filament vimentin (Vim). The binding of AKT (tail region) to Vim (head region) results in Vim Ser39 phosphorylation enhancing the ability of Vim to induce motility and invasion while protecting Vim from caspase-induced proteolysis. Moreover, vimentin phosphorylation was shown to enhance tumor and metastasis growth in vivo. Insights into this mesenchymal-related molecular mechanism may facilitate the development of critically lacking therapeutic options for these devastating malignancies.  \n",
       "1  The PI3K/AKT signaling pathway is aberrant in a wide variety of cancers. Downstream effectors of AKT are involved in survival, growth and metabolic-related pathways. In contrast, contradictory data relating to AKT effects on cell motility and invasion, crucial prometastatic processes, have been reported pointing to a potential cell type and isoform type-specific AKT-driven function. By implication, study of AKT signaling should optimally be conducted in an appropriate intracellular environment. Prognosis in soft-tissue sarcoma (STS), the aggressive malignancies of mesenchymal origin, is poor, reflecting our modest ability to control metastasis, an effort hampered by lack of insight into molecular mechanisms driving STS progression and dissemination. We examined the impact of the cancer progression-relevant AKT pathway on the mesenchymal tumor cell internal milieu. We demonstrate that AKT1 activation induces STS cell motility and invasiveness at least partially through a novel interaction with the intermediate filament vimentin (Vim). The binding of AKT (tail region) to Vim (head region) results in Vim Ser39 phosphorylation enhancing the ability of Vim to induce motility and invasion while protecting Vim from caspase-induced proteolysis. Moreover, vimentin phosphorylation was shown to enhance tumor and metastasis growth in vivo. Insights into this mesenchymal-related molecular mechanism may facilitate the development of critically lacking therapeutic options for these devastating malignancies.  \n",
       "2  The PI3K/AKT signaling pathway is aberrant in a wide variety of cancers. Downstream effectors of AKT are involved in survival, growth and metabolic-related pathways. In contrast, contradictory data relating to AKT effects on cell motility and invasion, crucial prometastatic processes, have been reported pointing to a potential cell type and isoform type-specific AKT-driven function. By implication, study of AKT signaling should optimally be conducted in an appropriate intracellular environment. Prognosis in soft-tissue sarcoma (STS), the aggressive malignancies of mesenchymal origin, is poor, reflecting our modest ability to control metastasis, an effort hampered by lack of insight into molecular mechanisms driving STS progression and dissemination. We examined the impact of the cancer progression-relevant AKT pathway on the mesenchymal tumor cell internal milieu. We demonstrate that AKT1 activation induces STS cell motility and invasiveness at least partially through a novel interaction with the intermediate filament vimentin (Vim). The binding of AKT (tail region) to Vim (head region) results in Vim Ser39 phosphorylation enhancing the ability of Vim to induce motility and invasion while protecting Vim from caspase-induced proteolysis. Moreover, vimentin phosphorylation was shown to enhance tumor and metastasis growth in vivo. Insights into this mesenchymal-related molecular mechanism may facilitate the development of critically lacking therapeutic options for these devastating malignancies.  "
      ]
     },
     "execution_count": 49,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "train.head(n=3)"
   ]
  }
 ],
 "metadata": {
  "kernelspec": {
   "display_name": "Python 3",
   "language": "python",
   "name": "python3"
  },
  "language_info": {
   "codemirror_mode": {
    "name": "ipython",
    "version": 3
   },
   "file_extension": ".py",
   "mimetype": "text/x-python",
   "name": "python",
   "nbconvert_exporter": "python",
   "pygments_lexer": "ipython3",
   "version": "3.6.4"
  }
 },
 "nbformat": 4,
 "nbformat_minor": 1
}
